Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,transmitter-gated ion channel activity (GO:0022824),-0.6323589276274507,-2.0433187599913363,0.0,0.012214048170916054,0.012,20/29,22.74%,GRIK2;GRID2;GABRG3;GRIA2;GABRB1;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GLRA3;GLRA2;GABRB2;GABRA1;GABRE;GRIA4;GRIK5;GABRB3;CHRNB1
prerank,"3',5'-cyclic-AMP phosphodiesterase activity (GO:0004115)",-0.7990219231488179,-1.9842098565170538,0.0028089887640449437,0.029517283079713796,0.051,9/12,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE4B;PDE2A
prerank,amino acid:sodium symporter activity (GO:0005283),-0.8101703119815429,-1.981937975159937,0.0,0.020696026067385537,0.053,7/11,14.33%,SLC1A3;SLC6A13;SLC6A12;SLC1A2;SLC1A1;SLC6A1;SLC6A15
prerank,phosphatidate phosphatase activity (GO:0008195),0.8649702190680186,1.9180323183523775,0.0032679738562091504,0.3891826044585211,0.278,1/13,0.01%,PLPPR2
prerank,lipid phosphatase activity (GO:0042577),0.8477726183438675,1.8951486998055438,0.003236245954692557,0.30826836399074187,0.384,1/14,0.01%,PLPPR2
prerank,platelet-derived growth factor binding (GO:0048407),-0.766929919851275,-1.8861054384166565,0.0,0.06361483422352111,0.199,6/11,3.97%,PDGFRB;COL1A2;COL1A1;COL5A1;PDGFRA;COL4A1
prerank,inhibitory extracellular ligand-gated ion channel activity (GO:0005237),-0.7167762961060484,-1.864485898080519,0.005305039787798408,0.06880580469616043,0.26,10/13,19.24%,GABRG3;GLRA1;GABRG2;GABRG1;GABRA3;GLRA3;GLRA2;GABRA1;GLRB;GABRE
prerank,cAMP binding (GO:0030552),-0.7671443057418621,-1.8598649553127107,0.0,0.06174879908629783,0.273,7/11,9.95%,RAPGEF2;PDE4D;PDE4A;PDE10A;PDE4B;CNBD2;PDE2A
prerank,mitogen-activated protein kinase kinase kinase binding (GO:0031435),-0.7386436985999846,-1.8471791581020736,0.0,0.060779430183844164,0.311,4/11,10.65%,SASH1;DAB2IP;ROR2;TRAF6
prerank,outward rectifier potassium channel activity (GO:0015271),-0.7353648824638196,-1.822479720789831,0.002652519893899204,0.07315705935704928,0.404,4/11,4.78%,KCNK2;KCNT2;KCND2;PKD2
prerank,C-C chemokine receptor activity (GO:0016493),0.7730126034652353,1.8165691087848277,0.010294117647058823,0.644666423031632,0.776,8/21,6.18%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;GPR75
prerank,retinoic acid binding (GO:0001972),-0.7081690992143648,-1.7952271385126315,0.007575757575757576,0.08923040747085895,0.502,2/12,5.05%,NR2F2;CYP26B1
prerank,androgen receptor binding (GO:0050681),0.7253492197104816,1.79405453469665,0.008915304606240713,0.6289468875624314,0.864,14/25,20.25%,PRKCB;DAXX;DDX5;EP300;TGFB1I1;KDM3A;KDM4C;SMARCA4;FOXP1;KDM1A;PRPF6;PARK7;ZBTB7A;PRMT2
prerank,tropomyosin binding (GO:0005523),0.8072042515222903,1.7931137887544066,0.012195121951219513,0.5083201364356195,0.866,6/16,5.10%,CALD1;NEBL;TMOD3;S100A6;TMOD2;LMOD3
prerank,chemokine receptor activity (GO:0004950),0.7358637689199133,1.7627711344051917,0.013100436681222707,0.5870832825760344,0.929,8/24,6.18%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2;GPR75
prerank,neurotransmitter receptor activity involved in regulation of postsynaptic membrane potential (GO:0099529),-0.6057259128459032,-1.7529427387312095,0.0030211480362537764,0.1280439383251033,0.657,13/19,22.74%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GABRA1;GABRE;GRIK5;CHRNB1
prerank,L-glutamate transmembrane transporter activity (GO:0005313),-0.6703774224890398,-1.7373477123045633,0.0058309037900874635,0.13361428453638471,0.702,5/14,9.99%,SLC7A11;SLC1A3;SLC1A2;SLC1A1;SLC17A6
prerank,C-C chemokine binding (GO:0019957),0.7251234333354662,1.7310802691035252,0.017467248908296942,0.6783747802934061,0.971,7/22,5.95%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2
prerank,protein binding involved in heterotypic cell-cell adhesion (GO:0086080),0.8172816866457207,1.7214365895046957,0.013769363166953529,0.6445836886344256,0.984,3/10,2.15%,CXADR;DSG2;CD200
prerank,disordered domain specific binding (GO:0097718),0.7116212266918647,1.7168541861087532,0.019943019943019943,0.597121722770401,0.985,2/23,1.24%,FN1;NCOA3
prerank,GABA-gated chloride ion channel activity (GO:0022851),-0.6805484322333928,-1.702207843253542,0.007537688442211055,0.16777352279216634,0.807,9/12,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,calcium:sodium antiporter activity (GO:0005432),-0.7117081749872007,-1.6969515927375083,0.016587677725118485,0.1618361382646377,0.82,4/10,8.59%,SLC24A3;SLC8A1;SLC8A3;SLC24A2
prerank,potassium:proton antiporter activity (GO:0015386),0.8442796097268979,1.692601965364872,0.010380622837370242,0.6609154586429529,0.997,2/10,0.16%,SLC9A2;SLC9A4
prerank,death domain binding (GO:0070513),0.808902898506348,1.6874285733702408,0.01129032258064516,0.624027951583074,0.998,1/11,0.02%,DAPL1
prerank,5'-nucleotidase activity (GO:0008253),0.7725494698389582,1.686469263365416,0.028286189683860232,0.5768242173224509,0.998,4/13,6.85%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,GABA-A receptor activity (GO:0004890),-0.5898789325782031,-1.67664513349724,0.014534883720930232,0.17972099451490764,0.873,9/18,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GABRB2;GABRA1;GABRE;GABRB3
prerank,serine-type peptidase activity (GO:0008236),0.5719510951966886,1.6728421723461793,0.0033482142857142855,0.5952294386086565,0.998,14/96,10.79%,DPP4;KLK11;KLK10;PIK3IP1;MMP9;HPN;PRSS12;PRSS36;GZMM;NAALAD2;PREP;KLK1;HP;HPR
prerank,transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential (GO:1904315),-0.5271644559896284,-1.672789908017106,0.003787878787878788,0.17303234908797743,0.88,13/28,22.74%,GRIK2;GRID2;GABRG3;GRIK3;GABRG2;GABRG1;GRIK1;GABRA3;GRIK4;GABRA1;GABRE;GRIK5;CHRNB1
prerank,cadherin binding involved in cell-cell adhesion (GO:0098641),0.7354188892020295,1.6645055500157726,0.015037593984962405,0.5898726136818474,0.999,6/18,6.90%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;S100A11;ANXA2
prerank,sodium:proton antiporter activity (GO:0015385),0.809415059647861,1.6572054695116887,0.021922428330522766,0.5817882811548301,0.999,2/11,0.16%,SLC9A2;SLC9A4
prerank,monovalent cation:proton antiporter activity (GO:0005451),0.7845240232562924,1.6541125784856783,0.02618657937806874,0.5576505207698866,0.999,2/12,0.16%,SLC9A2;SLC9A4
prerank,sterol transfer activity (GO:0120015),-0.5813166712922159,-1.6479238436708399,0.029585798816568046,0.19930527562229164,0.923,5/17,10.44%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,glutamate receptor activity (GO:0008066),-0.5716839632428444,-1.6373559343870727,0.017699115044247787,0.20452543407769233,0.932,13/19,20.40%,GRIK2;GRID2;GRM3;GRM7;GRIA2;GRM8;GRM5;GRIK3;GRIK1;GRIK4;GRM1;GRIA4;GRIK5
prerank,metal ion:proton antiporter activity (GO:0051139),0.7748355457595206,1.6361810030796302,0.0297029702970297,0.6008853267217472,0.999,2/13,0.16%,SLC9A2;SLC9A4
prerank,cholesterol transfer activity (GO:0120020),-0.5906786356328589,-1.6355720578506767,0.03197674418604651,0.19610332896637445,0.935,5/16,10.44%,ABCA1;PLTP;GRAMD1C;MTTP;GRAMD1B
prerank,ligand-gated channel activity (GO:0022834),-0.5124154752534784,-1.6346066599671987,0.018726591760299626,0.1877106350477625,0.936,16/29,25.51%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK1;GRIK4;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,nucleotidase activity (GO:0008252),0.737877509618402,1.6337281158828076,0.03594771241830065,0.5792510929738363,0.999,4/15,6.85%,NT5E;NT5C1A;NT5C3A;NT5C2
prerank,cytokine activity (GO:0005125),0.5408472234555147,1.632405232281333,0.002178649237472767,0.5548255765494867,0.999,19/131,7.96%,WNT16;TNFRSF11B;CRLF1;WNT1;CCL5;WNT10A;IL15;GDF15;WNT11;IL16;WNT6;BMP5;CLCF1;TIMP1;EPO;BMP4;TGFB2;SLURP1;WNT5B
prerank,insulin-like growth factor receptor binding (GO:0005159),-0.6325747948635496,-1.6274890934143498,0.021108179419525065,0.18804544996472838,0.949,6/12,9.34%,IGF1;PIK3R1;INSR;GNAS;IGF2;ARRB1
prerank,cell adhesion mediator activity (GO:0098631),-0.5359449356339396,-1.6244507261184167,0.006993006993006993,0.18316225411861814,0.951,11/24,10.61%,CD47;ESAM;PALLD;EMB;LRRC4C;NEXN;DSCAML1;CNTN6;BSG;NTNG1;ROBO4
prerank,ligand-gated ion channel activity (GO:0015276),-0.5086772837413133,-1.6189034620793161,0.01646090534979424,0.18297939589383708,0.954,16/30,25.51%,GRIK2;GRID2;GRIN2A;GRIA3;GRIA2;GRIN2B;GABRB1;GRIK3;GRIK1;GRIK4;ANXA6;GRIA4;GRIK5;CHRNB1;GRIN3A;CHRNA4
prerank,dipeptidyl-peptidase activity (GO:0008239),0.7806722112947371,1.6109327221534742,0.02702702702702703,0.6206569009623584,1.0,3/10,6.10%,DPP4;DPP7;NAALAD2
prerank,serine-type endopeptidase activity (GO:0004252),0.5575861381818333,1.6107086249884455,0.01611047180667434,0.5927564983844676,1.0,10/80,10.79%,DPP4;PIK3IP1;MMP9;HPN;PRSS12;PRSS36;GZMM;KLK1;HP;HPR
prerank,transmembrane receptor protein kinase activity (GO:0019199),-0.4239680925979781,-1.595583070920122,0.005952380952380952,0.20949747840984273,0.975,28/60,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;ACVRL1;TIE1;PDGFRA;KDR;BMPR1B;ACVR1B;EPHB2;EPHB4;ROR2;NTRK2;ACVR2A;ERBB4;FGFR2;RYK;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,frizzled binding (GO:0005109),0.620007921085021,1.584125655545888,0.037868162692847124,0.6831905668944285,1.0,8/34,7.96%,WNT16;WNT1;WNT10A;WNT11;RNF43;WNT6;DVL3;WNT5B
prerank,protein kinase C binding (GO:0005080),0.5919865413418788,1.580879171241401,0.02574002574002574,0.6703644462334554,1.0,10/43,10.17%,PRKCB;PDLIM5;GRK5;HDAC5;CAVIN2;HSPB1;ADCY6;PARD6B;DACT2;NELL2
prerank,platelet-derived growth factor receptor binding (GO:0005161),-0.6155113270468203,-1.566202896596149,0.02666666666666667,0.24894605126137928,0.99,5/13,3.60%,PDGFRB;PDGFD;PTPRJ;IL1R1;PDGFRA
prerank,extracellular ligand-gated ion channel activity (GO:0005230),-0.6591608647467175,-1.5565374092500999,0.041025641025641026,0.2568614330343646,0.993,6/10,19.24%,GABRG3;GABRG2;GABRG1;GABRA3;GABRA1;GABRE
prerank,sodium ion transmembrane transporter activity (GO:0015081),0.6239874838438987,1.5427463616901305,0.04936530324400564,0.8313979575262923,1.0,2/27,0.16%,SLC9A2;SLC9A4
prerank,receptor antagonist activity (GO:0048019),0.6716483277236083,1.540014928682368,0.058208955223880594,0.8138681934462176,1.0,4/17,6.77%,CCL5;ADH7;IGSF1;PXDN
prerank,enoyl-CoA hydratase activity (GO:0004300),0.7307682556969801,1.5342260235897918,0.05737704918032787,0.8125408791476522,1.0,6/10,17.91%,ECHDC1;EHHADH;HADHA;AUH;HADHB;ECHS1
prerank,chemorepellent activity (GO:0045499),0.6152897291906435,1.531750370749286,0.04836415362731152,0.7946546924558863,1.0,3/25,2.81%,DPP4;SEMA3D;SEMA3B
prerank,potassium ion antiporter activity (GO:0022821),0.6968670433157678,1.5227387093048885,0.05778491171749599,0.8117308093903903,1.0,2/15,0.16%,SLC9A2;SLC9A4
prerank,aminoacyl-tRNA ligase activity (GO:0004812),0.5852765452926537,1.5192470858390834,0.03780964797913951,0.8002755596254741,1.0,21/37,21.36%,EPRS1;QARS1;VARS1;VARS2;FARS2;HARS1;CARS2;NARS2;LARS2;AARS1;HARS2;TARS1;SARS2;SARS1;YARS1;TARS3;FARSA;DARS2;FARSB;NARS1;YARS2
prerank,ionotropic glutamate receptor activity (GO:0004970),-0.5397776566435142,-1.5189411536521236,0.06116207951070336,0.31662571027682385,0.995,8/17,11.93%,GRIK2;GRIN2A;GRIA3;GRIA2;GRIN2B;GRIK3;GRIK1;GRIK4
prerank,glycine binding (GO:0016594),-0.6215316014621953,-1.518340631587353,0.05384615384615385,0.30606746018415876,0.995,10/11,35.07%,GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;GRIN3A;GRIN1;GLDC;GNMT
prerank,ankyrin binding (GO:0030506),0.6519243365412455,1.5181565397209908,0.052316890881913304,0.7787623340236326,1.0,1/19,0.06%,CDH1
prerank,G protein-coupled chemoattractant receptor activity (GO:0001637),0.6777699216518384,1.515075540349413,0.057722308892355696,0.7678285831050893,1.0,4/15,5.95%,CCR4;ACKR4;ACKR2;CCRL2
prerank,exopeptidase activity (GO:0008238),0.5535700993216434,1.511120680937115,0.053549190535491904,0.762138925264953,1.0,6/50,7.08%,DPP4;CPB1;DPP7;NAALAD2;CTSZ;CPE
prerank,G protein-coupled receptor binding (GO:0001664),0.4955505592360672,1.5110013989433726,0.019736842105263157,0.7397056814951809,1.0,21/132,11.37%,WNT16;ITGB4;AGTR1;WNT1;CCL5;WNT10A;PENK;WNT11;ARHGEF12;RNF43;HOMER2;HOMER3;WNT6;CCRL2;DVL3;WNT5B;USP20;GRK2;GNAO1;GNAQ;GNA13
prerank,GABA receptor activity (GO:0016917),-0.5052661247224275,-1.5057429390267403,0.03164556962025317,0.32167295316796474,0.998,10/21,22.04%,GABRG3;GABRB1;GABRG2;GABRG1;GABRA3;GPR156;GABRB2;GABRA1;GABRE;GABRB3
prerank,protease binding (GO:0002020),0.5006243024715754,1.501910540016106,0.027180067950169876,0.7590929610972175,1.0,14/99,10.94%,FN1;DPP4;LDLR;TIMP4;SERPINC1;TIMP1;TIMP2;LCOR;ANXA2;DVL3;ADAMTSL4;POLG;CARD16;ATP9A
prerank,Wnt-activated receptor activity (GO:0042813),-0.5572556633337113,-1.4955624370673948,0.06552706552706553,0.33265732345960447,0.999,7/15,11.00%,ROR1;FZD6;FZD4;LRP5;TSPAN12;RYK;FZD1
prerank,ATP hydrolysis activity (GO:0140603),0.5586638485917802,1.4937524204815702,0.06382978723404255,0.7751031098271932,1.0,14/41,20.13%,CFTR;CLU;ABCD1;SHOC1;TOR1A;VPS4B;CHD3;DHX9;HSP90AA1;MYO1E;KIF20B;ABCB6;MYO18A;ABCA4
prerank,carboxypeptidase activity (GO:0004180),0.5843104978194184,1.4933011785353023,0.04365079365079365,0.7557235622149131,1.0,9/35,7.95%,CPB1;CPA4;CPA3;MINDY2;AGTPBP1;NAALAD2;CTSZ;CPE;AGBL1
prerank,acidic amino acid transmembrane transporter activity (GO:0015172),-0.5593288402622556,-1.4931505914411742,0.04437869822485207,0.3262168698982163,0.999,5/15,9.99%,SLC1A3;SLC1A5;SLC1A2;SLC1A1;SLC17A6
prerank,m7G(5')pppN diphosphatase activity (GO:0050072),0.6960808510973524,1.4763403496293652,0.09415584415584416,0.814965117389286,1.0,1/11,0.43%,NUDT4
prerank,receptor ligand activity (GO:0048018),0.46843847250856935,1.471765111411257,0.006179196704428424,0.8155434343563867,1.0,31/245,8.79%,DPP4;WNT16;SEMA3D;TNFRSF11B;CRLF1;WNT1;CCL5;EDA;WNT10A;NBL1;IL15;GDF15;WNT11;SEMA3B;IL16;NGF;TNFSF13;GDNF;WNT6;BMP5;CLCF1;TIMP1;EPO;BMP4;OSGIN2;TGFB2;SLURP1;WNT5B;FGF22;LGALS3;VEGFB
prerank,NAD binding (GO:0051287),-0.46882744601246157,-1.4681625046145912,0.06007067137809187,0.3675706163263581,1.0,11/26,28.68%,ALDH1A1;ZC3HAV1;ME1;HPGD;SIRT2;ALDH2;SORD;CRYZ;BDH2;NNT;SIRT6
prerank,protein phosphatase 2A binding (GO:0051721),-0.48477248839392634,-1.4665061691815104,0.05723905723905724,0.35942381336289425,1.0,13/23,24.42%,CTTNBP2NL;MFHAS1;FOXO1;DAB2IP;TP53;PPME1;BOD1L1;MASTL;STRN;BOD1;SPHK1;ADCY8;GRIN3A
prerank,potassium channel activity (GO:0005267),-0.35276865650031225,-1.4661845237036835,0.007246376811594203,0.34924158444263254,1.0,28/89,23.53%,KCNK2;KCNT2;GRIK2;KCND2;KCNK5;KCNN2;ABCC9;PKD2;KCNQ4;GRIK3;HCN2;GRIK1;GRIK4;CCDC51;KCNC1;TMEM38B;KCNMB4;KCNMA1;KCNK13;KCNH5;KCNQ3;HCN1;KCNK3;GRIK5;KCNK12;KCND1;KCNC3;KCNB2
prerank,chemokine binding (GO:0019956),0.5717498468356565,1.463668931441421,0.07343124165554073,0.8330717380236201,1.0,7/30,5.95%,CCR4;CXCR4;ACKR4;ACKR2;CCR10;ACKR3;CCRL2
prerank,inorganic cation transmembrane transporter activity (GO:0022890),0.523104621040335,1.45715082793702,0.062266500622665005,0.8432703435253989,1.0,13/48,13.39%,TRPM3;ATP6V1B1;NALCN;TRPM8;CALHM5;TMEM165;TRPM6;AQP1;TRPM4;PKD2L1;SLC41A1;SLC12A4;TRPM2
prerank,heparan sulfate sulfotransferase activity (GO:0034483),-0.5401188881385511,-1.4456866308996823,0.06042296072507553,0.3823476059777937,1.0,6/15,16.26%,HS6ST2;HS3ST3A1;NDST3;HS6ST3;HS3ST3B1;HS3ST1
prerank,ferrous iron binding (GO:0008198),0.5992402916135837,1.445531380805363,0.08064516129032258,0.8811334377200515,1.0,4/21,11.33%,EGLN3;EGLN2;HEPH;CDO1
prerank,pre-mRNA binding (GO:0036002),0.573743554645089,1.437222931722961,0.07692307692307693,0.9008830319799986,1.0,4/28,5.56%,CELF2;DDX5;CELF1;TARBP2
prerank,histone methyltransferase activity (H3-K9 specific) (GO:0046974),-0.6106312701042723,-1.4356984166238,0.08888888888888889,0.39413570204863163,1.0,3/10,5.48%,MECOM;SETD5;PRDM16
prerank,transmembrane receptor protein serine/threonine kinase activity (GO:0004675),-0.5017883093457018,-1.433618440684581,0.08450704225352113,0.38796566898451407,1.0,6/18,8.35%,LTBP1;ENG;ACVRL1;BMPR1B;ACVR1B;ACVR2A
prerank,estrogen receptor binding (GO:0030331),-0.43961690919767216,-1.4315512733631184,0.04946996466431095,0.38237673327867827,1.0,8/32,12.06%,LEF1;TACC1;ESR1;NCOA1;NSD1;RERG;PADI2;CCDC62
prerank,ionotropic glutamate receptor binding (GO:0035255),-0.6021002484840032,-1.4303067143203905,0.0951219512195122,0.37483199584166504,1.0,3/10,4.94%,GNAS;SHANK3;SHISA6
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines (GO:0016814)",-0.5812100510520877,-1.4296338982365941,0.10287081339712918,0.36665633066923,1.0,7/10,32.95%,ADARB2;GDA;APOBEC1;CDA;ADA;DCTD;LACC1
prerank,neuropeptide receptor activity (GO:0008188),0.5624329661541991,1.428241905586845,0.08011049723756906,0.9256940057282562,1.0,2/29,1.37%,SORCS2;GAL
prerank,insulin-like growth factor I binding (GO:0031994),0.6518632505387635,1.427400795243752,0.0959349593495935,0.9088975237821015,1.0,2/13,0.78%,ITGB4;IGFBP6
prerank,acetylglucosaminyltransferase activity (GO:0008375),0.5369290582536888,1.4225883488794393,0.07682619647355164,0.9124169948971995,1.0,12/46,12.38%,B3GALT1;OGT;HEXA;B4GAT1;MGAT3;GCNT2;LARGE1;MGAT1;EXT1;HEXB;MGAT4C;PIGA
prerank,nucleotide diphosphatase activity (GO:0004551),0.6483756000209637,1.4200420160386678,0.1168,0.9059200665229573,1.0,2/14,2.11%,NUDT4;FHIT
prerank,"N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity (GO:0008532)",0.6840414181954073,1.4178216377844237,0.11467116357504216,0.8974604935423757,1.0,2/12,2.17%,B3GALT1;B4GAT1
prerank,carboxylic acid transmembrane transporter activity (GO:0046943),0.5108932464502697,1.4165997520970337,0.08663366336633663,0.8842238701425265,1.0,7/55,7.34%,SLC7A14;SLC36A3;SLC16A5;SLC16A11;SLC16A2;SLC36A4;SLC3A1
prerank,phosphatase activity (GO:0016791),0.48936744007176014,1.416531496984334,0.05847255369928401,0.8666039762232095,1.0,4/73,5.44%,PLPPR2;ATP1A2;DUSP10;DUSP12
prerank,G protein-coupled photoreceptor activity (GO:0008020),0.6593435933621143,1.4160864036954584,0.11587301587301588,0.8517142161042758,1.0,1/12,1.14%,OPN1SW
prerank,O-acyltransferase activity (GO:0008374),0.5474170485440567,1.4158950381714102,0.11002785515320335,0.8359094155386604,1.0,10/30,12.86%,MBOAT2;SOAT1;DGAT1;MOGAT3;MOGAT1;SOAT2;GPAM;MBOAT7;LPCAT2;LPCAT3
prerank,chloride transmembrane transporter activity (GO:0015108),0.6293628320691993,1.4118857327246455,0.10510510510510511,0.8367693291603024,1.0,1/16,0.12%,CFTR
prerank,MAP kinase kinase activity (GO:0004708),-0.5355230612802722,-1.4053973737301881,0.08146067415730338,0.41031568074171115,1.0,8/15,21.53%,PAK3;MAPK10;MAP2K6;LRRK2;MAP2K4;MAP2K1;MAP3K9;MAPK14
prerank,growth factor receptor binding (GO:0070851),-0.3550672534990162,-1.403551518502098,0.0,0.4043545053005705,1.0,19/95,12.85%,PDGFRB;PDGFD;HIP1;PTPRJ;IL1R1;TGFA;VEGFC;GLMN;PDGFRA;KL;FGF2;IL6R;JAK2;ERBB4;PLSCR1;LINGO1;GRB2;IL6ST;CNOT9
prerank,insulin-like growth factor binding (GO:0005520),0.6178727369297599,1.4030507944916482,0.1140215716486903,0.8612182441269017,1.0,2/15,0.78%,ITGB4;IGFBP6
prerank,UDP-glycosyltransferase activity (GO:0008194),0.4892951792102155,1.3998416974620362,0.08284023668639054,0.8601067933568848,1.0,12/70,12.11%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;GCNT2;LARGE1;CHPF;EXT1;HEXB;CHPF2;MGAT4C
prerank,chloride channel inhibitor activity (GO:0019869),0.6774470068745979,1.3996450750306102,0.11908646003262642,0.8453349428011385,1.0,1/10,0.12%,CFTR
prerank,R-SMAD binding (GO:0070412),0.6076720676810089,1.3967456608982913,0.10698365527488855,0.841869768372692,1.0,7/18,11.46%,SMAD6;DDX5;TRIM33;FOS;PPM1A;JUN;LDLRAD4
prerank,neuropeptide binding (GO:0042923),-0.4934618332505841,-1.3943098178725435,0.10130718954248366,0.4152049351434618,1.0,12/18,44.29%,GPR37;SORL1;OPRM1;OPRK1;NMUR2;GPR149;OPRL1;SSTR2;MC4R;SSTR1;OPRD1;NMUR1
prerank,Lys48-specific deubiquitinase activity (GO:1990380),0.6306602357216431,1.394081682069401,0.11842105263157894,0.8392228897252267,1.0,5/14,11.05%,MINDY2;MINDY3;OTUD7B;DESI2;MINDY4
prerank,chloride channel regulator activity (GO:0017081),0.6335274528733736,1.393966266615404,0.10900473933649289,0.8252499359407883,1.0,2/14,3.69%,CFTR;SGK3
prerank,transmembrane receptor protein tyrosine kinase activity (GO:0004714),-0.37016700094954536,-1.3929597940389002,0.04046242774566474,0.4081527763781115,1.0,25/60,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;AXL;TIE1;PDGFRA;KDR;IGF2R;EPHB2;EPHB4;ROR2;NTRK2;ERBB4;FGFR2;RYK;KIT;IGF1R;FGFR4;FLT4;RET;EPHA5
prerank,amino acid transmembrane transporter activity (GO:0015171),0.5153194476190425,1.3922455930884943,0.09554973821989529,0.8184310936116004,1.0,6/47,7.34%,SLC7A14;SLC36A3;SLC66A1;SLC16A2;SLC36A4;SLC3A1
prerank,kinase activator activity (GO:0019209),0.5393440950020328,1.3874375686468026,0.10425240054869685,0.8250274089414058,1.0,5/30,4.46%,FGF13;DAXX;WNT11;GPRC5A;EPO
prerank,proton transmembrane transporter activity (GO:0015078),0.5207093159979311,1.3864002498944652,0.09736842105263158,0.8158805109945302,1.0,18/39,24.97%,ATP6V1B1;COX5A;CTNS;COX8A;UQCRC1;COX7A2L;CLCN4;COX5B;UQCR11;SLC9A1;SLC11A2;UQCRH;ATP6V1B2;COX4I1;COX10;SLC4A11;UQCRFS1;CYB5A
prerank,bicarbonate transmembrane transporter activity (GO:0015106),0.6181041858931455,1.386203529848103,0.13893129770992366,0.8036338951347656,1.0,1/15,0.12%,CFTR
prerank,cysteine-type endopeptidase activity involved in apoptotic process (GO:0097153),-0.5640157260815175,-1.3852256266333374,0.1315136476426799,0.415786556484934,1.0,7/11,27.55%,CFLAR;CASP9;CASP4;CASP7;CASP2;PYCARD;CASP1
prerank,monocarboxylic acid transmembrane transporter activity (GO:0008028),-0.43961880480213555,-1.3846275459862885,0.06756756756756757,0.4081527763781114,1.0,10/26,10.11%,SLC6A13;SLC16A12;SLC6A12;SLC16A9;SLC6A6;SLC16A6;SLC16A1;SLC16A4;SLC6A1;SLC16A7
prerank,sulfotransferase activity (GO:0008146),0.5349879579863834,1.382153030626977,0.09610389610389611,0.8075034756664675,1.0,5/33,5.35%,UST;SULT1A1;CHST12;SULT2B1;CHST11
prerank,NF-kappaB binding (GO:0051059),0.5701539192585715,1.3809653937666688,0.11678832116788321,0.7995865818004628,1.0,9/24,14.36%,EP300;ANXA4;MTDH;NFKBIA;COMMD7;FOXP3;HDAC3;COMMD6;GSK3B
prerank,"oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor (GO:0016620)",-0.4826341027842491,-1.3679135825991986,0.1111111111111111,0.4367628566045507,1.0,6/18,5.66%,ALDH1A1;ALDH1A2;AKR1B1;ALDH3A2;FAR2;ALDH6A1
prerank,GDP binding (GO:0019003),0.47628000808626686,1.3617388922152496,0.10283687943262411,0.8667713672610737,1.0,24/63,23.46%,RAB17;MRAS;RAP1B;RAP1A;RAB9B;ARL3;NRAS;KRAS;RHEB;RAB3B;RAB7A;RAB35;RAB5C;HRAS;RAP2C;DIRAS2;RAB8B;RAB27A;RAB9A;RAB10;MIEF1;GNAI3;ARL8B;RAB31
prerank,glucuronosyltransferase activity (GO:0015020),0.5832550565015402,1.3607363093104188,0.11773472429210134,0.8581813382946286,1.0,4/19,9.57%,B4GAT1;LARGE1;CHPF;EXT1
prerank,potassium ion leak channel activity (GO:0022841),-0.5132024780139798,-1.35472931870563,0.12103746397694524,0.4576586524751222,1.0,8/15,32.17%,KCNK2;KCNK5;KCNK13;KCNK3;KCNK12;KCNK1;KCNK6;KCNK4
prerank,sialyltransferase activity (GO:0008373),-0.47042670244717666,-1.3511382509632532,0.1027190332326284,0.4567545097248816,1.0,7/20,8.01%,ST6GALNAC3;ST3GAL1;ST3GAL5;ST8SIA4;ST3GAL3;ST6GALNAC5;ST8SIA6
prerank,MAP kinase kinase kinase activity (GO:0004709),0.6497681028484178,1.3500371583528101,0.15771812080536912,0.8896195111663027,1.0,5/11,19.71%,MAP3K5;MAP3K4;MAP3K13;MAP3K6;MAP3K1
prerank,sterol binding (GO:0032934),0.48106222443060964,1.3494707237405215,0.1090458488228005,0.8787268994575537,1.0,16/56,11.53%,RORC;SYP;OSBPL9;SOAT1;CAV1;STARD3;CD81;SULT2B1;ERLIN2;INSIG1;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4
prerank,Hsp70 protein binding (GO:0030544),-0.4149316387865102,-1.3465208128796173,0.10357142857142858,0.45827607269855436,1.0,7/31,8.26%,PACRG;SACS;TSC1;DNAJC18;GPR37;DNAJA1;DNAJB12
prerank,protein tyrosine kinase activity (GO:0004713),-0.3195064736625961,-1.3374588426089733,0.018518518518518517,0.469772649400383,1.0,32/108,13.71%,FLT1;ROR1;PDGFRB;EPHA7;TEK;INSR;MERTK;LYN;PTK2;AXL;TIE1;PDGFRA;KDR;BAZ1B;EPHB2;EPHB4;ROR2;BMX;PKDCC;NTRK2;JAK2;ERBB4;FGFR2;RYK;KIT;ABL2;IGF1R;TYK2;FGFR4;FLT4;RET;EPHA5
prerank,SUMO transferase activity (GO:0019789),0.5849161500444049,1.3368736942575157,0.14896988906497624,0.9211144184272829,1.0,7/16,15.24%,HDAC4;MUL1;NSMCE2;PIAS1;PIAS3;CBX4;MDM2
prerank,"racemase and epimerase activity, acting on carbohydrates and derivatives (GO:0016857)",0.6537453215616116,1.3356477104516271,0.1617161716171617,0.9131749995649374,1.0,7/10,25.20%,GFUS;DSE;GALE;FUOM;GNE;RPE;GLCE
prerank,low-density lipoprotein particle binding (GO:0030169),0.5828812149880933,1.3343726094288122,0.14791987673343607,0.9061164403891984,1.0,2/16,1.18%,CDH13;LDLR
prerank,core promoter sequence-specific DNA binding (GO:0001046),0.5108505345756504,1.333949046612686,0.132,0.8952413340371678,1.0,17/35,20.87%,FOS;SMARCB1;PIH1D1;TAF1C;ZBTB17;UBTF;SMARCA4;DR1;MMP12;MYC;FOXP1;TBPL1;H3-3A;PARK7;TBP;SNAPC3;KLF10
prerank,voltage-gated potassium channel activity (GO:0005249),-0.3308294850027419,-1.3337761922798534,0.043478260869565216,0.4688837381168329,1.0,24/80,25.53%,KCNK2;KCNT2;KCND2;KCNN2;PKD2;KCNQ4;KCNJ2;HCN2;KCNJ12;KCNJ6;KCNC1;KCNJ10;KCNMA1;KCNH5;KCNQ3;HCN1;KCNJ8;KCNJ15;KCNIP2;KCND1;KCNC3;KCNB2;KCNK1;KCNJ3
prerank,"oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen (GO:0016709)",-0.42826337876762366,-1.3324176488758457,0.1292517006802721,0.4631747145326708,1.0,7/25,7.18%,POR;FMO1;NOS3;MICAL3;FMO2;CYP26B1;FMO5
prerank,2-oxoglutarate-dependent dioxygenase activity (GO:0016706),0.5222931302579926,1.3323286586678469,0.1443850267379679,0.889913843309298,1.0,7/32,15.77%,EGLN3;KDM4B;EGLN2;RIOX2;KDM4C;TET1;JMJD4
prerank,"phosphotransferase activity, phosphate group as acceptor (GO:0016776)",0.5444655687747818,1.3261014867153251,0.15472779369627507,0.9044121810932628,1.0,7/24,10.00%,AK1;IP6K1;PMVK;CMPK1;PPIP5K2;AK3;AK5
prerank,metallocarboxypeptidase activity (GO:0004181),0.5468000908371833,1.3251833911418622,0.1394700139470014,0.8963907905956877,1.0,6/26,7.95%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,actin binding (GO:0003779),0.4340923099992484,1.32112794964012,0.057203389830508475,0.90163075187054,1.0,28/170,7.84%,SORBS1;UTRN;PHACTR1;PAWR;PDLIM5;CALD1;COBL;ABLIM1;PHACTR2;PARVA;DAG1;GSN;MICAL2;SSH3;EPS8L2;CXCR4;CORO7;MLPH;LMOD3;CAPZB;TWF1;AVIL;ADD1;DMTN;FLNB;ANG;MICAL1;MSRB2
prerank,UDP-galactosyltransferase activity (GO:0035250),0.6458547845614072,1.3205863645863125,0.16859504132231404,0.8921260795484209,1.0,1/10,0.66%,B3GALT1
prerank,general transcription initiation factor binding (GO:0140296),-0.42477792085835037,-1.3164281542361311,0.1103202846975089,0.49219157322705587,1.0,12/25,27.99%,AR;ESR1;TAF1B;RUVBL1;TAF12;THAP7;HHEX;AHR;YEATS2;GTF2A2;DRAP1;TAF1
prerank,deubiquitinase activity (GO:0101005),0.4521174977936305,1.3158636570451103,0.11032863849765258,0.9003793522431602,1.0,27/88,18.28%,USP53;MINDY2;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP32;USP10;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;MINDY4;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP16;USP21
prerank,cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:0097200),-0.5495416406204049,-1.3137659191050455,0.16666666666666666,0.4893158804274394,1.0,6/10,27.55%,CFLAR;CASP9;CASP4;CASP7;CASP2;CASP1
prerank,iron ion binding (GO:0005506),0.47097259983614465,1.3112529014873906,0.13892365456821026,0.908071798319535,1.0,18/48,23.55%,EGLN3;ALOX5;EGLN2;FDX1;KDM3A;HEPH;CDO1;SCD5;ACO2;TET1;HAAO;ISCA2;TYW5;MELTF;PHF2;AOX1;FTO;FTL
prerank,phospholipase inhibitor activity (GO:0004859),0.6443906161244899,1.3105717938646788,0.19322033898305085,0.8993146241929589,1.0,4/10,15.14%,ANXA4;ANXA5;ANXA2;SNCB
prerank,MAP kinase tyrosine/serine/threonine phosphatase activity (GO:0017017),0.6341941863172282,1.308537129471823,0.18537414965986396,0.8859643193520496,1.0,2/10,5.45%,DUSP10;DUSP1
prerank,protein tyrosine/threonine phosphatase activity (GO:0008330),0.6341941863172282,1.308537129471823,0.18537414965986396,0.8859643193520496,1.0,2/10,5.45%,DUSP10;DUSP1
prerank,cadherin binding (GO:0045296),0.40914119722006337,1.3069807590344147,0.038461538461538464,0.8815818518317392,1.0,62/315,12.98%,CDH1;PHLDB2;CDH13;BAIAP2L1;PLCB3;PDLIM5;CALD1;TJP2;FMNL2;TJP1;AHNAK;STXBP6;PARVA;TMOD3;NIBAN2;PKP4;NDRG1;MPRIP;ARHGAP18;EPS8L2;GPRC5A;SH3GLB2;CTNNA1;EHD1;PPP1R13L;TRIM25;SPTBN2;PFKP;S100A11;CAPZB;PAICS;TWF1;PKM;MRE11;ADD1;TES;HCFC1;ANK3;CC2D1A;ANXA2;FLNB;CLIC1;IQGAP1;CHMP4B;GOLGA3;PI4KA;YWHAB;BAG3;EZR;ABI1;PLEC;SPTAN1;ARFIP2;CDH4;YWHAZ;FASN;ARGLU1;RPS26;EIF4G2;OLA1;ESYT2;EEF1D
prerank,transforming growth factor beta-activated receptor activity (GO:0005024),-0.5166919228685298,-1.3025498282928973,0.14540816326530612,0.5074751953679697,1.0,4/12,5.07%,LTBP1;ENG;ACVRL1;BMPR1B
prerank,lipase activator activity (GO:0060229),0.6391313963263889,1.3018679191447546,0.1732418524871355,0.8915340450956848,1.0,1/10,1.51%,CCL5
prerank,myosin II binding (GO:0045159),0.6234078711793958,1.3015658400083865,0.194675540765391,0.8822367845908007,1.0,5/10,21.85%,GSN;LLGL2;MYL4;SHROOM4;LLGL1
prerank,double-stranded RNA binding (GO:0003725),0.45731902219819626,1.2985604000566122,0.1420256111757858,0.8842844778986195,1.0,18/70,15.50%,MBNL1;STRBP;VIM;DGCR8;MTDH;TARBP2;MSN;SIDT2;EIF4B;ILF2;FXR1;DUS2;ZFR2;APTX;EIF4A1;TLR3;DHX9;OAS2
prerank,"oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor (GO:0016628)",0.5692130118452179,1.2983003668632105,0.16793893129770993,0.8751131012639617,1.0,8/17,23.45%,DHCR7;SRD5A3;PECR;BLVRA;TM7SF2;DECR2;MECR;DECR1
prerank,protein kinase A catalytic subunit binding (GO:0034236),0.5937701390874175,1.2982855893586138,0.19899665551839466,0.8652024800939101,1.0,7/13,14.36%,SOX9;CSK;EZR;PKIA;GSK3A;PRKAR2A;GSK3B
prerank,phosphatidylinositol phospholipase C activity (GO:0004435),0.5339487309733348,1.2982514279255413,0.16569767441860464,0.855592655909313,1.0,4/23,1.59%,PLCB3;CHRM1;CCL5;PLCD3
prerank,ubiquitination-like modification-dependent protein binding (GO:0140035),0.6286727094122839,1.2957697099407193,0.1942675159235669,0.8555950108959002,1.0,4/10,19.32%,DAXX;PML;FAN1;IDE
prerank,E-box binding (GO:0070888),-0.3894954675522275,-1.2845317955533437,0.14553990610328638,0.542598184592793,1.0,5/34,9.23%,TCF4;ZEB1;MITF;ATOH8;PPARG
prerank,hexosyltransferase activity (GO:0016758),0.43371715150258056,1.2843126555151145,0.135498320268757,0.8915022241736823,1.0,19/101,13.79%,B3GALT1;B4GALNT2;OGT;HEXA;B4GAT1;TMTC1;A4GALT;GCNT2;LARGE1;CHPF;MTAP;EXT1;PIGZ;HEXB;ALG1;CHPF2;MGAT4C;ALG12;ALG5
prerank,phosphatase binding (GO:0019902),0.4230068405296805,1.284004210760256,0.1299559471365639,0.8830314156784441,1.0,24/105,13.37%,NFATC2;MAP3K5;ANK1;MAGI2;GTF2F1;IKBKE;PPP6R3;CHCHD3;SH3RF2;AP3B1;TSC2;ROS1;PXN;BAD;LGALS3;IQGAP1;CRY2;MTMR3;JAK1;MVP;EIF2AK3;ELL;ANAPC4;CARHSP1
prerank,phosphatidic acid binding (GO:0070300),-0.44192703398878375,-1.2830575144097978,0.15605095541401273,0.5366145637195883,1.0,6/19,10.44%,MARK1;RAPGEF2;PLTP;SMPD3;GSDMD;GRAMD1B
prerank,deoxyribonuclease activity (GO:0004536),0.5894137685545995,1.2819502835048906,0.2222222222222222,0.881585710412254,1.0,8/14,23.62%,MRE11;DNASE1L2;ERCC5;MBD4;DNASE1L1;ERCC4;MAP1S;APEX1
prerank,intracellular cyclic nucleotide activated cation channel activity (GO:0005221),0.6077258652276749,1.2799705255673601,0.19243986254295534,0.880234135860226,1.0,4/11,12.83%,CNGA2;CNGB3;AQP1;CNGB1
prerank,histone methyltransferase activity (H3-K36 specific) (GO:0046975),-0.5303471890760131,-1.2790770615833493,0.20100502512562815,0.5376462554775218,1.0,6/10,31.66%,SETD5;NSD1;NSD3;PRDM9;NSD2;SETD3
prerank,lipoprotein particle binding (GO:0071813),0.5348327926877576,1.2783909682144587,0.19558823529411765,0.876831334030044,1.0,2/20,1.18%,CDH13;LDLR
prerank,"3',5'-cyclic-nucleotide phosphodiesterase activity (GO:0004114)",-0.42955685847872793,-1.2757848235686193,0.156794425087108,0.5367798147430127,1.0,11/21,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE9A;PDE4B;PDE2A
prerank,GTPase activator activity (GO:0005096),-0.2654097989532185,-1.2731940821482755,0.0,0.5342458597870268,1.0,75/313,12.13%,PLCB1;DOCK4;FARP1;ALDH1A1;PREX2;DENND4A;ERRFI1;TBC1D4;ARHGAP28;ARHGAP24;ADGRB3;ARHGAP32;RAPGEF2;DENND5B;ARHGAP20;FGD5;RASGRP3;ASAP1;TBC1D12;VAV3;CHN2;DENND1A;DOCK10;PLCE1;RGS5;RASGRF2;RP2;ARHGEF28;CHN1;RASGRP2;RGS3;SH3BP5;RIC1;EIF2B3;RABGAP1L;ARHGAP22;SYDE2;TBC1D30;RALGPS1;RABIF;FNIP1;DOCK8;LRRK2;MTSS2;RALGAPA2;SPATA13;ARHGEF15;ELMOD2;RAB3IL1;RGL1;RIC8B;TIAM1;GARNL3;SGSM3;TBC1D14;ARRB1;FGD3;NF1;NPRL3;WDR41;ELMOD1;NCKAP1L;ARAP3;ALS2;DENND2C;TBC1D5;PGAM5;STARD8;ARHGEF2;RCC1;STXBP5L;LAMTOR1;ACAP2;TBC1D7;DENND4C
prerank,leucine zipper domain binding (GO:0043522),0.6182075683231898,1.2721485697417214,0.20903010033444816,0.8919802198806188,1.0,2/10,3.76%,PAWR;DAPK3
prerank,nucleoside-diphosphatase activity (GO:0017110),-0.5054795702555365,-1.2715500871509122,0.18662952646239556,0.5290585045836548,1.0,5/12,20.98%,ENTPD1;CANT1;ENTPD3;ENTPD5;ENTPD6
prerank,alanine transmembrane transporter activity (GO:0022858),0.5883428037004678,1.2692982536839226,0.21367521367521367,0.8936236064766732,1.0,3/12,10.88%,SLC36A3;SLC36A4;SLC1A4
prerank,"phosphatidylinositol-3,4,5-trisphosphate binding (GO:0005547)",0.48420591553528997,1.268962810912384,0.17962466487935658,0.8860043481395482,1.0,9/34,8.46%,ARAP1;OGT;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;JPH2;IQGAP1
prerank,C2H2 zinc finger domain binding (GO:0070742),-0.5075702757104217,-1.2671148480634826,0.20256410256410257,0.5311305113893107,1.0,5/11,14.97%,LEF1;MBD2;GATA2;HMGA2;THAP7
prerank,protein kinase C activity (GO:0004697),0.573243743664563,1.2661586844241277,0.21153846153846154,0.8877150109943386,1.0,1/14,0.09%,PRKCB
prerank,acetylcholine receptor activity (GO:0015464),0.5247841392233212,1.2624039181147548,0.2017167381974249,0.893382567913266,1.0,1/22,0.76%,CHRM1
prerank,acetylgalactosaminyltransferase activity (GO:0008376),0.5155034613423781,1.2599737090303684,0.19263456090651557,0.8937870653918845,1.0,3/26,6.69%,B3GALT1;B4GALNT2;CHPF
prerank,phospholipase C activity (GO:0004629),0.5117726084172611,1.2586161968769873,0.1876790830945559,0.890407049651387,1.0,4/25,1.59%,PLCB3;CHRM1;CCL5;PLCD3
prerank,cyclic-nucleotide phosphodiesterase activity (GO:0004112),-0.415585120080712,-1.2586069142559133,0.17328519855595667,0.543072771451286,1.0,11/23,9.95%,PDE7B;PDE3A;PDE8B;PDE8A;PDE4D;PDE3B;PDE4A;PDE10A;PDE9A;PDE4B;PDE2A
prerank,calcium channel regulator activity (GO:0005246),-0.36628407878878433,-1.258376722477544,0.13168724279835392,0.5351438891968154,1.0,9/37,12.48%,PRKG1;ITPR1;STIM1;NRXN1;SGK1;STIMATE;CACNG8;REM1;SLC30A1
prerank,alkali metal ion binding (GO:0031420),0.5807211867449313,1.2581949697852854,0.23274478330658105,0.8832756375609531,1.0,2/13,4.08%,ATP1A2;HDAC4
prerank,nuclear localization sequence binding (GO:0008139),0.5537184663991055,1.2573411742054468,0.20820668693009117,0.8784101876926825,1.0,9/18,17.57%,KPNA7;NFKBIA;TNPO2;KPNA4;TNPO1;BRAP;RANBP6;IPO4;KPNA1
prerank,metalloendopeptidase inhibitor activity (GO:0008191),0.5732640323214522,1.257027641688017,0.2480127186009539,0.8713492160172632,1.0,5/14,5.53%,COL4A3;NGF;TIMP4;TIMP1;TIMP2
prerank,thiol-dependent deubiquitinase (GO:0004843),0.43223684857993216,1.2565883581094923,0.1588235294117647,0.8648804119730531,1.0,25/83,18.28%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP32;USP10;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP16;USP21
prerank,nuclear export signal receptor activity (GO:0005049),-0.5106526421154195,-1.2559052681295533,0.19656019656019655,0.5331588616966022,1.0,5/11,15.61%,XPO1;EIF4ENIF1;RAN;RANBP17;NUP214
prerank,FMN binding (GO:0010181),-0.5144974417673815,-1.2554453790720874,0.20105820105820105,0.5261139562510115,1.0,2/11,2.50%,POR;NOS3
prerank,fibroblast growth factor binding (GO:0017134),0.5255654165381609,1.254347930320674,0.21029411764705883,0.8650089996960254,1.0,2/21,1.48%,FGFR1;GPC1
prerank,acylglycerol O-acyltransferase activity (GO:0016411),0.5284119687450505,1.2534793194484497,0.19850746268656716,0.8602354913080946,1.0,5/20,11.96%,ABHD5;DGAT1;MOGAT3;MOGAT1;LPCAT2
prerank,metalloendopeptidase activity (GO:0004222),0.4281012953242973,1.2509664921936177,0.17633410672853828,0.8614426882108582,1.0,12/76,9.04%,THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1
prerank,TBP-class protein binding (GO:0017025),-0.4225863533794066,-1.2492415731144753,0.15772870662460567,0.5329973632793404,1.0,10/21,27.99%,ESR1;TAF1B;RUVBL1;TAF12;HHEX;AHR;YEATS2;GTF2A2;DRAP1;TAF1
prerank,nuclear receptor coactivator activity (GO:0030374),0.4618345569564443,1.2469553740353687,0.17202970297029702,0.8683140455597516,1.0,14/52,16.83%,PRKCB;CNOT6;PPARGC1A;NCOA3;MED30;ENY2;CALCOCO1;DCAF6;MED12;MED24;ZMIZ2;ACTN4;SFR1;KDM1A
prerank,MAP kinase phosphatase activity (GO:0033549),0.5835680977433373,1.2467112221113104,0.2313915857605178,0.8614126551938709,1.0,6/12,27.01%,DUSP10;DUSP1;DUSP3;DUSP16;DUSP29;DUSP8
prerank,metallopeptidase activity (GO:0008237),0.41230734820575976,1.2457105886958513,0.16517857142857142,0.8576395354401963,1.0,20/113,13.27%,ADAM12;THSD4;ADAMTS14;MMP9;ADAMTS7;ADAMTSL5;ADAM10;ADAM33;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1;ADAM15;PSMD7;MMP12;COPS5;MPND;MYSM1;CHMP1A
prerank,"oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor (GO:0016655)",0.5692691713246784,1.2454234937293827,0.22937293729372937,0.8511129054340314,1.0,4/12,14.93%,DHRS4;CRYZL1;NQO2;DCXR
prerank,peptidase inhibitor activity (GO:0030414),0.4872771725898729,1.2410138495964298,0.1953551912568306,0.8592010694295735,1.0,6/33,7.23%,SLPI;SPINT2;TIMP1;TIMP2;PSMF1;GPC3
prerank,5'-3' exonuclease activity (GO:0008409),0.574915248275425,1.2382641046825418,0.22685185185185186,0.8618046470734666,1.0,6/14,19.75%,FEN1;MRE11;XRN2;FAN1;DCLRE1C;DXO
prerank,nucleoside monophosphate kinase activity (GO:0050145),0.5218239758133794,1.236433923180877,0.22814814814814816,0.8606830812270805,1.0,6/20,10.18%,TJP2;AK1;CMPK1;AK3;AK6;CASK
prerank,guanyl-nucleotide exchange factor activity (GO:0005085),-0.28410205229340835,-1.236197467868008,0.04838709677419355,0.5571012976388782,1.0,36/147,12.58%,DOCK4;FARP1;PREX2;DENND4A;RAPGEF2;DENND5B;FGD5;VAV3;DENND1A;DOCK10;PLCE1;RASGRF2;ARHGEF28;RASGRP2;SH3BP5;RIC1;EIF2B3;RALGPS1;RABIF;FNIP1;DOCK8;SPATA13;ARHGEF15;RAB3IL1;RGL1;RIC8B;TIAM1;FGD3;WDR41;ALS2;DENND2C;ARHGEF2;RCC1;LAMTOR1;DENND4C;RASGEF1A
prerank,phospholipase A2 activity (GO:0004623),0.49027221213227995,1.234836065437461,0.22043795620437956,0.8593261200704251,1.0,2/26,5.58%,PLB1;PLA2G12A
prerank,protein kinase regulator activity (GO:0019887),0.41749375718466114,1.2334505119891594,0.18013856812933027,0.8569993454889321,1.0,27/95,19.02%,FGF13;DAXX;PARVA;CDKN1A;WNT11;QARS1;GPRC5A;EPO;ITPRIP;CCND2;ELP4;YWHAB;GPRC5D;CCND1;SMCR8;CCNL2;PRKAR2A;DUS2;WNK1;DNAJC3;PPP1R1B;HEXIM1;CCNG1;PRKAG1;CAB39;SH3BP5L;TAOK3
prerank,K63-linked polyubiquitin modification-dependent protein binding (GO:0070530),0.5181762970948194,1.233372281801878,0.21162444113263784,0.8501480748225713,1.0,9/22,23.35%,MINDY2;IKBKE;OTUD7B;TAB3;IKBKG;TAB2;PRPF8;RNF168;RNF169
prerank,aldehyde dehydrogenase [NAD(P)+] activity (GO:0004030),-0.449409269975731,-1.2307410865664963,0.19230769230769232,0.5625247740938559,1.0,8/15,18.52%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1;ALDH7A1;ALDH2;ALDH3B1
prerank,cell-cell adhesion mediator activity (GO:0098632),0.4606199104086076,1.2293068018930322,0.23791348600508905,0.8572772769724287,1.0,7/42,6.90%,BAIAP2L1;PDLIM5;STXBP6;TMOD3;CD200;S100A11;ANXA2
prerank,phosphatidylcholine transporter activity (GO:0008525),0.5371106080934858,1.227128624365315,0.24233128834355827,0.8579297163262656,1.0,4/17,6.78%,PITPNM2;ATP10A;PITPNC1;ATP8B2
prerank,alcohol dehydrogenase (NADP+) activity (GO:0008106),0.5827227471518885,1.2258642329011153,0.25259515570934254,0.8552105446041829,1.0,3/11,10.37%,ALDH3A1;DHRS13;AKR1B10
prerank,vinculin binding (GO:0017166),0.584044774293784,1.2236612863042242,0.2638888888888889,0.8557642464596166,1.0,4/11,6.77%,UTRN;DAG1;CTNNA1;PXN
prerank,ribosome binding (GO:0043022),0.4548643038751998,1.2230176836128186,0.19676214196762143,0.8509926654065757,1.0,23/46,24.57%,CPEB2;YTHDF1;ZC3H12A;EIF6;RPSA;MRPS27;NAA15;CPEB3;NAA10;PYM1;CCDC47;EEF2;TMEM147;YTHDF3;ETF1;GEMIN5;IGHMBP2;EFL1;GTPBP6;C1QBP;EIF2S1;EIF2A;MAIP1
prerank,N-acyltransferase activity (GO:0016410),-0.3724043860889517,-1.2207273502611284,0.16319444444444445,0.5788295590331266,1.0,9/32,12.82%,TGM2;SAT1;NMT2;CERS4;PLAAT3;NAT10;SMARCE1;CERS5;CERS6
prerank,adenyl nucleotide binding (GO:0030554),0.5688957074680796,1.2186958789215494,0.2628099173553719,0.852046099229069,1.0,5/11,15.52%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,adenyl-nucleotide exchange factor activity (GO:0000774),0.5688957074680796,1.2186958789215494,0.2628099173553719,0.852046099229069,1.0,5/11,15.52%,BAG1;SIL1;BAG3;HSPBP1;HSPH1
prerank,bHLH transcription factor binding (GO:0043425),-0.4314099725385089,-1.2149291547171561,0.22006472491909385,0.5844680093054548,1.0,5/19,13.93%,FHL2;TCF12;LMO2;BHLHE40;SMAD3
prerank,phospholipase activator activity (GO:0016004),0.5966879509632916,1.2139753309362717,0.24048442906574394,0.8617692987243691,1.0,1/10,1.51%,CCL5
prerank,neuropeptide hormone activity (GO:0005184),0.502497664453091,1.211826122589776,0.25441176470588234,0.8625293599250821,1.0,2/22,2.38%,GAL;PENK
prerank,ligand-gated anion channel activity (GO:0099095),0.5191406886651654,1.210547709522067,0.24923076923076923,0.8607763647575313,1.0,1/17,0.12%,CFTR
prerank,secondary active transmembrane transporter activity (GO:0015291),0.4463329686326768,1.2093304483720155,0.21890547263681592,0.8584317400226769,1.0,13/51,16.25%,SLCO2A1;ANKH;SLC35D3;MCU;SLC25A3;SLC16A2;SLC20A1;CLCN4;SLC22A8;SLC25A14;SLC35E2B;SLC35E2A;SLC4A4
prerank,low-density lipoprotein particle receptor binding (GO:0050750),0.5003210858953773,1.2027700352486803,0.2547584187408492,0.874251217477745,1.0,4/22,12.41%,CLU;APBB1;AP2A1;MESD
prerank,"endodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016888)",0.5606831830905261,1.1990962640346685,0.2711598746081505,0.8808430418203229,1.0,5/13,15.74%,FEN1;DNASE1L2;DNASE1L1;ENDOV;FAN1
prerank,mRNA 3'-UTR binding (GO:0003730),0.4179481257229238,1.198458436696592,0.21428571428571427,0.8763998710382974,1.0,17/79,13.99%,CELF2;PABPC4L;DDX5;CPEB2;ZC3H12A;PABPC1L;CELF1;YBX3;UTP23;RBMS3;CPEB3;FXR1;DAZAP1;CARHSP1;RNPS1;BOLL;AUH
prerank,aspartic-type endopeptidase activity (GO:0004190),0.5605172732657082,1.1984473946318814,0.2665589660743134,0.869904027796212,1.0,8/12,24.00%,NAPSA;SPPL2B;HM13;BACE1;SPPL3;SPPL2A;DDI2;PSEN1
prerank,phosphatidylinositol-3-phosphate binding (GO:0032266),-0.3453850881185915,-1.1981060830327597,0.16740088105726872,0.617445580973496,1.0,9/38,12.00%,PLA2G4A;HIP1;DENND1A;SH3PXD2B;DAB2IP;ZFYVE28;PLEKHA4;LANCL2;PLEKHF1
prerank,cholesterol binding (GO:0015485),0.44100585769152173,1.1975823126635072,0.22791293213828426,0.8664902117368922,1.0,15/47,15.05%,SYP;SOAT1;CAV1;STARD3;CD81;SULT2B1;ERLIN2;NPC1;VDAC2;ERLIN1;SOAT2;OSBPL7;STARD4;VDAC1;OSBPL5
prerank,nucleoside-triphosphatase activity (GO:0017111),0.37598270408146134,1.192904961747699,0.14917695473251028,0.8760769653823277,1.0,63/248,19.44%,CFTR;RAB17;CLU;DYNC1I1;MRAS;RAP1B;ABCD1;EEF1A1;KIF2A;RAP1A;SHOC1;RHOQ;KIF1C;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;TOR1A;BMS1;RAB35;GNAO1;AGAP3;GNAQ;KLC1;GNA13;VPS4B;RHOA;RABL3;OPA1;CHD3;SEPTIN9;RHOU;RAB5C;RAB1B;HRAS;GNG5;DNM1L;ATL2;GNA11;GPN1;DHX9;ARHGDIB;HSP90AA1;RAP2C;RAB33B;ARL8A;EEF2;DIRAS2;RAP1GAP;RAB8B;MYO1E;HBS1L;KIF20B;RNF112;ABCB6;RAB27A;RAB9A;RHOT2;MYO18A
prerank,amyloid-beta binding (GO:0001540),0.41194141140668755,1.1928580109880533,0.19953596287703015,0.8697836983264763,1.0,12/79,9.68%,CLU;COL25A1;LDLR;EPHA4;CACNA1A;ITM2C;PFDN1;CRYAB;TGFB2;FZD5;TLR6;APBB1
prerank,exoribonuclease activity (GO:0004532),0.5637467900420778,1.1877983988928889,0.30842607313195547,0.8805889523870054,1.0,3/12,8.91%,CNOT6;ZC3H12A;EXOSC3
prerank,nuclear receptor binding (GO:0016922),0.3951369513952986,1.1876711041751011,0.22879464285714285,0.8746466196515318,1.0,30/111,20.25%,PRKCB;DAXX;PPARGC1A;NCOA3;DDX5;EP300;LCOR;MED30;LATS1;TGFB1I1;TCF7L2;GAS2L1;BCAS3;KDM3A;KDM4C;SMARCA4;NCOR1;MED12;MED24;FOXP1;NCOR2;ACTN4;KDM1A;PRPF6;PARK7;ZBTB7A;YWHAH;TACC2;DCAF1;PRMT2
prerank,protein tyrosine kinase binding (GO:1990782),0.4124320773959609,1.1863199759624323,0.22743682310469315,0.8730015401214695,1.0,9/71,7.76%,PITPNM2;ANGPT1;PTPN14;TJP2;EPHA4;PRR7;PITPNM3;SHC1;FIZ1
prerank,cGMP binding (GO:0030553),0.5619844286153954,1.1853957760311462,0.27929373996789725,0.8699433850928188,1.0,4/11,12.83%,PDE5A;CNGA2;CNGB3;CNGB1
prerank,endonuclease activity (GO:0004519),0.4417069643416794,1.183458665777558,0.26329113924050634,0.86999763227924,1.0,12/49,13.78%,ZC3H12A;FEN1;KHNYN;RNASEL;MRE11;ANG;TSNAX;YBEY;LACTB2;ERCC5;MBD4;REXO4
prerank,GABA receptor binding (GO:0050811),0.5662557846059637,1.1825624099635763,0.2688679245283019,0.8668921710522393,1.0,2/11,10.22%,PLCL2;AKAP5
prerank,solute:proton symporter activity (GO:0015295),0.5237438083271867,1.181045855703267,0.28728414442700156,0.8657740995655174,1.0,3/16,5.98%,SLC36A3;SLC25A3;CTNS
prerank,protein kinase activator activity (GO:0030295),0.4180660244772695,1.1801119249515462,0.2397094430992736,0.8629460096361856,1.0,11/60,10.17%,FGF13;DAXX;CDKN1A;WNT11;GPRC5A;EPO;ERBB3;IQGAP1;GPRC5D;MAP2K2;ABI1
prerank,1-phosphatidylinositol-3-kinase regulator activity (GO:0046935),-0.4458321292701269,-1.1756915233268073,0.23676880222841226,0.6651915640845469,1.0,8/15,24.38%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR
prerank,oxidoreduction-driven active transmembrane transporter activity (GO:0015453),0.4181829534952509,1.1734575315817255,0.23558897243107768,0.8787616999050492,1.0,21/57,21.45%,NDUFV1;COX5A;NDUFB8;COX8A;UQCRC1;NDUFB6;NDUFS3;COX7A2L;COX5B;NDUFB7;NDUFV2;NDUFA1;UQCR11;NDUFB4;UQCRH;NDUFB5;NDUFB9;COX4I1;COX10;NDUFA2;NDUFA12
prerank,lipoprotein particle receptor binding (GO:0070325),0.46669211600985294,1.1709489474483845,0.26177285318559557,0.8812867990417023,1.0,6/27,18.15%,CLU;APBB1;AP2A1;MESD;RELN;APBB3
prerank,G protein-coupled receptor activity (GO:0004930),0.3716499513723883,1.170115956935784,0.17707267144319344,0.8778477313956666,1.0,21/239,11.57%,ADRA1B;AGTR1;GPR4;LPAR1;OPN1SW;LPAR4;PROKR2;CXCR4;ADGRL2;CCR10;ADGRD1;CRHR2;GPR75;GRM2;LGR4;HCRTR1;ADGRG2;ADGRG6;TPRA1;GPR63;GABBR2
prerank,omega peptidase activity (GO:0008242),0.3982150910660257,1.1676524833875315,0.2482598607888631,0.8801118595484902,1.0,25/89,18.28%,USP53;ZC3H12A;USP46;USP29;MINDY3;OTUD1;USP32;USP10;OTUD7B;DESI2;USP19;USP20;USP24;USP39;USP42;USP3;COPS5;MPND;MYSM1;USP28;OTUD6B;USP25;OTULIN;USP16;USP21
prerank,semaphorin receptor binding (GO:0030215),0.4790217681934208,1.1671276966369821,0.27445255474452557,0.876163885166687,1.0,3/23,2.81%,SEMA3D;PLXNB1;SEMA3B
prerank,endopeptidase inhibitor activity (GO:0004866),0.4044309314268696,1.1665454314770207,0.25207100591715975,0.8724654494057967,1.0,13/82,10.41%,COL4A3;SLPI;CRB2;SPINT2;NGF;TIMP4;SERPINC1;TIMP1;TIMP2;ANXA2;PSMF1;SERPINB8;CARD16
prerank,"intramolecular oxidoreductase activity, transposing C=C bonds (GO:0016863)",0.5454929470237558,1.1660897602719433,0.3073089700996678,0.868293144238352,1.0,2/13,8.88%,SREBF2;EHHADH
prerank,hyaluronic acid binding (GO:0005540),0.5593783393835402,1.1660514595249551,0.31569965870307165,0.8626764263995279,1.0,3/10,8.15%,CD44;IMPG1;STAB2
prerank,basic amino acid transmembrane transporter activity (GO:0015174),0.5378664361903827,1.1651410980511154,0.2947882736156352,0.8601433254283785,1.0,5/13,19.16%,SLC66A1;SLC3A1;SLC7A6;SLC7A3;SLC38A7
prerank,cAMP-dependent protein kinase regulator activity (GO:0008603),-0.48813494191226375,-1.1618973359247387,0.28205128205128205,0.6936974160495273,1.0,3/10,9.87%,PRKAG2;PKIG;PRKAR2B
prerank,kinase inhibitor activity (GO:0019210),0.4549594947008898,1.157702275250024,0.2774869109947644,0.8786585140620641,1.0,12/33,19.02%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;SH3BP5L;TAOK3
prerank,solute:anion antiporter activity (GO:0140323),-0.4414941838891462,-1.1535593872880454,0.3033033033033033,0.7069083946387181,1.0,2/14,1.56%,SLC7A11;SLC26A7
prerank,nuclear import signal receptor activity (GO:0061608),0.5184517756268883,1.1529535182660913,0.3098159509202454,0.8890956533010986,1.0,8/15,20.58%,KPNA7;TNPO2;KPNA4;TNPO1;RANBP6;IPO4;KPNA1;HIKESHI
prerank,quaternary ammonium group transmembrane transporter activity (GO:0015651),0.5429428046164335,1.152318936303422,0.3150684931506849,0.8855447221590719,1.0,2/11,11.85%,SLC25A47;SLC25A45
prerank,carboxy-lyase activity (GO:0016831),0.4687712855841051,1.1511307528236567,0.30071942446043165,0.883961528794423,1.0,10/23,22.89%,ECHDC1;AZIN1;UMPS;CSAD;PPCDC;PCK2;PISD;GAD1;UXS1;MLYCD
prerank,tRNA binding (GO:0000049),0.4262925991244633,1.1510558863403106,0.27989821882951654,0.8786642747528981,1.0,22/43,24.40%,EEF1A1;FARS2;ELP5;THG1L;AARS1;MRPS27;PSTK;SARS2;SARS1;TRNT1;TRNAU1AP;CTU1;EIF2AK4;DARS2;TRMT10B;HSD17B10;TYW5;YARS2;IGHMBP2;NSUN6;KARS1;EIF2A
prerank,protein-lysine N-methyltransferase activity (GO:0016279),0.4353410545115139,1.1493632412488526,0.27823691460055094,0.8789867827993666,1.0,17/34,27.19%,EEF2KMT;DOT1L;SMYD3;EEF1AKMT3;SETDB1;SETD7;SMYD1;MEN1;ATPSCKMT;ANTKMT;KMT5A;KMT2E;N6AMT1;SMYD2;CAMKMT;EHMT1;EEF1AKMT2
prerank,syntaxin-1 binding (GO:0017075),0.4731714473314959,1.1476186176833687,0.3035190615835777,0.8790771225945768,1.0,4/22,8.20%,UNC13C;SYP;DAPK1;STXBP1
prerank,C4-dicarboxylate transmembrane transporter activity (GO:0015556),-0.4210699758523852,-1.1455312690727242,0.26988636363636365,0.7201868863936521,1.0,3/16,5.61%,SLC13A3;SLC1A5;SLC1A1
prerank,aldehyde dehydrogenase (NAD+) activity (GO:0004029),-0.43808292757705,-1.1453001321931573,0.2823529411764706,0.7112832446199371,1.0,5/13,10.15%,ALDH1A1;ALDH1A2;ALDH3A2;ALDH4A1;ALDH9A1
prerank,endopeptidase activity (GO:0004175),0.36237447476839446,1.1435441326225515,0.20901639344262296,0.886912738051732,1.0,29/257,10.92%,DPP4;THSD4;ADAMTS14;PIK3IP1;MMP9;ADAMTS7;ADAMTSL5;ADAM10;HPN;ADAM33;USP46;USP29;PRSS12;USP10;PRSS36;GZMM;CTSZ;ADAMTS20;AFG3L2;ADAMTS1;ADAMTSL4;PITRM1;PREP;KLK1;USP20;USP24;HP;HPR;USP42
prerank,lipase activity (GO:0016298),0.4270350676184394,1.1425161192044258,0.29654255319148937,0.8848519917164088,1.0,4/43,4.99%,PLB1;ABHD5;PITPNM3;ABHD15
prerank,lysophospholipase activity (GO:0004622),0.4689924979776766,1.1399608547931877,0.33781763826606875,0.8879923210396681,1.0,1/20,0.17%,PLB1
prerank,epidermal growth factor receptor binding (GO:0005154),-0.36696951436328823,-1.1395125360005107,0.27702702702702703,0.7184496262244927,1.0,9/25,17.58%,HIP1;TGFA;ERBB4;PLSCR1;LINGO1;GRB2;CNOT9;ATXN2;EGF
prerank,phosphatidylinositol 3-kinase regulator activity (GO:0035014),-0.4013909047659251,-1.1384720240269455,0.2819767441860465,0.7125634474057839,1.0,10/18,25.62%,PIK3R1;SOCS5;PIK3R6;PIK3R3;PIK3R5;PIK3R2;SOCS3;CCKBR;WDR81;AGAP2
prerank,endodeoxyribonuclease activity (GO:0004520),0.4891940697777615,1.1370695747532158,0.3293591654247392,0.8915578983894247,1.0,8/20,19.89%,FEN1;MRE11;ERCC5;MBD4;ENDOV;DCLRE1C;RAD50;ERCC4
prerank,"oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0016616)",0.3963460765529096,1.1353341595090056,0.28041714947856317,0.8916056722932661,1.0,17/75,14.93%,GFUS;ADH7;DHRS4;IMPDH2;HMGCR;ME3;LDHB;PHGDH;PGD;LDHAL6B;EHHADH;AKR1B10;HADHA;HSD17B11;MDH2;HADHB;DCXR
prerank,"DNA binding, bending (GO:0008301)",-0.4310200621023458,-1.1339255909929022,0.2861356932153392,0.7154760405119419,1.0,5/14,17.01%,LEF1;SAP30L;HMGA2;HMGB1;HHEX
prerank,PDZ domain binding (GO:0030165),0.4030468355638484,1.132299604408734,0.2893772893772894,0.8961829538632565,1.0,7/61,9.60%,CXADR;CFTR;CRIM1;ARHGAP29;CXXC4;MAP2K2;LLGL2
prerank,damaged DNA binding (GO:0003684),0.4229706496321325,1.1304702760423269,0.3201530612244898,0.8967758601186852,1.0,15/44,19.89%,FEN1;EP300;CRY2;SDE2;ERCC5;RPA3;APTX;PCNA;DCLRE1C;DDB1;ERCC2;SMC6;NBN;PNKP;ERCC4
prerank,methyltransferase activity (GO:0008168),0.42446913577022505,1.1303972597958258,0.2923076923076923,0.8916809808256344,1.0,19/46,27.60%,CARNMT1;NTMT1;BUD23;GAMT;NNMT;AMT;EEF1AKMT3;MEPCE;PRMT1;ARMT1;COQ3;N6AMT1;TRMT11;LRTOMT;FTSJ1;MGMT;EHMT1;EEF1AKMT2;NDUFAF7
prerank,transmembrane receptor protein phosphatase activity (GO:0019198),-0.4266719496198874,-1.1288145412149104,0.3162162162162162,0.7119399866779077,1.0,3/16,0.50%,PTPRM;PTPRG;PTPRB
prerank,transmembrane receptor protein tyrosine phosphatase activity (GO:0005001),-0.4266719496198874,-1.1288145412149104,0.3162162162162162,0.7119399866779077,1.0,3/16,0.50%,PTPRM;PTPRG;PTPRB
prerank,calcium channel inhibitor activity (GO:0019855),-0.45533438443244434,-1.1285386091816891,0.3258145363408521,0.7039387622039099,1.0,4/11,17.15%,ITPR1;SLC30A1;PACSIN3;FKBP1A
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides (GO:0016812)",-0.4848765464597007,-1.127158194838398,0.3248081841432225,0.6993633117864702,1.0,7/10,39.62%,DPYSL5;CAD;OPLAH;CRMP1;DPYSL4;DPEP1;DPYS
prerank,manganese ion binding (GO:0030145),0.41840449476621655,1.1263877471049524,0.32169576059850374,0.8993423645496694,1.0,6/48,5.73%,FAM20C;MPPED2;FEN1;GALNT1;LARGE1;MGAT1
prerank,poly-pyrimidine tract binding (GO:0008187),0.4699536159501775,1.1259882081977661,0.31484049930651875,0.8954648620576902,1.0,7/23,18.83%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2;PTBP1
prerank,phosphatidylinositol 3-kinase activity (GO:0035004),-0.4488274849061542,-1.124394152124968,0.28888888888888886,0.6988471228459135,1.0,6/12,16.25%,PIK3CB;PIK3R6;PIK3CD;PIK3R3;PIK3C3;IPMK
prerank,semaphorin receptor activity (GO:0017154),0.5291488808198066,1.1226367500033994,0.3639291465378422,0.9007062937161991,1.0,5/11,16.33%,PLXNB1;PLXNA2;NRP2;PLXNB2;PLXNA3
prerank,ATPase activator activity (GO:0001671),-0.378715084035746,-1.1205952782540385,0.326984126984127,0.700366777676481,1.0,8/20,24.17%,ATP1B1;DNAJB4;DNAJA1;DNAJC19;DNAJB2;DNAJC1;DNAJB1;AHSA1
prerank,RNA stem-loop binding (GO:0035613),0.5210916618725004,1.1172791329320635,0.3488372093023256,0.9132787079175049,1.0,4/12,15.32%,ZC3H12A;EPRS1;CPEB3;DHX9
prerank,mRNA methyltransferase activity (GO:0008174),-0.444391824202999,-1.114947916559729,0.3400576368876081,0.7072799637669829,1.0,3/12,10.23%,METTL8;METTL16;TRMT61B
prerank,RNA polymerase core enzyme binding (GO:0043175),0.4336840301621684,1.1139857086007152,0.3252840909090909,0.9183974555541087,1.0,9/33,16.80%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2;SPTY2D1
prerank,phospholipase activity (GO:0004620),0.3889705721463933,1.113654399481573,0.30498177399756987,0.914164975723509,1.0,6/67,7.23%,PLB1;PLCB3;NAPEPLD;PITPNM3;PLA2G12A;PLCL1
prerank,protein serine/threonine phosphatase inhibitor activity (GO:0004865),0.5215001357570193,1.1073710366940883,0.3868378812199037,0.9286127545709254,1.0,2/11,10.21%,PPP1R14B;PPP1R11
prerank,histone acetyltransferase activity (GO:0004402),0.42983983271315357,1.1070442917987013,0.3526170798898072,0.9245106136092878,1.0,4/30,6.62%,NCOA3;EP300;NAA40;KAT6B
prerank,histone deacetylase activity (GO:0004407),0.4707025601329134,1.1015892803231526,0.36,0.9370535011586351,1.0,5/19,17.35%,HDAC5;HDAC4;HDAC3;MIER2;HDAC6
prerank,poly(U) RNA binding (GO:0008266),0.4682573312200391,1.1014037979850242,0.349002849002849,0.9324730453222414,1.0,6/20,18.30%,PABPC4L;PABPC1L;RBMS3;DAZAP1;PATL1;RBMS2
prerank,neuropeptide receptor binding (GO:0071855),0.5090994381263898,1.1008047404028098,0.37576687116564417,0.9291072806269542,1.0,1/14,1.37%,GAL
prerank,dicarboxylic acid transmembrane transporter activity (GO:0005310),-0.3371619308482814,-1.100499438262831,0.3236363636363636,0.7383484649986717,1.0,4/29,5.61%,SLC13A3;SLC26A7;SLC1A5;SLC1A1
prerank,heme binding (GO:0020037),-0.2844004887001671,-1.1003923104221365,0.2710843373493976,0.7302697059492926,1.0,14/65,10.38%,GUCY1B1;NOS3;PTGIS;FLVCR2;NOX4;CYP1B1;CYP26B1;PTGS2;HEBP1;PGRMC2;JAK2;COX15;RSAD1;SDHC
prerank,phospholipid transfer activity (GO:0120014),0.4611067835911393,1.0990735629403376,0.3493253373313343,0.9292837197281787,1.0,3/21,6.33%,PITPNM2;PITPNC1;PRELID3B
prerank,protein tyrosine/serine/threonine phosphatase activity (GO:0008138),0.4615238381543907,1.0954593607898868,0.3712230215827338,0.9353005412178271,1.0,4/22,10.12%,DUSP10;DUSP12;DUSP1;MTMR3
prerank,CoA hydrolase activity (GO:0016289),0.4902151550232828,1.0953968777716243,0.3882896764252696,0.9303957671408231,1.0,2/16,2.68%,ACOT8;ABCD1
prerank,histone demethylase activity (H3-K9 specific) (GO:0032454),0.5223840844904031,1.0928465856719893,0.3824,0.9336163052746985,1.0,5/12,16.83%,KDM4D;KDM4B;KDM3A;KDM4C;KDM1A
prerank,retinoid binding (GO:0005501),-0.3638661752514184,-1.0927821911586033,0.33225806451612905,0.7420034263831502,1.0,3/22,5.05%,ALDH1A2;NR2F2;CYP26B1
prerank,transmembrane receptor protein tyrosine kinase adaptor activity (GO:0005068),-0.4205236694477477,-1.09054031510197,0.34120734908136485,0.739811161326832,1.0,6/12,19.38%,PIK3R1;SH2B3;GAB2;BLNK;SH2B2;TRADD
prerank,intracellular ligand-gated ion channel activity (GO:0005217),-0.4517687099955786,-1.089574429919704,0.3515625,0.7339271082991206,1.0,3/11,14.11%,ITPR1;MCOLN1;RYR2
prerank,death receptor activity (GO:0005035),0.5273554659561764,1.0894866164658512,0.3780290791599354,0.9393672403064532,1.0,3/11,9.01%,EDA2R;TNFRSF10B;TNFRSF1A
prerank,antiporter activity (GO:0015297),0.4686494809036274,1.088494143373922,0.3770491803278688,0.9374447727841327,1.0,8/20,22.76%,SLC35D3;CLCN4;SLC25A14;SLC35E2B;SLC35E2A;ATP1A3;SLC35C2;SLC25A11
prerank,cation transmembrane transporter activity (GO:0008324),0.399198748689121,1.0872714152595457,0.3393782383419689,0.9365569158149756,1.0,16/48,20.86%,SLC36A3;SLC66A1;OCA2;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;PKD2L1;SLC41A1;SLC6A7;SLC7A3;SLC8B1;SLC38A7;SLC25A2;SLC38A6
prerank,RNA polymerase II complex binding (GO:0000993),0.4164119725224963,1.0859502697347583,0.3627450980392157,0.935873898134637,1.0,8/32,15.56%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,protein kinase inhibitor activity (GO:0004860),0.40981679759125705,1.0857414079659757,0.35714285714285715,0.9316155774311456,1.0,13/42,19.02%,PARVA;CDKN1A;QARS1;ITPRIP;YWHAB;SMCR8;DUS2;DNAJC3;PPP1R1B;HEXIM1;CAMK2N1;SH3BP5L;TAOK3
prerank,cytokine receptor activity (GO:0004896),0.3732921247615863,1.0846978637232,0.3491329479768786,0.9300147463310487,1.0,10/83,5.95%,CD44;CRLF1;CCR4;IL17RE;IL17RA;ACKR4;ACKR2;IL3RA;GFRA3;CCRL2
prerank,retinoid X receptor binding (GO:0046965),-0.43922062477346613,-1.0837334865405928,0.3316708229426434,0.7413248681514327,1.0,5/11,21.27%,TACC1;NSD1;PPARG;NR4A2;NRIP1
prerank,transforming growth factor beta binding (GO:0050431),0.4502065437920861,1.0825216964515214,0.4029197080291971,0.9316118370910742,1.0,3/23,5.04%,CD109;TWSG1;LTBP4
prerank,chemoattractant activity (GO:0042056),0.4325704079752186,1.0812071349278367,0.37047353760445684,0.9305499616782393,1.0,5/26,8.79%,CCL5;GDNF;BMP4;LGALS3;VEGFB
prerank,RNA 7-methylguanosine cap binding (GO:0000340),0.5031973630145414,1.0750673544098115,0.39800995024875624,0.9442421025324789,1.0,1/12,0.78%,CYFIP2
prerank,lysine N-methyltransferase activity (GO:0016278),0.44538871761578197,1.0742323528012834,0.378125,0.941918318214984,1.0,9/20,27.19%,EEF2KMT;EEF1AKMT3;SETD7;ATPSCKMT;ANTKMT;KMT5A;SMYD2;EHMT1;EEF1AKMT2
prerank,polynucleotide adenylyltransferase activity (GO:0004652),-0.4329126746431621,-1.0739702466829129,0.36923076923076925,0.760486919492861,1.0,6/12,20.08%,TENT5A;PAPOLA;PAPOLG;TENT5D;TENT2;PAPOLB
prerank,peptide alpha-N-acetyltransferase activity (GO:0004596),0.5109592613026573,1.0720490909031435,0.3927392739273927,0.9434979743933332,1.0,4/11,13.92%,NAA40;NAA15;NAA20;NAA10
prerank,voltage-gated anion channel activity (GO:0008308),0.4816333825143231,1.0712725762650985,0.39069767441860465,0.940999083882548,1.0,6/15,15.06%,VDAC2;CLCN4;ANO6;VDAC1;GPR89A;GPR89B
prerank,ligand-gated calcium channel activity (GO:0099604),-0.36678214889472516,-1.070885499370009,0.38857142857142857,0.76060306465044,1.0,4/19,7.83%,ITPR1;GRIN2A;GRIN2B;MCOLN1
prerank,protein kinase binding (GO:0019901),0.33587879543082055,1.0707779261748818,0.3173173173173173,0.937658741519924,1.0,116/479,18.47%,PRKCB;UTRN;ANK2;DAXX;PDLIM5;TJP2;TRIB2;EPHA4;GRK5;CDKN1A;ADAM10;EMP2;CAV1;MAVS;NBEAL2;EEF1A1;HDAC5;QARS1;PRR7;FOXO3;RELB;AP2A2;DUSP10;CAVIN2;HSPB1;PPP1R15A;PIH1D1;DUSP1;CAV2;BCL2L1;RNF138;FOXM1;SPRED3;SOX9;SHC1;PFKFB2;CSK;MAPK7;MSN;CCND2;SYN1;TRIM21;BAD;ILK;LATS1;SRCIN1;ADCY6;PKD1;PARD6B;FZD5;LRBA;TCF7L2;IQGAP1;OXSR1;CDC42;ACSL3;FBXO5;CDK5RAP1;ACTB;PTPN6;EZR;CCND1;DACT2;SMCR8;NELL2;ZC3HC1;EXOC2;PKIA;MVP;AP2A1;SLC12A4;RHOA;YWHAZ;BCAR1;PPP1CB;JTB;PTPN2;MAPKAP1;KCNA5;PTN;PPM1D;MAP3K13;VDAC1;GSK3A;IRAK1;SHC2;PRKAR2A;GSK3B;CCDC88A;WNK1;DNAJC3;TNIP1;TNNI3;HSP90AA1;RB1CC1;ITGB2;PRKCSH;EEF2;FAM83H;AP1B1;CRK;ARHGAP33;ABL1;PRKAG1;NSF;CDC25B;MAPKAPK2;MTCP1;CDH5;CHEK2;DUSP3;PTPN11;CAMK2N1;SUFU;RARA;ATF2
prerank,"phosphatidylinositol-3,5-bisphosphate binding (GO:0080025)",-0.3471538794049711,-1.069944635841952,0.3742138364779874,0.7548960327857839,1.0,5/23,8.09%,HIP1;SH3PXD2B;CLVS2;SNX14;PLEKHA4
prerank,phosphatase activator activity (GO:0019211),0.48906326720931625,1.0694421210048597,0.3981623277182236,0.9368040866700875,1.0,2/14,5.00%,GTF2F1;PPP1R15A
prerank,steroid hydroxylase activity (GO:0008395),-0.4002093682848764,-1.0690430258379662,0.36065573770491804,0.7493696306924141,1.0,2/16,4.52%,CYP7B1;CYP1B1
prerank,active ion transmembrane transporter activity (GO:0022853),0.40468327478699956,1.0663073659203008,0.36712328767123287,0.9414808541428056,1.0,8/37,11.32%,SLCO2A1;ATP13A3;COX5A;COX8A;UQCRC1;COX7A2L;COX5B;SLC22A8
prerank,guanyl ribonucleotide binding (GO:0032561),0.341457804136942,1.0615648591783426,0.3590010405827263,0.9513131928371299,1.0,47/196,19.25%,RAB17;PDE5A;MPPED2;MRAS;RAP1B;EEF1A1;RAP1A;RAB9B;ARL4A;CNGA2;ARL3;RHOQ;EIF2B2;NRAS;KRAS;RHEB;GLUD1;CNGB3;RAB3B;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;ARFIP2;RHOA;RABL3;CNGB1;ARF4;RHOU;RAB5C;TUBB2B;RAB1B;HRAS;ATL2;RAP2C;ARL8A;ADSS2;DIRAS2;RAB8B;SLC19A1;RNF112;RAB27A;RAB9A;RHOT2
prerank,tRNA (guanine) methyltransferase activity (GO:0016423),-0.41738189480196236,-1.0589699166888866,0.40700808625336926,0.7677921012202119,1.0,7/13,21.98%,TARBP1;METTL1;TRMT10A;THUMPD2;TRMT5;TRMT1L;TRMT10C
prerank,zinc ion transmembrane transporter activity (GO:0005385),-0.3550328542047251,-1.0584146401858614,0.37941176470588234,0.7617330210296047,1.0,5/20,12.48%,SLC30A10;SLC39A12;SLC39A8;SLC39A10;SLC30A1
prerank,glycerophospholipid flippase activity (GO:0140333),0.5006008909980193,1.0582521124925441,0.41318327974276525,0.9564689041090079,1.0,2/11,6.78%,ATP10A;ATP8B2
prerank,LRR domain binding (GO:0030275),0.4816523668562078,1.0578764798393077,0.4180064308681672,0.9526038494335485,1.0,4/14,14.31%,PAWR;DAPK3;LRRFIP2;ZXDC
prerank,serine-type endopeptidase inhibitor activity (GO:0004867),0.4046893600219503,1.0567895887877965,0.39021164021164023,0.95123200716263,1.0,5/38,8.78%,SLPI;SPINT2;SERPINC1;ANXA2;SERPINB8
prerank,phosphate ion binding (GO:0042301),-0.43840854803389717,-1.0562054143784525,0.38563829787234044,0.7598766502065907,1.0,4/10,21.50%,RPH3A;PDE2A;PNP;ADSS1
prerank,ribonuclease activity (GO:0004540),0.38169138947166914,1.050760363302255,0.39167686658506734,0.964863140407826,1.0,10/56,10.61%,CNOT6;ZC3H12A;KHNYN;RNASEL;ANG;TSNAX;EXOSC3;YBEY;RNASE3;LACTB2
prerank,purinergic nucleotide receptor activity (GO:0001614),-0.39093728788787374,-1.0504597328296952,0.40607734806629836,0.7675702912425678,1.0,12/15,50.59%,P2RY14;P2RY1;P2RY12;PTAFR;GPR34;P2RX5;P2RX3;P2RX6;GPR171;P2RX1;GPR87;P2RY13
prerank,titin binding (GO:0031432),0.4877054511247286,1.0491051613686342,0.4386503067484663,0.9651883566222677,1.0,1/13,1.06%,ACTN2
prerank,calmodulin-dependent protein kinase activity (GO:0004683),0.43237412660570607,1.0482493656719625,0.4142857142857143,0.963062119837687,1.0,5/24,6.26%,MKNK2;PTK2B;DAPK1;CAMKK1;PHKA2
prerank,syntaxin binding (GO:0019905),0.37453658562303044,1.0474505778410355,0.39324487334137515,0.9607741709199812,1.0,19/61,17.47%,UNC13C;SYP;CACNA1A;BLOC1S6;DAPK1;STXBP1;VPS54;VPS11;PTPN2;NAPA;NAPB;VPS52;VPS18;SYT6;STX16;SYT12;ABL1;NSF;VAMP1
prerank,lysine-acetylated histone binding (GO:0070577),0.44539018769824895,1.0471380196783713,0.4305343511450382,0.9524779664751197,1.0,7/20,17.90%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRD9;BRDT
prerank,acetylation-dependent protein binding (GO:0140033),0.44539018769824895,1.0471380196783713,0.4305343511450382,0.9524779664751197,1.0,7/20,17.90%,MLLT3;KMT2A;BRD7;DPF2;SMARCA4;BRD9;BRDT
prerank,ribosomal large subunit binding (GO:0043023),0.4902354952454871,1.0460820855379485,0.4278523489932886,0.951365197315374,1.0,3/11,9.97%,CPEB2;EIF6;LTN1
prerank,microtubule binding (GO:0008017),0.33138465119468563,1.0459751998684392,0.36522633744855965,0.9471339686703819,1.0,48/222,19.21%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;NDRG1;NDEL1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;KIF1C;EML2;KIF1B;MAP4;CLIP4;KRIT1;PSRC1;CETN3;CCDC181;CHP1;GAS2L1;EZR;HDGFL3;HOOK1;PAFAH1B1;MARK4;ABRAXAS1;OPA1;TPGS1;CCDC88A;GAPDH;DNM1L;MAP1LC3B;REEP4;KIF17;CAMSAP1;RMDN3;HDAC6;NUMA1;SUN2;FHDC1;KIF20B;RAE1;TUBGCP5;HOOK3
prerank,GDP-dissociation inhibitor activity (GO:0005092),0.47586226784438557,1.0422503094236792,0.4330708661417323,0.9536434929908959,1.0,4/13,15.34%,SH3BP4;CCDC88A;ITGB1BP1;ARHGDIB
prerank,nucleobase-containing compound kinase activity (GO:0019205),0.4528686079990334,1.0417686161274353,0.42255639097744363,0.9505506380549917,1.0,5/17,16.64%,AK1;CMPK1;AK3;AK5;CLP1
prerank,calcium-release channel activity (GO:0015278),0.4539121577202547,1.0414109367755948,0.4355083459787557,0.9470737895380383,1.0,5/17,13.39%,ITPR2;TPCN1;ITPR3;RASA3;TRPM2
prerank,voltage-gated ion channel activity (GO:0005244),-0.3928040841244238,-1.0410299361858624,0.37771739130434784,0.78508189529969,1.0,4/14,6.83%,KCND2;CACNA1E;PKD2;VDAC3
prerank,"phosphatidylinositol-4,5-bisphosphate binding (GO:0005546)",0.3639269168906447,1.0402527061429154,0.4106280193236715,0.9460859181782898,1.0,16/72,10.90%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;TWF1;AVIL;ANXA2;KRIT1;JPH2;RAB35;GSDME;SNX18
prerank,ubiquitin-ubiquitin ligase activity (GO:0034450),0.49785767377110696,1.038847976541766,0.43106180665610144,0.9458150325072301,1.0,5/11,17.31%,RBX1;UBE4A;UBR5;PRPF19;STUB1
prerank,basal RNA polymerase II transcription machinery binding (GO:0001099),0.39709727636053216,1.0387891744069369,0.4061624649859944,0.9416348696749044,1.0,8/33,15.56%,NCOA3;ESRRB;ELP4;RPRD2;WDR43;ERCC5;DHX9;ELP2
prerank,NADH dehydrogenase (quinone) activity (GO:0050136),0.3998365188248801,1.0370104127144106,0.41620879120879123,0.9381355300536052,1.0,13/34,23.41%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12;NDUFB10
prerank,NADH dehydrogenase (ubiquinone) activity (GO:0008137),0.3998365188248801,1.0370104127144106,0.41620879120879123,0.9381355300536052,1.0,13/34,23.41%,NDUFV1;NDUFB8;NDUFB6;NDUFS3;NDUFB7;NDUFV2;NDUFA1;NDUFB4;NDUFB5;NDUFB9;NDUFA2;NDUFA12;NDUFB10
prerank,potassium channel regulator activity (GO:0015459),-0.281454942245713,-1.0361725064839549,0.4106280193236715,0.7906125711669173,1.0,10/49,16.57%,DPP10;SGK1;ABCC9;KCNIP4;WNK2;KCNIP3;KCNIP1;DPP6;KCNMB4;SLC5A3
prerank,sequence-specific mRNA binding (GO:1990825),-0.43817276970489355,-1.0342971192185229,0.40848806366047746,0.7880116318731153,1.0,6/10,27.59%,DHFR;SHFL;LARP6;TYMS;FMR1;RBM24
prerank,monocarboxylic acid binding (GO:0033293),0.4525038508794698,1.033417149580899,0.41384615384615386,0.9441243258507847,1.0,1/18,0.90%,NAPEPLD
prerank,postsynaptic neurotransmitter receptor activity (GO:0098960),-0.35825622063396156,-1.030212587329331,0.38485804416403785,0.7912861413838941,1.0,14/21,52.93%,GRM5;GRM1;CHRNB1;ANXA9;CHRNA4;CHRNB2;CHRNA5;CHRNG;CHRNA3;CHRNE;CHRNB4;CHRNB3;DRD5;CHRNA1
prerank,hydro-lyase activity (GO:0016836),0.38264738336884657,1.0297169011553426,0.4064516129032258,0.9506069929869491,1.0,12/41,18.91%,ECHDC1;UROS;EHHADH;HACD4;ENO2;HADHA;ACO2;AUH;HADHB;ECHS1;PARK7;APIP
prerank,FAD binding (GO:0071949),0.4205899802535236,1.0288626814515447,0.4289897510980966,0.9487846507733217,1.0,5/24,8.62%,MICAL2;CYB5R3;NQO2;MICAL1;CRY2
prerank,microtubule motor activity (GO:0003777),0.37493785243324973,1.0288291983215494,0.4308641975308642,0.944641312963405,1.0,6/51,6.67%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,Notch binding (GO:0005112),-0.3454311001897119,-1.0286899143627097,0.39628482972136225,0.7877388913501889,1.0,6/22,13.64%,JAG1;MEGF10;DTX1;JAG2;NOTCH4;CCN3
prerank,RNA polymerase II core promoter sequence-specific DNA binding (GO:0000979),0.49100448939970287,1.0271273923578856,0.42857142857142855,0.9455078974731567,1.0,4/12,19.86%,FOS;TBPL1;H3-3A;TBP
prerank,cis-regulatory region sequence-specific DNA binding (GO:0000987),0.31846770841726657,1.0261134839317385,0.389,0.9442576034433752,1.0,118/732,14.34%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;FOXN3;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZIK1;HOXA5;ZBTB17;RXRB;SOX9;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;SIX1;MAZ;JUN;POU3F1;TCF7L2;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,receptor tyrosine kinase binding (GO:0030971),0.3631816135553289,1.0257431641083858,0.43209876543209874,0.9411557517811769,1.0,6/56,7.76%,PITPNM2;ANGPT1;PTPN14;PITPNM3;SHC1;FIZ1
prerank,nuclease activity (GO:0004518),0.37530358987587836,1.0254963506057244,0.4352651048088779,0.9376438667563214,1.0,17/52,23.62%,ZC3H12A;FEN1;RNASEL;MRE11;ANG;XRN2;RNASE3;DNASE1L2;ERCC5;DNASE1L1;REXO4;RNASE4;RNASE7;PNKP;N4BP2;MAP1S;APEX1
prerank,H4 histone acetyltransferase activity (GO:0010485),0.5038939683947339,1.0251607965769154,0.4623287671232877,0.9344937253292813,1.0,5/10,21.65%,EP300;NAA40;ATF2;USP22;HAT1
prerank,NAD+ ADP-ribosyltransferase activity (GO:0003950),-0.33219756967585434,-1.0215794871839892,0.41,0.7991545178246329,1.0,5/25,9.01%,ZC3HAV1;ART3;PARP14;PARP8;TNKS
prerank,excitatory extracellular ligand-gated ion channel activity (GO:0005231),-0.3524403157808341,-1.020817345682034,0.4369230769230769,0.7939131311095434,1.0,8/21,38.35%,GRIK2;GLRB;CHRNB1;CHRNA4;CHRNB2;P2RX5;P2RX3;P2RX6
prerank,beta-tubulin binding (GO:0048487),0.4026705061899458,1.0205742799319337,0.431266846361186,0.9432761783982966,1.0,2/31,3.65%,FGF13;GJB6
prerank,gated channel activity (GO:0022836),0.4656598222521312,1.020039562534172,0.456,0.9407721112035041,1.0,6/14,21.05%,TMC6;TMC2;PACC1;TMEM63B;TMC4;TMEM266
prerank,adrenergic receptor binding (GO:0031690),-0.36080441226176646,-1.019353229108013,0.38699690402476783,0.7904020591582709,1.0,3/16,1.74%,RAPGEF2;GNAS;PDE4D
prerank,actin monomer binding (GO:0003785),0.4291236560950187,1.0181002401405357,0.4531024531024531,0.9419558250658262,1.0,6/22,16.82%,COBL;LMOD3;TWF1;MYL4;PFN2;ABL1
prerank,"inositol 1,4,5 trisphosphate binding (GO:0070679)",-0.4121310192598048,-1.0179173537580684,0.40789473684210525,0.7871121270143743,1.0,6/11,10.96%,ITPR1;TRPC3;TRPC4;RPH3A;TRPC6;TRPC5
prerank,leak channel activity (GO:0022840),-0.3673149790839057,-1.0172812607251938,0.4349112426035503,0.7817174223502954,1.0,3/18,8.33%,KCNK2;KCNK5;PANX1
prerank,ubiquitin-like protein ligase binding (GO:0044389),0.3211436528939821,1.01724284711271,0.4418367346938776,0.9403605851021377,1.0,62/268,18.00%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;PRR7;ERLIN2;BAG1;NFKBIA;ELOB;PATZ1;POLR2A;DDRGK1;MUL1;ERBB3;UQCRC1;JUN;FZD5;RBX1;PML;SUMO2;SUMO3;UBE2B;APBB1;ACTG1;HSPBP1;JAK1;YWHAZ;UBXN7;NPLOC4;PRKAR2A;GSK3B;DNM1L;WASHC1;MAP1LC3B;MDM2;SYT11;HSP90AA1;IKBKG;RNF31;UBE2N;CCDC50;TPI1;HM13;RPS27A;UBC;VCL;SMC6;SMAD5;STUB1;HDAC6;UBE2J1;CHEK2;PSMD1;USP25;STAM;TRIM37;TSG101
prerank,calcium-dependent phospholipase A2 activity (GO:0047498),-0.37957846159053366,-1.016030111347217,0.42934782608695654,0.7776913483825456,1.0,1/15,0.46%,PLA2G4A
prerank,snRNA binding (GO:0017069),0.38562945319065733,1.012370280909725,0.4514501891551072,0.949320749705782,1.0,13/42,24.66%,LSM10;SNRNP70;LARP7;LSM4;DDX39B;SF3B3;MEPCE;HEXIM1;TUT1;PRPF8;GEMIN5;CDK9;SNRPB2
prerank,nucleoside diphosphate kinase activity (GO:0004550),0.45343595023274863,1.0109645459207415,0.4666666666666667,0.9491629470676857,1.0,3/14,10.00%,AK1;CMPK1;AK5
prerank,RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978),0.3136482004170848,1.010230469110064,0.457,0.9470884576606371,1.0,118/731,14.34%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZIK1;HOXA5;ZBTB17;RXRB;SOX9;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;SIX1;MAZ;JUN;POU3F1;TCF7L2;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;TWIST1;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,sodium channel regulator activity (GO:0017080),0.3871915725295555,1.0094323268484955,0.4425363276089828,0.9451703741862486,1.0,2/37,3.69%,FGF13;SGK3
prerank,superoxide-generating NAD(P)H oxidase activity (GO:0016175),-0.4236922315652405,-1.0087958203019667,0.4623376623376623,0.7901660484848375,1.0,3/10,21.29%,NOX4;NCF2;CYBB
prerank,carbohydrate kinase activity (GO:0019200),0.4871702388634828,1.0086918322037968,0.4909983633387889,0.9431846954022369,1.0,4/11,17.14%,NAGK;HK1;GALK2;GNE
prerank,glutamate receptor binding (GO:0035254),-0.3651891250922762,-1.008252876783113,0.44610778443113774,0.7844401010588551,1.0,4/17,4.94%,HIP1;GNAS;SHANK3;SHISA6
prerank,metalloexopeptidase activity (GO:0008235),0.36713233673689977,1.0081936569894474,0.43703703703703706,0.9405983236271729,1.0,6/51,7.95%,CPB1;CPA4;CPA3;AGTPBP1;CPE;AGBL1
prerank,RNA binding (GO:0003723),0.31247518424876997,1.008121092192107,0.469,0.9368413890051281,1.0,320/1321,20.02%,MBNL1;MSI2;NUDT4;CELF2;NSA2;PPARGC1A;STRBP;AHNAK;VIM;LSM10;PABPC4L;SAMD4A;DDX5;CPEB2;GTF2F1;YTHDF1;ZC3H12A;SRSF2;SLPI;GRWD1;PABPC1L;EEF1A1;SAMD4B;CELF1;DGCR8;PEF1;EPRS1;DIAPH1;RBFOX2;CDC42EP4;CMSS1;CTNNA1;PCDH20;MRPL37;MRPL2;ACIN1;NOP2;YBX3;RBM19;PES1;HSPB1;TRIM25;PPAN;ADK;BUD23;MTDH;UTP11;FARS2;DMGDH;FDPS;KHNYN;SNRNP70;SON;CCDC9;SNRPB;RPS4X;UNK;EIF3L;TARBP2;USP10;SLTM;MRPS7;POLR2A;KIF1C;SRRM2;PKM;RNASEL;ADD1;SUCLG1;MOV10;TES;EIF4A3;SLIRP;ANXA2;UTP23;RBMS3;MAP4;PSMD4;MSN;SSRP1;FLNB;RBM20;DHX32;SMG7;SIDT2;NKAP;UNC50;KRR1;PRRC2C;ANG;RALY;MAK16;TSNAX;LARP7;LSM4;POP4;ABCF1;STXBP1;LGALS3;L1TD1;MAZ;JUN;ELP5;UBTF;DDX39B;RBM8A;XRN2;RPL31;RPSA;EXOSC3;EIF4B;HNRNPH2;SUMO2;POP1;GSPT2;WDR33;RPL22;MOV10L1;ERI3;GTPBP10;MYO5A;AGFG1;EZR;THG1L;PHF5A;AARS1;DBR1;MRPS23;ILF2;RRP12;LUC7L3;BMS1;DDX55;SRPK2;NIP7;MTREX;DHX57;MRPS27;WDR43;KHDC4;LACTB2;SRRM4;R3HDM2;HABP4;PLEC;WDR36;RPL28;CSNK1E;ZMAT3;TBRG4;PWP2;SRSF7;ANKRD17;MDH2;DDX47;SRBD1;YWHAZ;SF3A2;ZCCHC24;FASN;RPS26;POLDIP3;EIF4G2;RBM42;PSTK;MRPL9;NAA15;WDR6;RPP21;ZCCHC8;CPEB3;FRG1;FAM133B;SRPK1;HNRNPUL1;GPATCH1;SYNCRIP;GAR1;GOLGB1;CHD3;TUT7;IBA57;CCDC9B;FXR1;RBM10;NOC4L;DAZAP1;LGALS1;RNPS1;HARS2;PNN;RPL10A;REXO4;R3HDM1;NOL6;PINX1;RRP9;CSTF1;TPD52L2;LTA4H;FNDC3A;SRSF9;MRPS15;DCP1A;SRRT;TNPO1;SARS2;SARS1;DUS2;UPF3B;EIF4G1;ALDOA;TRNT1;ENDOV;YARS1;PYM1;RPF1;ZFR2;HADHB;RBM18;UTP14A;APTX;GRSF1;EIF4A1;RBM46;DDX18;TLR3;UTP4;ISY1;FBRSL1;DHX9;EIF5B;HSP90AA1;EIF3B;TRNAU1AP;MBNL2;PABPN1;RBM47;OAS2;IMMT;IMP4;LUC7L2;CCDC47;ACTN4;FLNA;CWC15;FSCN1;UBE2N;MEPCE;MRPS28;MRPS35;CDC5L;RPL14;DUSP11;MEX3D;RRBP1;MAGOHB;MAGOH;EEF2;RBPMS2;ATXN2L;ARHGEF1;CANX;EIF1;CTU1;RPS27A;UBC;PRR3;HEXIM1;SELENOH;RBM28;KDM1A;PRPF40B;DYNC1H1;EIF2AK4;ZYX;PRMT1;ASS1;PRPF6;FARSA;EIF4A2;CLUH;PATL1;PDCD11;SEC23IP;HNRNPA3;PPP1R10;IGF2BP3;IMP3;RBMS2;SRSF1;PARK7;RAE1;SNUPN;UBAP2L;YTHDF3;ROCK2;DARS2;PTBP1;SRSF5;IGF2BP2;UBFD1;TRMT10B;RPL6;MYO18A;ALDH18A1;HDGF;PCBP2;NUCKS1;GCN1;DXO;CSTF3;TRUB2;CDK11B;ANKHD1;WBP4;SF3A3;RPS28;DDX20;HSD17B10
prerank,Hsp90 protein binding (GO:0051879),-0.30386411520683904,-1.0079530921171977,0.44,0.7783888988691183,1.0,7/33,9.24%,PACRG;HIF1A;KDR;TSC1;SLC12A2;NPAS2;HSF1
prerank,small GTPase binding (GO:0031267),0.3280651766027881,1.005838917973259,0.4702127659574468,0.9391015958094774,1.0,39/169,16.15%,RNF152;SRGAP2;NDRG1;AKAP13;CAV1;CDC42EP4;EHD1;DAPK3;UNC13D;CDC42EP5;YBX3;MLPH;SH3BP4;RAB11FIP3;TSC2;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;DMXL2;MYO5A;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;WASF1;MAPKAP1;EXOC8;OCRL;CHML;ULK1;DNM1L;USP6NL;ARHGDIB;FLNA;RIN3
prerank,phosphoric diester hydrolase activity (GO:0008081),0.38768407920002523,1.004355319025486,0.46226415094339623,0.9391308446503155,1.0,3/35,1.74%,PLCB3;NAPEPLD;MPPED2
prerank,histone methyltransferase activity (GO:0042054),0.39920634003366023,1.004181305393094,0.4535367545076283,0.9357547501281097,1.0,15/32,26.59%,NTMT1;DOT1L;SMYD3;SETDB1;PRMT1;PRMT2;SETD7;SMYD1;MEN1;KMT5A;KMT2C;KMT2E;N6AMT1;SMYD2;EHMT1
prerank,"exodeoxyribonuclease activity, producing 5'-phosphomonoesters (GO:0016895)",0.4894340619905839,1.0037910288921705,0.47163695299837927,0.9329375767939133,1.0,4/10,27.17%,FEN1;DCLRE1C;APEX1;POLD1
prerank,exonuclease activity (GO:0004527),0.3796897356074532,1.0026188739449997,0.4719387755102041,0.9321128449582525,1.0,13/46,20.45%,CNOT6;ZC3H12A;FEN1;MRE11;XRN2;EXOSC3;POLG;REXO4;FAN1;DCLRE1C;RAD50;DXO;APEX2
prerank,endoribonuclease activity (GO:0004521),0.39456659808097466,1.00173272762419,0.44850948509485095,0.9307842562046136,1.0,7/32,14.49%,ZC3H12A;KHNYN;RNASEL;TSNAX;YBEY;LACTB2;ENDOV
prerank,transferrin receptor binding (GO:1990459),0.48397306929099543,1.001341720383038,0.4743150684931507,0.9280781454421927,1.0,7/10,28.09%,CD81;CHUK;IKBKG;IKBKB;SNX2;HFE;SNX4
prerank,protein phosphatase inhibitor activity (GO:0004864),0.4107546099380189,1.000959328715148,0.46657381615598886,0.9253175762950014,1.0,7/26,15.10%,PPP1R14B;LGALS3;LMTK2;PPP1R11;PTN;SET;PPP1R1B
prerank,ion channel inhibitor activity (GO:0008200),0.3917101722354789,1.0004978132155902,0.4651474530831099,0.922839482825695,1.0,7/35,15.16%,CFTR;MCUB;VTI1B;RASA1;WNK1;NEDD4;TNNI3
prerank,actinin binding (GO:0042805),0.42251707906327446,0.9998210916384404,0.4654919236417034,0.9208757065049088,1.0,6/21,12.56%,PDLIM5;DAG1;CSRP3;MYOT;PKD2L1;KCNA5
prerank,BMP binding (GO:0036122),-0.4092741239454202,-0.9990744421898442,0.45454545454545453,0.7944045008635459,1.0,2/11,1.85%,ENG;GREM2
prerank,"proton-transporting ATPase activity, rotational mechanism (GO:0046961)",0.4356933314508117,0.9988839522899935,0.4597875569044006,0.9160339273919065,1.0,11/16,31.12%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,"ATPase activity, coupled to transmembrane movement of ions, rotational mechanism (GO:0044769)",0.4356933314508117,0.9988839522899935,0.4597875569044006,0.9160339273919065,1.0,11/16,31.12%,ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,SH3 domain binding (GO:0017124),0.3541467812908708,0.9981173925968515,0.48954489544895446,0.9143805579242295,1.0,10/62,10.44%,ADAM12;ENAH;ESPN;MAPK15;AFAP1;AFAP1L1;MICAL1;ABI1;AKAP5;ADAM15
prerank,acylglycerol lipase activity (GO:0047372),-0.4144609686155946,-0.9976002443845776,0.4617283950617284,0.7916164724791148,1.0,5/11,17.24%,ABHD3;MGLL;LIPE;ABHD12;ABHD2
prerank,protein serine/threonine kinase activity (GO:0004674),0.31388559190458937,0.9967243602079473,0.5086119554204661,0.914274605573657,1.0,85/334,20.47%,PRKCB;MAP3K8;PRKAA2;LIMK2;FAM20C;NRBP2;MAP3K5;GRK5;TSSK6;TSSK4;IKBKE;NEK7;CDK10;CDK6;MKNK2;PTK2B;SGK3;DAPK3;DAPK1;CDKL2;CDK4;CAMKK1;STK39;SIK3;MAPK15;MAPK7;MAP3K4;CDK16;PLK3;ILK;LATS1;DYRK1B;STK16;OXSR1;MAPK9;AURKC;BCR;LMTK2;TRIO;RAF1;CASK;SRPK2;CDKL4;GRK2;PKMYT1;CSNK1E;MARK4;TGFBR2;EIF2AK3;SRPK1;MAP3K13;CDK2;GSK3A;IRAK1;CHUK;ULK1;GSK3B;WNK1;CDC42BPA;PLK2;TESK1;AAK1;PAK6;TTK;ATR;PRKCZ;MAP3K6;MAPK6;EIF2AK4;MAPKAPK2;CHEK2;BMPR1A;PRKCQ;STK38L;STK24;ROCK2;TAOK3;PRKD2;IRAK4;MAP3K1;CDK11B;CDC42BPG;CAMK2B;PRKAB2;PIK3R4
prerank,tubulin binding (GO:0015631),0.31255938212449474,0.9944447780194976,0.48582995951417,0.9164013618622924,1.0,61/295,18.92%,FGF13;MAPRE2;RP1;DYNC1I1;FMN1;DAG1;NDRG1;DIXDC1;NDEL1;KIF2A;KIF13A;GJB6;REEP3;MAP6;ARL3;AGTPBP1;KIF1C;EML2;KIF1B;MAP4;KRIT1;AGBL1;GPAA1;PSRC1;CETN3;CCDC181;CHP1;GAS2L1;EZR;HDGFL3;HOOK1;BCAS3;PAFAH1B1;RAB11FIP5;EFHC2;MARK4;ABRAXAS1;BLOC1S2;OPA1;TPGS1;ALDOA;CCDC88A;GAPDH;DNM1L;WASHC1;MAP1LC3B;ARL8A;REEP4;KIF17;CAMSAP1;RMDN3;GIT1;HDAC6;RITA1;NUMA1;SUN2;FHDC1;KIF20B;RAE1;TBCE;TUBGCP5
prerank,CCR chemokine receptor binding (GO:0048020),0.40376293115337086,0.9928430100195197,0.46582984658298465,0.9171214998363824,1.0,2/28,5.95%,CCL5;CCRL2
prerank,calcium ion binding (GO:0005509),0.308484288343793,0.9915681231329907,0.5217831813576495,0.9167889045179071,1.0,41/323,12.09%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;ANXA8;ANXA8L1;GSN;S100A6;S100A10;OTOF;PITPNM3;ANXA4;LTBP4;S100A11;ANXA5;FBLN1;ANXA2;MICU1;DSC3;DSC2;HPGDS;CETN3;IQGAP1;CALR3;CHP1;PCLO;PCDHA4;ITPR3;DNASE1L2;NDUFAB1;S100A1;TRPM4;PKD2L1;LETM1;CALU;PLSCR3;CDH4;MMP12
prerank,gamma-tubulin binding (GO:0043015),0.4230156559852416,0.9914669491552335,0.464339908952959,0.913499774613893,1.0,7/21,18.92%,NDRG1;DIXDC1;RAB11FIP5;MARK4;BLOC1S2;GIT1;TUBGCP5
prerank,phosphatidylinositol phosphate kinase activity (GO:0016307),-0.3904753328328967,-0.9909079002064625,0.4782608695652174,0.8020730813706216,1.0,4/13,9.69%,PIP5K1B;PIP4K2A;PIK3CB;PIK3CD
prerank,polyubiquitin modification-dependent protein binding (GO:0031593),0.36935152182772096,0.9908892513265591,0.48672566371681414,0.91142520829379,1.0,16/49,23.35%,MINDY2;IKBKE;OTUD7B;PSMD4;TAB3;AGAP3;ABRAXAS1;ZFAND6;TNIP1;IKBKG;HDAC6;TAB2;PRPF8;RNF168;UBQLN2;RNF169
prerank,ubiquitin protein ligase binding (GO:0031625),0.31249071878171997,0.987964308637965,0.5066124109867752,0.9154002034681776,1.0,58/253,18.00%,CLU;DAXX;PPARGC1A;TRIB2;CDKN1A;SMAD6;FHIT;IKBKE;CXCR4;ERLIN2;BAG1;NFKBIA;ELOB;PATZ1;POLR2A;MUL1;ERBB3;UQCRC1;JUN;FZD5;RBX1;PML;SUMO2;UBE2B;APBB1;ACTG1;HSPBP1;JAK1;YWHAZ;UBXN7;NPLOC4;PRKAR2A;GSK3B;DNM1L;WASHC1;MAP1LC3B;MDM2;SYT11;HSP90AA1;IKBKG;RNF31;UBE2N;CCDC50;TPI1;HM13;RPS27A;UBC;VCL;SMC6;SMAD5;STUB1;HDAC6;UBE2J1;CHEK2;PSMD1;USP25;TRIM37;TSG101
prerank,cytochrome-c oxidase activity (GO:0004129),0.4360522157535792,0.9865442915728445,0.46238244514106586,0.9155413851588782,1.0,4/15,10.27%,COX5A;COX8A;COX7A2L;COX5B
prerank,poly(A) binding (GO:0008143),0.4151668056746457,0.9861042531627189,0.49028400597907323,0.9132203744231754,1.0,4/21,6.96%,PABPC4L;PABPC1L;EIF4A3;RBMS3
prerank,Lys63-specific deubiquitinase activity (GO:0061578),-0.40993834845256594,-0.9840194704097066,0.4953051643192488,0.8131921679283425,1.0,6/10,23.80%,STAMBPL1;TNFAIP3;OTUD5;ATXN3;CYLD;YOD1
prerank,sequence-specific double-stranded DNA binding (GO:1990837),0.30449826370109373,0.9830440274386868,0.5465465465465466,0.9173211026066159,1.0,83/597,14.34%,BNC2;NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;SMAD6;GLI3;HOXA4;HIVEP1;GABPB1;GABPB2;KLF12;GRWD1;HDAC5;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;FOXD2;POU2F3;BEND3;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;SOX9;ZBTB7B;MEF2D;SIX1;JUN;POU3F1;TCF7L2;CRY2;FOXP3;BRD7;NR2C1;ZIC1;NFIB;NFYC;ARID4A;NFIC;SP2;ZW10;CREB3L4;CREB3;NCOR1;CALCOCO1;MEF2B;HOXB5;MAFG;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3;MBD4;MLH3;ZNF177;ZFP1;MEF2C;PAX3;FOXP1;IRF2
prerank,double-stranded DNA binding (GO:0003690),0.3049951917366666,0.9826594923875789,0.5545545545545546,0.9148146775749698,1.0,114/531,21.82%,NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;GLI3;HOXA4;HIVEP1;KLF12;FEN1;FOXO3;FOS;FOXC2;GLIS2;KLF16;CGGBP1;NR6A1;FOXD2;POU2F3;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;MRE11;SOX9;ZBTB7B;MEF2D;CENPS;SIX1;JUN;POU3F1;FOXP3;NR2C1;ZIC1;HDGFL3;NFIB;NFIC;SP2;CREB3L4;CREB3;MEF2B;HOXB5;MAFG;SP1;FOXK1;TFEB;ERCC5;GATA3;ZNF177;REXO4;ZFP1;MEF2C;PAX3;FOXP1;IRF2;APTX;DHX9;MBNL2;KLF6;HMBOX1;E2F1;POU4F1;ABL1;CAMTA2;SMAD5;HSF2;DMRTA1;MEOX2;RAD50;RARA;PARK7;ATF2;HOXA9;NFKB2;ZBTB26;KLF2;HDGF;PNKP;ZBTB7A;NUCKS1;TEAD1;USF1;SREBF1;NFAT5;MAPT;SOX4;ZBTB32;IRF6;ZBP1;HOXA1;ELF1;KLF10;TERF2;MTF1;UBP1;YY1;YBX1;GABPA;ARNT;HOXA2
prerank,signaling receptor complex adaptor activity (GO:0030159),0.3759896377519518,0.9826582636365783,0.4889753566796368,0.9113494704629435,1.0,3/38,6.54%,SORBS1;MAGI2;SHC1
prerank,acyl-CoA hydrolase activity (GO:0047617),0.435974349993551,0.978193372309411,0.5007776049766719,0.9188201168988477,1.0,2/17,2.68%,ACOT8;ABCD1
prerank,diacylglycerol kinase activity (GO:0004143),-0.4076311297159434,-0.978119691612205,0.4763157894736842,0.8209282307097988,1.0,7/11,23.01%,DGKH;DGKB;DGKI;DGKG;DGKZ;DGKQ;DGKK
prerank,protein serine/threonine kinase activator activity (GO:0043539),-0.3002016862333651,-0.9779571987054584,0.44583333333333336,0.8146063532172939,1.0,10/34,17.84%,STK3;IGF2;STRADA;ETAA1;IRGM;ALS2;FAM20A;DBF4;INCENP;MAP2K1
prerank,adenylate cyclase binding (GO:0008179),-0.4154530239884761,-0.977826196900347,0.5089058524173028,0.8082212544791617,1.0,3/10,17.44%,ADCY5;CAP2;ADCY2
prerank,protein homodimerization activity (GO:0042803),0.30471016443246507,0.9772324281118979,0.5671342685370742,0.9175493475435452,1.0,115/589,18.80%,CUBN;DPP4;FGFR1;NECTIN3;SRGAP2;CCL5;MAP3K5;PDGFC;ADAM10;FOXP2;S100A6;GDF15;ABCD1;STARD3;DGCR8;TIMM10;EPRS1;S100A10;DAPK3;GDNF;BLOC1S6;CARNMT1;NR6A1;ZBTB16;HSPB1;HARS1;CRYAB;S100A11;TARBP2;RAB11FIP3;IRF3;TSC2;CAV2;BCL2L1;HSPB8;ADD1;NRF1;ZBTB7B;NADK2;GLB1;PSMF1;NQO2;TRIM21;TGFB2;ANG;GALE;HPGDS;CHMP4A;CHMP4B;PML;TMEM192;FOXP3;KMT2A;SHMT1;EXT1;HOOK1;NFS1;ATP5IF1;CR2;PSMD7;PDK2;S100A1;PON3;VPS4B;RABL3;SP1;PHETA2;ERCC5;FXR1;MAP3K13;PAXX;CHMP1A;SLC39A13;FLRT3;IRAK1;SYT6;PHETA1;BNIP3L;CHUK;SARS1;CCDC88A;NAGA;SDCBP2;DNM1L;DNTTIP1;ABCB9;HSP90AA1;IKBKG;SPPL2B;ACTN4;FLNA;GSTM2;TPI1;RBPMS2;TPD52;TBC1D22A;HM13;SLC8B1;FICD;RAP1GAP;STUB1;CHEK2;PDCD6IP;SPPL3;BMPR1A;TRIM37;PDXK;TSG101;HMGCS1;SPPL2A;PARK7;KIF20B;PDLIM4;TOX3;DARS2
prerank,mRNA binding (GO:0003729),0.3104060339225393,0.9747322158488648,0.5292307692307693,0.9204489865193177,1.0,62/249,20.23%,CELF2;PABPC4L;SAMD4A;DDX5;CPEB2;YTHDF1;ZC3H12A;SLPI;PABPC1L;SAMD4B;CELF1;RBFOX2;YBX3;KHNYN;SNRNP70;UNK;MRPS7;SRRM2;PKM;EIF4A3;UTP23;RBMS3;RBM20;RBM8A;SHMT1;LUC7L3;SRRM4;SRBD1;RPS26;EIF4G2;CPEB3;SYNCRIP;FXR1;DAZAP1;CARHSP1;RNPS1;BOLL;AUH;DCP1A;UPF3B;EIF4G1;GRSF1;EIF4A1;RBM46;DHX9;RBM47;LUC7L2;RBPMS2;CLUH;IGF2BP3;RBMS2;SRSF1;PARK7;YTHDF3;PTBP1;SRSF5;IGF2BP2;PCBP2;DXO;CSTF3;ETF1;RPL41
prerank,RNA cap binding (GO:0000339),0.42670601123910096,0.974278038981854,0.503125,0.9182184460812033,1.0,1/16,0.78%,CYFIP2
prerank,MAP-kinase scaffold activity (GO:0005078),-0.3978218413220219,-0.9717881796193765,0.4918918918918919,0.8164462294627985,1.0,2/11,0.54%,SH3RF1;KSR1
prerank,neurexin family protein binding (GO:0042043),0.4681277845426432,0.9700433961049391,0.5245346869712352,0.9252092295109955,1.0,2/10,7.08%,SYTL4;CPE
prerank,monocarboxylate:sodium symporter activity (GO:0140161),-0.4122354640797875,-0.9700250722441797,0.4890710382513661,0.8144012119123705,1.0,3/10,8.62%,SLC6A13;SLC6A12;SLC6A1
prerank,purine ribonucleotide transmembrane transporter activity (GO:0005346),-0.38817220612848247,-0.9683124386371804,0.48586118251928023,0.8125843394134838,1.0,4/11,16.11%,SLC35B3;LRRC8A;SLC25A25;SLC25A23
prerank,histone demethylase activity (GO:0032452),0.3885082532342473,0.9643755832427338,0.5228215767634855,0.9357444178250609,1.0,7/27,12.11%,KDM4D;KDM4B;KDM5C;KDM3A;RIOX2;KDM4C;KDM6A
prerank,amino acid binding (GO:0016597),-0.29770433856649564,-0.9633101899583442,0.5036231884057971,0.8187774434574797,1.0,19/31,36.30%,NOS3;GRM7;GRIN2B;GLRA1;GLRA3;GLRA2;SRR;GLRB;THNSL2;CASTOR1;CAD;GRIN3A;AARS2;SHMT2;GRIN1;GLDC;GCLC;GNMT;NOS2
prerank,RNA polymerase II transcription regulatory region sequence-specific DNA binding (GO:0000977),0.2983586403986876,0.9632756206924777,0.618,0.9351087300006878,1.0,126/831,14.34%,NFATC2;ZBTB7C;NR3C2;KLF5;THRB;TBR1;KLF4;TFAP2C;PBX3;PBX1;KLF3;ZIC4;TFAP2D;DMRT2;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXP4;ZNF436;ZFHX4;HDAC5;ZNF692;MXD4;CC2D1B;FOXO3;FOS;RELB;MGA;FOXC2;SP5;ZNF219;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;ZBTB16;ZBTB8A;FOXD2;POU2F3;NFE2L1;NACC1;ESRRB;RARG;RFX7;IRF3;PRRX2;JUND;OVOL2;NKX2-8;PATZ1;CREB1;ZBTB46;ZIK1;FOXM1;HOXA5;ZBTB17;RXRB;SOX9;FOXD1;ZIC2;NRF1;ZBTB7B;MEF2D;CC2D1A;KLF7;STAT4;ZNF471;ZFHX3;ZNF418;CIC;SIX1;MAZ;JUN;POU3F1;TCF7L2;ZFP57;GRHL2;FOXP3;POU5F2;NR2C1;DNMT3A;ZIC1;PRDM15;NFIB;ZNF467;NFYC;TWIST1;ZNF205;NFE2L3;NFIC;SP2;MYT1;CREB3L4;CREB3;CALCOCO1;MEF2B;KDM6A;MED8;HOXB5;MAFG;SP1;ZBTB42;ZNF148;MAFK;FOXK1;TFEB;ZFP30;GATA3;ZSCAN20;RREB1;NFIA;MYC;ZNF177;ZFP1;MEF2C;PAX3;ZFP92;MYBL1;FOXP1;SARS1;IRF2
prerank,histone demethylase activity (H3-K36 specific) (GO:0051864),0.4702499814821989,0.9625889040725678,0.5132450331125827,0.9333790522238861,1.0,3/10,10.86%,KDM4B;RIOX2;KDM4C
prerank,organic anion transmembrane transporter activity (GO:0008514),0.3123086693151422,0.95686397722654,0.5412647374062165,0.9438776434512822,1.0,24/134,15.34%,CFTR;SLCO2A1;SLC36A3;SLC35D3;SLC16A11;SLC66A1;OCA2;CTNS;SFXN3;SLC36A4;SLC3A1;SLC2A8;SLC25A1;SFXN1;SLC25A38;SLC1A4;SLC25A17;SLC25A21;PDPN;SLC26A4;SLC6A7;SLC19A2;SLC25A12;SLC7A3
prerank,"steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor (GO:0033764)",0.42278356576829806,0.9544547483229922,0.524024024024024,0.9461904238982851,1.0,1/18,3.45%,HSD17B14
prerank,anion channel activity (GO:0005253),0.3392799283270569,0.9533024365703845,0.5473554735547356,0.9453671469230003,1.0,12/61,15.06%,CFTR;ANO7;VDAC2;CLIC1;CLCN4;SLC1A4;ANO6;VDAC1;ANO3;CLCC1;GPR89A;GPR89B
prerank,RNA polymerase II-specific DNA-binding transcription factor binding (GO:0061629),0.30585459352714145,0.9527213178380903,0.5665961945031712,0.9432764454354624,1.0,36/181,15.64%,KLF4;PPARGC1A;NCOA3;EP300;HDAC5;FOS;HDAC4;NFE2L2;ANXA4;WWP2;HSPB1;MTDH;SMARCB1;NFKBIA;CREB1;DDRGK1;COMMD7;FIZ1;JUN;TCF7L2;FOXP3;ACTB;BCAS3;HDAC3;COMMD6;SMARCA4;NCOR1;SP1;MIER2;PIAS1;PIAS3;MKKS;GSK3B;NCOR2;DHX9;ACTN4
prerank,"oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen (GO:0016702)",0.41976957338342624,0.951492792569781,0.5378670788253478,0.9428208803140694,1.0,4/16,17.47%,ALOX5;TDO2;CDO1;HAAO
prerank,death receptor binding (GO:0005123),0.42804863787434305,0.9501497453622598,0.5398496240601504,0.9425614411625772,1.0,3/15,11.00%,EDA;NGF;FEM1B
prerank,protein heterodimerization activity (GO:0046982),0.30653045082917835,0.9497079672394029,0.5594111461619348,0.9402648592265418,1.0,26/178,14.73%,ADRA1B;AGTR1;HEXA;ATP1A2;PGLYRP3;PEF1;PPP2CA;BUD23;BCL2L1;ADD1;PSMF1;MICU1;ERBB3;TLR6;EXT1;KCNB1;PAFAH1B1;TLR4;SAE1;GABBR2;FXR1;TUBB2B;IRAK1;MEF2C;CHUK;SDCBP2
prerank,protein phosphatase binding (GO:0019903),0.31251521248811687,0.9491525797040278,0.5489130434782609,0.9382116100795294,1.0,22/117,12.96%,MAP3K5;ANK1;GTF2F1;IKBKE;PPP6R3;SH3RF2;AP3B1;PPP1R15A;ROS1;PXN;SMG7;BAD;LGALS3;IQGAP1;PPP1R16A;MTMR3;PPP1R11;AKAP5;JAK1;MVP;EIF2AK3;ANAPC4
prerank,phosphatidylinositol-5-phosphate binding (GO:0010314),0.4295449368864572,0.9484632987019094,0.5540123456790124,0.9363566981643704,1.0,4/15,7.99%,VEPH1;PHLDA3;RUBCNL;JPH2
prerank,GTPase binding (GO:0051020),0.30555581042595575,0.9484516539460931,0.5763239875389408,0.9330679698549161,1.0,42/194,16.15%,RNF152;SRGAP2;NDRG1;AKAP13;CAV1;EPRS1;CDC42EP4;EHD1;DAPK3;UNC13D;CDC42EP5;YBX3;MLPH;SH3BP4;RAB11FIP3;TSC2;DOCK7;GCC2;DVL3;EXOC4;IQGAP1;DMXL2;MYO5A;MYO1C;RAF1;GGA1;EXOC2;SGSM2;ARFIP2;WASF1;MAPKAP1;RASA1;EXOC8;OCRL;CHML;ULK1;DNM1L;USP6NL;ARHGDIB;HSP90AA1;FLNA;RIN3
prerank,sequence-specific DNA binding (GO:0043565),0.2947107079020126,0.9484295963899659,0.6462925851703407,0.9298235324755602,1.0,72/590,12.95%,NFATC2;NR3C2;KLF5;THRB;KLF4;TFAP2C;PPARGC1A;PBX1;KLF3;ZIC4;ELF3;SREBF2;RORC;FOXP2;GLI3;HOXA4;HIVEP1;KLF12;FOXO3;FOS;FOXC2;GLIS2;KLF16;HDAC4;NFE2L2;NR6A1;FOXD2;POU2F3;ESRRB;RARG;RFX7;IRF3;PRRX2;SLTM;JUND;OVOL2;NKX2-8;CREB1;HOXA5;RXRB;SOX9;FOXD1;ZBTB7B;MEF2D;UPF3A;SMG7;SIX1;JUN;POU3F1;TCF7L2;CXXC4;GRHL2;FOXP3;KMT2A;NR2C1;ZIC1;NFIB;NFIC;SP2;CREB3L4;CREB3;CALCOCO1;MEF2B;MMP12;HOXB5;MAFG;SP1;ZNF148;MAFK;FOXK1;TFEB;GATA3
prerank,I-SMAD binding (GO:0070411),0.43385584733502913,0.9479459814344501,0.5275590551181102,0.9276856473228456,1.0,2/13,7.68%,SMAD6;TGFB1I1
prerank,adenine nucleotide transmembrane transporter activity (GO:0000295),-0.3731527022577371,-0.9469586361342922,0.5078125,0.8514970786869922,1.0,5/12,21.07%,SLC35B3;LRRC8A;SLC25A25;SLC25A23;SLC25A5
prerank,thyroid hormone receptor binding (GO:0046966),0.37833118895806245,0.9468816902055159,0.521923620933522,0.9270049560495222,1.0,6/28,13.65%,NCOA3;MED30;GAS2L1;NCOR1;MED12;MED24
prerank,rRNA binding (GO:0019843),0.35964914146192295,0.9460421146017044,0.5375494071146245,0.9256312788198523,1.0,7/42,15.51%,PPAN;MRPS7;UTP23;ANG;MRPS27;MDM2;MRPS18C
prerank,SH2 domain binding (GO:0042169),-0.289988697053426,-0.9451050447273658,0.553030303030303,0.8493534591353421,1.0,11/31,18.47%,AFAP1L2;SH3PXD2B;PTK2;PAG1;JAK2;BLNK;RACK1;RUFY1;SKAP1;SH2B2;INPPL1
prerank,cyclin-dependent protein kinase activity (GO:0097472),0.4034033869936736,0.9447360474893542,0.5116279069767442,0.9222782455908826,1.0,6/21,13.18%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,cyclin-dependent protein serine/threonine kinase activity (GO:0004693),0.4034033869936736,0.9447360474893542,0.5116279069767442,0.9222782455908826,1.0,6/21,13.18%,CDK10;CDK6;CDKL2;CDK4;CDKL4;CDK2
prerank,sodium-independent organic anion transmembrane transporter activity (GO:0015347),0.46718785236832105,0.9443483105729845,0.5409556313993175,0.9200694781362848,1.0,1/10,0.70%,SLCO2A1
prerank,dynactin binding (GO:0034452),0.43717397306594685,0.94379974674487,0.5240464344941956,0.9181977518367141,1.0,4/12,20.10%,PAFAH1B1;GSK3B;HOOK3;MAPT
prerank,G protein-coupled amine receptor activity (GO:0008227),0.39524070217434226,0.9407498360498204,0.5446685878962536,0.915959570720058,1.0,1/22,0.76%,CHRM1
prerank,serotonin receptor activity (GO:0099589),0.39524070217434226,0.9407498360498204,0.5446685878962536,0.915959570720058,1.0,1/22,0.76%,CHRM1
prerank,G protein-coupled serotonin receptor activity (GO:0004993),0.39524070217434226,0.9407498360498204,0.5446685878962536,0.915959570720058,1.0,1/22,0.76%,CHRM1
prerank,retinoic acid receptor binding (GO:0042974),-0.3358316942755453,-0.9376406402176864,0.5247252747252747,0.8606801050257525,1.0,3/17,9.23%,TACC1;NSD1;PPARG
prerank,histone-lysine N-methyltransferase activity (GO:0018024),-0.2658813984546622,-0.9374613780691093,0.5695067264573991,0.8544822828083938,1.0,7/44,10.14%,MECOM;SETD5;PRDM16;NSD1;EZH2;RBBP5;NSD3
prerank,ubiquitin-like protein ligase activity (GO:0061659),0.2963598915389576,0.9360738437585157,0.6323377960865088,0.9232348268823916,1.0,48/232,17.79%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;CBLL1;TRIM41;TRIM21;RBX1;CDC42;TRIM26;TRIM11;RNF121;LTN1;PPP1R11;SIAH3;COP1;VPS11;NSMCE2;RNF126;PIAS1;PIAS3;DTX3;PELI1;CBX4;VPS18;BRAP;UBR5;NEDD4;MDM2;BFAR;MSL2;PRPF19;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;PDZRN3;TRIM37
prerank,ATP binding (GO:0005524),0.29519075260807964,0.9326757645813628,0.6578411405295316,0.9275260720457703,1.0,84/266,22.54%,PRAG1;MAP3K5;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;HSPA14;LMTK2;MOV10L1;THG1L;AARS1;AK6;SRPK2;MTREX;ABCA2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;SARS2;EIF4G1;TRNT1;WNK1;CDC42BPA;ABCB9;DHX9;HSP90AA1;OAS2;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;PRKAG1;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;DARS2;ABCB6;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;ATP1A3;ATP1A1;WNK4;YARS2;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1
prerank,transition metal ion transmembrane transporter activity (GO:0046915),-0.28928490336052426,-0.9326425046368553,0.5821428571428572,0.8596996106662522,1.0,7/30,12.48%,SLC30A10;SLC39A12;SLC40A1;SLC39A8;SLC39A10;TTYH1;SLC30A1
prerank,pyrophosphatase activity (GO:0016462),-0.25556145277381204,-0.9302026446180109,0.5902439024390244,0.859501952916243,1.0,20/50,23.18%,ENPP1;ENTPD1;ALPL;PPA1;ITPA;ENPP3;LHPP;PRUNE1;PPA2;ATCAY;PRUNE2;DHX29;DOLPP1;NUDT1;ENTPD3;ENTPD5;ENTPD6;CILP;FITM2;NUDT16
prerank,tau protein binding (GO:0048156),0.3537505040353502,0.9301798476747302,0.5651612903225807,0.9297289066383962,1.0,12/40,18.80%,CLU;EP300;PPP2CA;ACTB;MARK4;GSK3A;GSK3B;PPP2CB;HSP90AA1;STUB1;HDAC6;ROCK2
prerank,motor activity (GO:0003774),0.33337662271801627,0.9299934889168913,0.576969696969697,0.9270130139663578,1.0,6/60,6.67%,DYNC1I1;KIF2A;DYNLRB1;KIF13A;KIF1C;KIF1B
prerank,transmembrane receptor protein serine/threonine kinase binding (GO:0070696),0.42719407877623866,0.9269874677519195,0.5555555555555556,0.9304887784809764,1.0,3/13,6.81%,GDF15;BMP5;BMP4
prerank,transcription regulatory region nucleic acid binding (GO:0001067),0.29720700960784885,0.9257192438945692,0.6374085684430512,0.9301659488667916,1.0,29/188,12.95%,BNC2;KLF4;PBX1;SMAD6;GABPB1;GABPB2;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;JUND;SIX1;JUN;TCF7L2;CRY2;BRD7;NFYC;ARID4A;NCOR1;CALCOCO1;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3
prerank,phosphatidylinositol bisphosphate binding (GO:1902936),0.31268894199493386,0.9210848004723984,0.6060961313012896,0.9372218703049497,1.0,16/91,10.90%,ACTN2;STXBP6;VILL;ANXA8;GSN;AMER3;PHLDA3;AMER2;TWF1;AVIL;ANXA2;KRIT1;JPH2;RAB35;GSDME;SNX18
prerank,"acyltransferase activity, transferring groups other than amino-acyl groups (GO:0016747)",0.32068091202245913,0.9199821766716321,0.5952941176470589,0.9364929060519833,1.0,13/69,13.92%,SOAT1;EP300;DGAT1;MOGAT3;ZDHHC12;MOGAT1;KAT6B;SOAT2;CERS2;MBOAT7;NAA15;LPCAT3;NAA10
prerank,GTPase activity (GO:0003924),0.2949499737157579,0.9197913085934992,0.6384535005224661,0.9338160184388157,1.0,46/192,19.25%,RAB17;MRAS;RAP1B;EEF1A1;RAP1A;RHOQ;NRAS;KRAS;RHEB;RAB3B;CDC42;RAB7A;GSPT2;GTPBP10;BMS1;RAB35;GNAO1;AGAP3;GNAQ;GNA13;RHOA;RABL3;OPA1;SEPTIN9;RHOU;RAB5C;RAB1B;HRAS;GNG5;DNM1L;ATL2;GNA11;GPN1;ARHGDIB;RAP2C;RAB33B;ARL8A;EEF2;DIRAS2;RAP1GAP;RAB8B;HBS1L;RNF112;RAB27A;RAB9A;RHOT2
prerank,translation initiation factor activity (GO:0003743),0.35729785837292755,0.916694613310797,0.5601604278074866,0.9371333363084147,1.0,13/36,17.44%,EIF3L;EIF2B2;EIF3K;EIF4G2;COPS5;EIF3M;EIF4G1;EIF4A1;EIF5B;EIF3B;EIF1;EIF2B4;EIF4A2
prerank,mRNA 3'-UTR AU-rich region binding (GO:0035925),0.39045707013015896,0.9149545856965889,0.5749636098981077,0.9378063670490027,1.0,5/22,15.91%,CPEB2;ZC3H12A;RBMS3;CPEB3;MEX3D
prerank,snoRNA binding (GO:0030515),0.3581005175257942,0.9128805973638261,0.573187414500684,0.9392529590673172,1.0,6/30,18.26%,NUDT4;BMS1;GAR1;RRP9;IMP4;IMP3
prerank,myosin binding (GO:0017022),0.33230048907526977,0.9117253997397652,0.5788819875776398,0.9385876692009486,1.0,10/55,13.56%,CALD1;GSN;CXCR4;MLPH;NCKIPSD;RAB3B;LMTK2;LLGL2;RHOA;ARFGEF1
prerank,poly(A)-specific ribonuclease activity (GO:0004535),0.43062405418199695,0.9115334999274937,0.5698587127158555,0.9359895967046576,1.0,1/12,0.98%,CNOT6
prerank,ligand-gated cation channel activity (GO:0099094),-0.23277178378093752,-0.9101545683963548,0.660377358490566,0.9012911448226532,1.0,15/75,14.60%,GRIK2;KCNN2;GRIN2A;GRIA3;GRIA2;GRIN2B;KCNJ2;GRIK3;MCOLN1;GRIK1;GRIK4;KCNJ12;CCDC51;KCNJ6;KCNJ10
prerank,BMP receptor binding (GO:0070700),0.4271983462380481,0.910126737480655,0.5945945945945946,0.9358517457083056,1.0,3/12,6.81%,GDF15;BMP5;BMP4
prerank,"2 iron, 2 sulfur cluster binding (GO:0051537)",0.42153912863484555,0.9097323407644267,0.584518167456556,0.9336809666239714,1.0,8/12,26.85%,SDHB;FDX1;ISCA1;CIAPIN1;ISCA2;AOX1;CISD2;CISD1
prerank,protein tyrosine phosphatase activity (GO:0004725),0.3181158425268267,0.9096417796415676,0.6138259833134684,0.9308932760660016,1.0,23/71,18.01%,PTPN14;EYA2;PTPRU;PTPRD;DUSP1;PTPRF;EYA1;PTPN9;PTPRA;PTPN6;MTMR3;ACP1;PTPRE;PTPN2;PGP;PTP4A3;DUSP11;PTPDC1;CDC25B;PTPN13;PTP4A2;DUSP3;PTPN11
prerank,microtubule plus-end binding (GO:0051010),0.38460298618005134,0.9089835219281216,0.5712209302325582,0.9293461728735499,1.0,3/20,10.56%,MAPRE2;CLIP4;PAFAH1B1
prerank,metal ion binding (GO:0046872),0.2811058661972358,0.9083615376924102,0.749498997995992,0.9276944316900464,1.0,56/477,11.74%,CDH1;PITPNM2;DSG2;CDH13;ITPR2;ANXA3;STIM2;MAP3K5;TSSK6;TSSK4;ANXA8;ANXA8L1;GSN;S100A6;FEN1;EYA2;S100A10;OTOF;IDH3G;PITPNM3;ANXA4;LTBP4;S100A11;ANXA5;FBLN1;RHEB;NT5C3A;SIK3;ANXA2;DCTPP1;MICU1;DSC3;DSC2;LATS1;HPGDS;CETN3;IQGAP1;OXSR1;CALR3;CHP1;PCLO;TRIM26;MOV10L1;PCDHA4;THG1L;ITPR3;DNASE1L2;SRPK2;NDUFAB1;S100A1;TRPM4;PKD2L1;LETM1;CALU;PLSCR3;CDH4
prerank,inward rectifier potassium channel activity (GO:0005242),-0.30085575393799446,-0.905664403337793,0.6254071661237784,0.9049561474096813,1.0,10/24,25.53%,KCNN2;ABCC9;KCNJ2;KCNJ12;KCNJ6;KCNJ10;KCNJ8;KCNJ15;KCNK1;KCNJ3
prerank,ubiquitin protein ligase activity (GO:0061630),0.28624740549673117,0.9046373139243309,0.7012320328542094,0.9325842399268004,1.0,45/228,17.79%,RNF152;TRIM60;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;MUL1;CBLL1;TRIM41;TRIM21;RBX1;CDC42;TRIM26;TRIM11;RNF121;LTN1;PPP1R11;SIAH3;COP1;VPS11;RNF126;DTX3;PELI1;VPS18;UBE4A;BRAP;UBR5;NEDD4;MDM2;BFAR;MSL2;PRPF19;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;PDZRN3;TRIM37
prerank,phosphatidylinositol binding (GO:0035091),0.3054303715292821,0.9038159887143762,0.6097838452787259,0.9312994786675802,1.0,16/91,14.68%,PITPNM2;ITPR2;PIGU;SNX8;PITPNC1;RUBCNL;WDFY3;GPAA1;RUBCN;ITPR3;BCAS3;SNX12;ESYT2;EXOC8;CCDC88A;SNX16
prerank,filamin binding (GO:0031005),0.43139411002933664,0.9036091871689288,0.5608974358974359,0.9287653117851681,1.0,1/11,1.59%,NEBL
prerank,cyclin-dependent protein serine/threonine kinase inhibitor activity (GO:0004861),0.4373007792596898,0.8987501036541935,0.5938511326860841,0.9357103233406989,1.0,3/10,18.87%,CDKN1A;HEXIM1;CDKN2D
prerank,"phosphotransferase activity, alcohol group as acceptor (GO:0016773)",0.31763589353072447,0.8982940539415231,0.6269185360094451,0.9337200495109431,1.0,13/74,10.64%,FAM20C;ADK;PIK3C2B;AGK;PKM;NT5C3A;NADK2;DCAKD;TRPT1;NADK;PI4KA;HK1;DGKA
prerank,ATPase binding (GO:0051117),0.3136085244749357,0.8976516486361146,0.6247086247086248,0.932185624613574,1.0,13/71,14.50%,ANK2;ANK1;PEX26;BBC3;CAV1;PIH1D1;CHMP4A;EZR;ATP5IF1;S100A1;TOR1AIP1;DNAJC10;ATP6V1E1
prerank,neutral amino acid transmembrane transporter activity (GO:0015175),0.3494661473444232,0.8964440000168916,0.6025641025641025,0.9318123582534805,1.0,7/32,13.72%,SLC36A3;SFXN3;SLC36A4;SFXN1;SLC25A38;SLC1A4;SLC6A7
prerank,ATPase regulator activity (GO:0060590),-0.26255092079884323,-0.8955015152287601,0.6561264822134387,0.9221003206168982,1.0,16/38,24.17%,TSC1;ATP1B1;DNAJB4;FNIP1;DNAJA1;DNAJC19;FNIP2;BAG4;DNAJB2;BAG5;BRSK2;GRPEL1;DNAJC1;BAG2;DNAJB1;AHSA1
prerank,mannose binding (GO:0005537),-0.35700839133856327,-0.8944742035499925,0.599483204134367,0.9177150826066595,1.0,2/12,12.44%,LMAN2L;LMAN2
prerank,5'-3' RNA polymerase activity (GO:0034062),0.359623650799988,0.8938579278372798,0.6031073446327684,0.9341654548361554,1.0,9/27,18.70%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,histone deacetylase binding (GO:0042826),0.3060815080475271,0.8937757736237433,0.6524741081703107,0.9314130186874144,1.0,20/88,17.35%,GLI3;HDAC5;HDAC4;NACC1;LCOR;MEF2D;YWHAB;FOXP3;CCND1;HDAC3;SP2;NCOR1;MEF2B;SP1;MIER2;MEF2C;NCOR2;HSP90AA1;CAMTA2;HDAC6
prerank,"4 iron, 4 sulfur cluster binding (GO:0051539)",0.4012965610338645,0.8928025659315367,0.6,0.930512223744731,1.0,5/14,21.41%,SDHB;ACO2;CIAO3;ISCA2;ACO1
prerank,phosphotyrosine residue binding (GO:0001784),-0.2663335408195993,-0.8919428669948234,0.6440677966101694,0.9166108230454793,1.0,10/37,13.37%,PIK3R1;NCK2;CRKL;SHE;ABL2;PTPN3;GRB2;BCAR3;SHF;PIK3R3
prerank,alpha-actinin binding (GO:0051393),0.37016485119029796,0.8918631159792937,0.5754583921015515,0.9294602465692152,1.0,10/24,18.64%,PDLIM5;DAG1;MYOT;PKD2L1;KCNA5;PDLIM7;NRAP;PDLIM3;RARA;PDLIM4
prerank,phosphatidylinositol-4-phosphate binding (GO:0070273),-0.29131205426044426,-0.8907692772987893,0.6192170818505338,0.9127640805214645,1.0,6/24,12.00%,PLA2G4A;DAB2IP;PLEKHA8;GSDMD;LANCL2;PLEKHF1
prerank,kinase binding (GO:0019900),0.2801717774863039,0.8905540691945348,0.7662988966900702,0.9291256660485556,1.0,107/434,20.10%,MYOM2;UTRN;ANK2;DAXX;PIK3IP1;CDKN1A;ADAM10;EMP2;GSN;CAV1;MAVS;NBEAL2;EEF1A1;QARS1;FOXO3;RELB;AP2A2;HSPB1;PPP1R15A;PIH1D1;CAV2;BCL2L1;POLR2A;RNF138;FOXM1;SPRED3;SHC1;PFKFB2;MSN;CCND2;SYN1;TRIM21;BAD;ILK;LATS1;SRCIN1;ADCY6;PKD1;FZD5;LRBA;TCF7L2;IQGAP1;OXSR1;CDC42;ACSL3;FBXO5;CHP1;CDK5RAP1;ACTB;PTPN6;CCND1;SMCR8;ZC3HC1;CARD16;EXOC2;MVP;AP2A1;SLC12A4;RHOA;YWHAZ;BCAR1;PPP1CB;JTB;PTPN2;MAPKAP1;KCNA5;PTN;MAP3K13;VDAC1;IRAK1;SHC2;GSK3B;WNK1;DNAJC3;TNNI3;RB1CC1;ITGB2;FLNA;EEF2;FAM83H;AP1B1;CRK;ARHGAP33;PRKAG1;NSF;CDC25B;STUB1;MTCP1;CHEK2;DUSP3;PTPN11;CAMK2N1;SUFU;PARK7;ATF2;MOB1B;CDKN2D;CAB39;CDK5RAP3;IRAK4;SIKE1;TOM1L2;MAP3K1;RB1;PRKAB1;USF1;MAPT
prerank,ion channel activity (GO:0005216),0.3080922779576035,0.8887641056146575,0.6516203703703703,0.9299203688259603,1.0,13/80,13.39%,TRPM3;NALCN;TRPM8;TMC6;MCUB;CALHM5;GRID1;TMC2;TRPM6;TRPM4;PKD2L1;CNGB1;TRPM2
prerank,U6 snRNA binding (GO:0017070),0.40705210982745876,0.888592150268996,0.6009036144578314,0.9274272140333781,1.0,5/14,21.21%,LARP7;LSM4;DDX39B;TUT1;PRPF8
prerank,MHC class II protein complex binding (GO:0023026),0.4119242562795362,0.8881090984536109,0.5954692556634305,0.9255960024482712,1.0,2/11,6.08%,CD81;PKM
prerank,adenyl ribonucleotide binding (GO:0032559),0.27990637463871043,0.8877544284091418,0.7373225152129818,0.9235338073322261,1.0,91/291,22.84%,PRAG1;MAP3K5;MPPED2;TSSK6;TSSK4;ABCD1;ATP1A2;CDK6;MKNK2;DAPK3;DAPK1;HMGCR;HARS1;PFKP;CARS2;TWF1;PMVK;EIF2B2;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;HSPA14;LMTK2;MOV10L1;THG1L;AARS1;AK6;SRPK2;MTREX;ABCA2;PDK2;MARK4;SRPK1;OLA1;TARS1;VPS4A;SARS2;EIF4G1;TRNT1;WNK1;CDC42BPA;ABCB9;DHX9;HSP90AA1;OAS2;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;PRKAG1;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;SLC19A1;DARS2;ABCB6;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;ATP1A3;ATP1A1;WNK4;MIEF1;YARS2;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1;APRT;ABCB8
prerank,cation channel activity (GO:0005261),0.2997611616745643,0.8844346395180896,0.6407657657657657,0.9270245867738759,1.0,18/94,15.71%,TRPM3;NALCN;TRPM8;MCU;CALHM5;ABCC8;ANXA2;PKD1;TRPM6;AQP1;TRPM4;PKD2L1;ANO6;CACNB2;TRPM2;TMEM175;HVCN1;TMEM63B
prerank,calcium-dependent cysteine-type endopeptidase activity (GO:0004198),0.4026567723848607,0.8841290517657547,0.61875,0.9248351772075734,1.0,3/14,18.60%,CAPN2;CAPNS1;CAPN15
prerank,"DNA-binding transcription repressor activity, RNA polymerase II-specific (GO:0001227)",0.2854783009681974,0.8819863561650396,0.7160751565762005,0.9261023473241916,1.0,28/173,14.18%,TFAP2C;SREBF2;RORC;FOXP2;KLF12;FOXP4;ZNF436;ZNF692;FOXO3;ZNF219;ZBTB16;NACC1;OVOL2;PATZ1;ZBTB17;CC2D1A;ZFHX3;JUN;ZFP57;FOXP3;SP2;ZNF148;MAFK;FOXK1;GATA3;MYC;ZNF177;FOXP1
prerank,DNA-directed 5'-3' RNA polymerase activity (GO:0003899),0.3547970152570044,0.8812736038626829,0.615819209039548,0.9247363127745482,1.0,9/27,18.70%,POLR2A;POLR3B;POLR1D;POLR1C;POLR1F;MED21;POLR2C;POLR3H;POLR2E
prerank,protein phosphatase 1 binding (GO:0008157),0.37021451500051394,0.880304758106313,0.5806451612903226,0.9238435841128009,1.0,4/21,10.21%,SH3RF2;PPP1R15A;PPP1R16A;PPP1R11
prerank,transcription cis-regulatory region binding (GO:0000976),0.2736327859463965,0.8795211849944822,0.7901606425702812,0.9226619242936954,1.0,66/406,16.71%,BNC2;FOXN3;KLF4;TFAP2C;PBX1;TFAP2D;SMAD6;GLI3;GABPB1;GABPB2;ZNF436;HDAC5;FOXO3;FOS;FOXC2;GLIS2;HDAC4;NFE2L2;ZBTB8A;ESRRB;JUND;ZBTB46;FOXM1;ZBTB17;RXRB;SOX9;ZBTB7B;MEF2D;CIC;SIX1;JUN;TCF7L2;CRY2;ZFP57;XRN2;GRHL2;BRD7;NFYC;TWIST1;ARID4A;CREB3;NCOR1;DR1;CALCOCO1;MMP12;SP1;MAFK;FOXK1;TFEB;CHD3;GATA3;RREB1;MYC;ZNF177;MEF2C;FOXP1;IRF2;ATMIN;RFXAP;ZFP3;ACTN4;CDC5L;CREB3L2;RNF10;E2F1;HINFP
prerank,mechanosensitive ion channel activity (GO:0008381),0.41271724663249615,0.8792564059564628,0.6,0.9204352339896329,1.0,4/12,21.01%,TMC6;TMC2;TMEM63B;TMC4
prerank,phosphatidylinositol phosphate binding (GO:1901981),0.29430825482238787,0.8774338125311816,0.6576879910213244,0.921250467692254,1.0,14/100,8.46%,ARAP1;OGT;VEPH1;ANXA8;PHLDA3;ARAP2;FCHSD2;PLEKHB2;RUBCNL;GOLPH3;ZFYVE19;JPH2;RUBCN;IQGAP1
prerank,cyclic nucleotide binding (GO:0030551),0.36424654534188283,0.8773330773631157,0.6325036603221084,0.9187141709197367,1.0,3/21,7.35%,PDE5A;CNGA2;CNGB3
prerank,tau-protein kinase activity (GO:0050321),-0.305109006236381,-0.8766990767110803,0.6298701298701299,0.9381970670566238,1.0,4/20,7.58%,MARK1;BRSK1;PRKAA1;ROCK1
prerank,endopeptidase activator activity (GO:0061133),-0.3611151654602325,-0.8760469621642906,0.6274038461538461,0.9330514965232289,1.0,5/10,33.20%,PSME1;APH1B;VSIR;PSME2;NLRC4
prerank,NADP binding (GO:0050661),0.3446047748082063,0.8759266033363131,0.6148555708390646,0.9186661017889874,1.0,5/32,8.17%,DHCR7;HMGCR;ME3;CRYZL1;PGD
prerank,purine ribonucleoside triphosphate binding (GO:0035639),0.2735365164530741,0.8751946294260917,0.8082329317269076,0.9174146405969993,1.0,121/431,22.54%,PRAG1;MAP3K5;TSSK6;TSSK4;MRAS;RAP1B;ABCD1;ATP1A2;EEF1A1;CDK6;RAP1A;MKNK2;ARL4A;DAPK3;DAPK1;ARL3;HARS1;RHOQ;PFKP;CARS2;TWF1;PMVK;EIF2B2;NRAS;KRAS;RHEB;SIK3;EIF4A3;GLUD1;SYN1;LATS1;PPIP5K2;ABCF1;HSPA4;OXSR1;CDC42;RAB7A;HSPA14;ARHGEF5;LMTK2;MOV10L1;GTPBP10;THG1L;AARS1;AK6;BMS1;RAB35;SRPK2;MTREX;ABCA2;PDK2;ARFIP2;RHOA;RABL3;MARK4;SRPK1;OLA1;ARF4;RHOU;TARS1;TUBB2B;VPS4A;SARS2;RAB1B;HRAS;EIF4G1;TRNT1;WNK1;ATL2;CDC42BPA;ABCB9;DHX9;HSP90AA1;RAP2C;OAS2;ARL8A;PEX6;MCM6;SYN3;CLP1;PI4K2A;ABL1;ADSS2;PRKAG1;DIRAS2;MAP3K6;FICD;BMPR1A;PEAK1;PDXK;STK38L;RNF112;DARS2;ABCB6;RAB27A;RAB9A;RHOT2;IDE;MYO18A;PNKP;CDK11B;TBCK;CDC42BPG;RAB10;ATP1A3;ATP1A1;WNK4;YARS2;RABL6;RHOC;ACLY;LONP1;N4BP2;CDC42BPB;ABCF3;HSPA13;SMC4;IGHMBP2;MKNK1;PRPS1L1;PRPS1
prerank,sodium channel activity (GO:0005272),0.338532144081128,0.8745512590307652,0.6227154046997389,0.9159048175245249,1.0,2/37,1.20%,ASIC5;SCN3A
prerank,peptidase activator activity involved in apoptotic process (GO:0016505),-0.3283533356637632,-0.8740247699991279,0.6370757180156658,0.9310829557807888,1.0,3/14,12.35%,NOD1;MAL;RACK1
prerank,1-phosphatidylinositol-3-kinase activity (GO:0016303),-0.36707736164636573,-0.8728329956637656,0.6201550387596899,0.9271351377437254,1.0,4/10,14.80%,PIK3CB;PIK3CD;PIK3R3;PIK3C3
prerank,NAD+ binding (GO:0070403),-0.3451374726323613,-0.8697748018019307,0.6213333333333333,0.9276412995449577,1.0,3/12,15.80%,ZC3HAV1;HPGD;SIRT2
prerank,muscle alpha-actinin binding (GO:0051371),0.394606598526798,0.8696919603169141,0.6293494704992436,0.9224511649291298,1.0,7/15,20.70%,PDLIM5;PKD2L1;PDLIM7;NRAP;PDLIM3;PDLIM4;MYPN
prerank,RNA polymerase II CTD heptapeptide repeat kinase activity (GO:0008353),0.407082083936001,0.8681796266050904,0.6161449752883031,0.9226801242966107,1.0,2/12,5.41%,CDK6;CDK4
prerank,AMP binding (GO:0016208),0.41668998134564816,0.8663313968141904,0.6365159128978225,0.9235879556214877,1.0,2/11,5.22%,MPPED2;PFKP
prerank,tRNA methyltransferase activity (GO:0008175),-0.3224683271842931,-0.8659335720144301,0.6508379888268156,0.930197310961067,1.0,8/16,24.67%,TARBP1;THUMPD2;TRMT5;TRMT9B;TRMT44;ALKBH8;TYW3;BCDIN3D
prerank,protein tyrosine kinase activator activity (GO:0030296),0.36579045515312125,0.8655296752135774,0.6346433770014556,0.922323060056036,1.0,4/19,10.17%,CCL5;EFNA5;ERBB3;ABI1
prerank,sulfuric ester hydrolase activity (GO:0008484),0.4037973686518098,0.8646098163157333,0.6455906821963394,0.9212813260807773,1.0,2/12,7.81%,ARSI;ARSB
prerank,Tat protein binding (GO:0030957),0.42551039300578153,0.8638401097663695,0.611864406779661,0.9200763190266992,1.0,3/10,11.02%,SMARCB1;ACTB;SMARCA4
prerank,CXCR chemokine receptor binding (GO:0045236),-0.35822269990240524,-0.8623863577510913,0.6363636363636364,0.9317142688355511,1.0,1/11,2.67%,CXCL12
prerank,peptidase activator activity (GO:0016504),0.3600621160353764,0.8617401861375867,0.6221889055472264,0.9213044971025334,1.0,2/22,5.01%,CAV1;PCOLCE2
prerank,magnesium ion binding (GO:0000287),0.28238890318193116,0.8604750730790839,0.7066950053134963,0.9209565160470076,1.0,28/135,16.94%,MAP3K5;TSSK6;TSSK4;FEN1;EYA2;IDH3G;RHEB;NT5C3A;SIK3;DCTPP1;LATS1;HPGDS;OXSR1;MOV10L1;THG1L;SRPK2;PLSCR3;SRPK1;OPA1;PGP;ENDOV;CDC42BPA;FAN1;IDH3A;PI4K2A;ABL1;YDJC;MAP3K6
prerank,mRNA 5'-UTR binding (GO:0048027),0.3559259055085547,0.8574386805651417,0.622478386167147,0.9240156778097699,1.0,11/24,28.55%,UTP23;SHMT1;SYNCRIP;IGF2BP3;IGF2BP2;RPL41;IGF2BP1;RPL26;CCT5;LARP1;DDX3X
prerank,"endoribonuclease activity, producing 5'-phosphomonoesters (GO:0016891)",0.33738484890567044,0.8569651071977397,0.6323119777158774,0.9222606546821432,1.0,6/28,14.49%,FEN1;POP4;POP1;DBR1;RPP21;ENDOV
prerank,transcription coactivator binding (GO:0001223),0.365857632804516,0.855811448468784,0.6597938144329897,0.9217856400399951,1.0,2/20,6.15%,THRB;ZBTB17
prerank,chemokine receptor binding (GO:0042379),0.33068619318093795,0.8548830705096584,0.6177248677248677,0.9207943540349284,1.0,2/35,5.95%,CCL5;CCRL2
prerank,poly-purine tract binding (GO:0070717),0.3466100849464286,0.8548400076872268,0.6442857142857142,0.9182477464622019,1.0,4/27,6.96%,PABPC4L;PABPC1L;EIF4A3;RBMS3
prerank,chloride channel activity (GO:0005254),0.30704616664794426,0.8534098780262037,0.6691086691086691,0.9183069360967326,1.0,9/59,15.64%,CFTR;ANO7;CLIC1;CLCN4;SLC1A4;ANO6;ANO3;CLCC1;PACC1
prerank,cysteine-type peptidase activity (GO:0008234),0.2984980831228894,0.8524316144226463,0.6720741599073001,0.9173785728134185,1.0,27/73,24.46%,TINAGL1;USP46;USP29;USP10;CTSZ;OTUD7B;CAPN2;USP20;USP24;USP42;SFRP1;USP28;CTSH;ATG4B;USP25;OTULIN;USP16;USP21;CTSK;USP2;USP11;BLMH;CASP3;ATG4D;USP13;USP34;CTSF
prerank,fatty acid synthase activity (GO:0004312),0.4113406510995378,0.8522987339146533,0.6225490196078431,0.9150219819025706,1.0,2/10,8.14%,ELOVL1;ELOVL6
prerank,cation:chloride symporter activity (GO:0015377),0.41556022635850426,0.8522207058572285,0.6391231028667791,0.9125756966204681,1.0,3/10,16.21%,SLC12A8;SLC12A4;SLC12A6
prerank,adenylyltransferase activity (GO:0070566),-0.2868793977338751,-0.8509846684398252,0.6576576576576577,0.9494679580716725,1.0,6/21,20.08%,GPHN;PAPOLA;PAPOLG;SELENOO;TENT2;PAPOLB
prerank,clathrin adaptor activity (GO:0035615),-0.3161544851943328,-0.8506818026345917,0.6510989010989011,0.9436113859027437,1.0,4/15,12.53%,HIP1;DAB2;AP2B1;STON2
prerank,"phosphotransferase activity, for other substituted phosphate groups (GO:0016780)",-0.34481099193442977,-0.8488692175485819,0.6756756756756757,0.9409631187168224,1.0,2/11,5.73%,SGMS1;PTDSS1
prerank,organic cation transmembrane transporter activity (GO:0015101),-0.3016179954789916,-0.8481607748879253,0.6460674157303371,0.9363147240462975,1.0,9/16,38.88%,SLC44A2;SLC44A1;SLC5A7;SLC22A2;SLC25A26;SLC22A3;SLC22A5;SLC29A4;SLC7A8
prerank,ribonuclease P RNA binding (GO:0033204),0.40576755589546676,0.8430866493126454,0.6447811447811448,0.92643851856288,1.0,3/10,12.36%,POP4;POP1;RPP21
prerank,microtubule minus-end binding (GO:0051011),-0.3249740134036646,-0.841927423903925,0.6502732240437158,0.9425716685142262,1.0,7/13,29.32%,TUBGCP2;MACF1;CAMSAP2;HAUS4;HAUS7;TUBGCP3;CAMSAP3
prerank,nucleotidyltransferase activity (GO:0016779),0.3642137448054894,0.836016517382172,0.6484018264840182,0.9365902496444727,1.0,5/19,12.99%,MOCS3;REV1;TENT4A;THG1L;TUT7
prerank,CARD domain binding (GO:0050700),-0.3090885567361843,-0.835971736013021,0.6830601092896175,0.9484693731133703,1.0,4/14,11.65%,NOD1;CARD10;IRGM;CASP4
prerank,histone methyltransferase binding (GO:1990226),0.40002259919067534,0.8348695686157626,0.6661211129296236,0.9361038528173686,1.0,2/11,6.02%,PHF1;LCOR
prerank,DNA-binding transcription factor binding (GO:0140297),0.26832708278604356,0.8339507137807158,0.7752341311134235,0.9351278695870926,1.0,46/189,19.98%,KLF4;EP300;HDAC5;FOS;DAPK3;CGGBP1;HDAC4;NFE2L2;WWP2;HSPB1;MTDH;CREB1;ZBTB17;HCFC1;DDRGK1;MEF2D;FIZ1;JUN;TCF7L2;TWIST1;TLE2;PTMA;NCOR1;TLE4;YWHAZ;SP1;MIER2;PIAS1;PIAS3;MKKS;MYC;MEF2C;TLE5;GSK3B;DHX9;KDM1A;RERE;NBN;PARK7;ATF2;TLE6;ZBTB7A;RB1;TBP;USF1;DDX20
prerank,high voltage-gated calcium channel activity (GO:0008331),0.41010247987714965,0.8338823440009069,0.641156462585034,0.9326406336126162,1.0,2/10,3.47%,CACNA1A;CACNB3
prerank,calcium-dependent phospholipid binding (GO:0005544),0.3037456920520975,0.8304476975787379,0.6939820742637645,0.9358039805132242,1.0,11/49,15.28%,ANXA3;ANXA8;ANXA4;ANXA5;ANXA2;PCLO;ESYT2;CPNE2;SYT6;SYT11;SYT12
prerank,ubiquitin-protein transferase activity (GO:0004842),0.2577833473483862,0.8300540386078623,0.8456104944500504,0.9338795097581186,1.0,101/346,25.38%,RNF152;TRIM60;FBXW8;RNF43;RNF220;TRIM59;SH3RF2;WWP2;RNF5;TRIM25;TRIM44;RNF138;KLHL21;MUL1;CBLL1;TRIM41;TRIM21;MAGEL2;UBE2G2;RMND5B;RBX1;CDC42;RNF146;PML;TRIM47;TRIM26;TRIM11;RNF121;UBE2B;RNF182;LTN1;PPP1R11;SIAH3;COP1;UBE2Q1;VPS11;KLHL13;RNF126;MIB2;RNF123;RNF141;ANAPC4;DTX3;PELI1;VPS18;BRAP;UBR5;NEDD4;UBE2H;MDM2;BFAR;RNF31;UBE2N;MSL2;PRPF19;MAEA;RNF10;DTX2;UBE2D3;SIAH1;XIAP;STUB1;UBE2J1;PDZRN3;TRIM37;RNF112;RNF41;RNF130;UBE2Z;UBE3C;FBXO9;RMND5A;ZFP91;CHFR;CUL2;TRIM5;UBE2E1;FBXW2;RCHY1;ARIH2;TRAF3IP2;SMURF2;RNF168;NSMCE1;RNF213;TRIM3;RNF14;RNF7;CDC23;FBXO4;UBR4;UBE3D;RNF150;BIRC3;UBA7;TMEM129;RING1;UBE2M;LRSAM1;TRIM39;TSPAN17
prerank,ADP binding (GO:0043531),-0.268278297742196,-0.8291393779988421,0.7015873015873015,0.955936765727682,1.0,2/25,2.14%,PRKAG2;ME1
prerank,ephrin receptor binding (GO:0046875),0.3587565250583009,0.8290850136138863,0.6785185185185185,0.9329665569196522,1.0,6/21,16.82%,EFNB2;EFNA5;SHC1;EFNA4;CRK;ABL1
prerank,store-operated calcium channel activity (GO:0015279),0.3957221154262482,0.8268626913250751,0.6841216216216216,0.9344212702704681,1.0,1/10,1.25%,STIM2
prerank,DNA-directed DNA polymerase activity (GO:0003887),0.3559932230510304,0.8256248000531474,0.6820143884892086,0.9339798181234592,1.0,5/21,14.43%,REV1;POLK;POLG;POLE4;POLH
prerank,GTPase regulator activity (GO:0030695),0.26409403021091876,0.8254036194398189,0.8092307692307692,0.931781759945341,1.0,44/212,15.23%,ARHGAP42;SRGAP2;ARAP1;RANBP3L;ASAP2;CPEB2;SIPA1L1;ARHGAP18;WNT11;GRTP1;TBC1D16;ADAP1;IPO7;SH3BP4;TSC2;ARHGAP29;ARHGAP10;KRIT1;JUN;IQGAP1;BCR;RALGDS;OPHN1;LLGL2;DLC1;SGSM2;GNAQ;TBC1D1;RASA1;RGS6;DOCK1;ASAP3;ARHGEF10L;OCRL;ARHGAP31;ARFGEF1;PREB;CCDC88A;ARHGAP27;DNM1L;FLCN;ITGB1BP1;SEC23A;USP6NL
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides (GO:0016811)",0.292376080671431,0.8232208849110935,0.7177322074788902,0.93310140136363,1.0,23/54,30.48%,PDF;HDAC5;HDAC4;HDAC3;NIT1;MIER2;NTAQ1;VNN1;HDAC6;ACR;NADSYN1;SIRT4;SIRT7;NGLY1;HDAC8;PM20D1;SUDS3;NTAN1;ASRGL1;ASAH1;HINT3;HDAC11;FAAH
prerank,mitogen-activated protein kinase binding (GO:0051019),0.334799153134324,0.8225656383944507,0.6908831908831908,0.9317252652823367,1.0,11/29,22.77%,DUSP10;DUSP1;MAPK7;PPM1D;TNIP1;ABL1;PRMT1;MAPKAPK2;CDK5RAP3;DUSP16;TPR
prerank,tRNA-specific ribonuclease activity (GO:0004549),0.3661074859049992,0.8220303235337338,0.6848,0.9301076755214759,1.0,5/14,21.58%,POP4;POP1;RPP21;TSEN2;RPP40
prerank,DNA binding (GO:0003677),0.25290691642762947,0.8200729223403797,0.935,0.9308500406713324,1.0,165/694,22.47%,NFATC2;THRB;TFAP2C;PPARGC1A;PBX1;ZIC4;FOXP2;NUPR1;ZC3H12A;KLF12;FEN1;SLPI;EP300;MLH1;FOXO3;FOXC2;ZNF219;CGGBP1;SHOC1;HDAC4;NFE2L2;NR6A1;ZBTB16;ZMYM6;POLR2H;SMARCB1;FOXD2;POU2F3;NABP2;ESRRB;RARG;IRF3;SLTM;NKX2-8;PATZ1;PHF1;POLR2A;RNF138;HOXA5;SYCP2;MRE11;SOX9;FOXD1;ZIC2;CENPS;ANG;TSNAX;SIX1;JUN;POU3F1;TCF7L2;CRY2;GRHL2;FOXP3;SDE2;NR2C1;TRIM26;DNMT3A;HDGFL3;ILF2;NFIB;POLG;DNASE1L2;NFYC;CR2;ARID4A;SMARCA4;ARID3B;JRKL;GTF3C3;CALCOCO1;MMP12;SP1;ZNF148;MAFK;ZMYM4;ERCC5;CHD3;GATA3;HMGN1;MBD4;MYC;POLR3C;RPA3;DNASE1L1;REXO4;PAX3;SRRT;IRF2;ENDOV;DNTTIP1;APTX;DHX9;TET1;MCM8;HMBOX1;PCNA;FAN1;CDC5L;ZGPAT;DCLRE1C;GTF3C2;DDB1;MCM6;E2F1;POU4F1;HINFP;ERCC2;SPTY2D1;ABL1;CAMTA2;SMC6;NBN;BCLAF3;MCM7;GTF3C5;TRIM16;TSG101;PLAGL2;MEOX2;RAD50;PARK7;RFC1;ZKSCAN3;RPL6;JCHAIN;APP;KLF2;HDGF;PNKP;ZBTB7A;PCBP2;NUCKS1;ERCC4;TEAD1;USF1;SREBF1;MAPT;IKZF1;NABP1;ZBTB32;ZNF513;IRF6;ZBP1;HOXA1;SNAPC3;ACR;TWNK;ZNF8;MTF1;YY1;SFPQ;TAF6;YBX1;MCM4;ZBTB49;ARNT;LONP1;PGR;MEN1;GTF3C4;RPL7;POLR3F;TFAM;IGHMBP2
prerank,calcium channel activity (GO:0005262),0.28190729601687065,0.8144498437677888,0.7462514417531718,0.9378806756593903,1.0,14/84,13.39%,STIM2;CACNA2D3;CACNA1A;TRPM8;MCU;CACNB3;CACNA2D4;ANXA2;TMC2;PKD1;TRPM4;PKD2L1;CACNB2;TRPM2
prerank,carboxylic ester hydrolase activity (GO:0052689),0.273274786114712,0.8116578586523944,0.76,0.93992823189365,1.0,7/85,11.30%,PLB1;ABHD5;ABHD15;PLA2G12A;PAFAH2;AARS1;PON3
prerank,transcription coregulator binding (GO:0001221),0.2954997408035407,0.8089052901049045,0.7217496962332929,0.9420389978478905,1.0,5/50,6.15%,THRB;ZBTB16;PHF1;LCOR;ZBTB17
prerank,hexose transmembrane transporter activity (GO:0015149),-0.32012584400483235,-0.8088078828727278,0.7229551451187335,0.9893046391857828,1.0,4/12,26.86%,SLC2A1;SLC5A3;SLC2A3;SLC2A4
prerank,vitamin D receptor binding (GO:0042809),0.372954229422671,0.8080982542398976,0.6900958466453674,0.9408062764531923,1.0,3/14,13.65%,MED30;MED12;MED24
prerank,Toll-like receptor binding (GO:0035325),-0.32898905482518326,-0.8064325013375765,0.7018469656992085,0.9873286644827509,1.0,3/11,13.65%,DAB2IP;TIRAP;UNC93B1
prerank,"DNA-binding transcription activator activity, RNA polymerase II-specific (GO:0001228)",0.2559134429215773,0.8063476069273983,0.854230377166157,0.9412470720981985,1.0,43/254,15.87%,KLF5;KLF4;TFAP2C;ELF3;FOXO3;FOXC2;GLIS2;ZBTB16;FOXD2;POU2F3;ESRRB;IRF3;NKX2-8;CREB1;HOXA5;ZBTB17;RXRB;SOX9;NRF1;KLF7;SIX1;JUN;GRHL2;PRDM15;NFIB;NFYC;NFIC;CREB3;MEF2B;SP1;GATA3;SMARCD2;RREB1;NFIA;MYC;MEF2C;MYBL1;IRF2;ATMIN;RFXAP;MDM2;KLF6;CDC5L
prerank,DNA polymerase activity (GO:0034061),0.34465351062280775,0.8026565211039726,0.7057971014492753,0.9450920914649749,1.0,5/22,14.43%,REV1;POLK;POLG;POLE4;POLH
prerank,MAP kinase activity (GO:0004707),-0.29991578401552277,-0.8006398564852244,0.7062146892655368,0.991347309769093,1.0,2/14,4.32%,MAPK4;MAPK10
prerank,potassium ion transmembrane transporter activity (GO:0015079),-0.24977857659577613,-0.8005585521458494,0.7918088737201365,0.9851686834781664,1.0,5/31,5.23%,KCNK5;ABCC9;PKD2;SLC12A2;KCNQ4
prerank,ribonuclease P activity (GO:0004526),0.37305808349488123,0.8004234690342363,0.7071197411003236,0.9462815443889855,1.0,3/11,12.36%,POP4;POP1;RPP21
prerank,transforming growth factor beta receptor binding (GO:0005160),0.3519166599183566,0.7992917891472818,0.718266253869969,0.9455209141442961,1.0,4/18,14.17%,SMAD6;TGFB2;TGFBR2;TGFBR3
prerank,NAD-retinol dehydrogenase activity (GO:0004745),0.36376601546695536,0.7983798846717225,0.7153846153846154,0.9444880610839712,1.0,1/14,2.95%,ADH7
prerank,voltage-gated calcium channel activity (GO:0005245),0.30836721432835373,0.7980682257507361,0.7235142118863049,0.942535376508608,1.0,5/37,7.73%,CACNA2D3;CACNA1A;CACNB3;CACNA2D4;TMC2
prerank,telomerase RNA binding (GO:0070034),0.33141571755158117,0.797252424955887,0.7094395280235988,0.9414353538608042,1.0,4/22,13.85%,SNRPB;SMG7;GAR1;PINX1
prerank,growth factor activity (GO:0008083),-0.202647609398165,-0.7938112209597831,0.9299363057324841,0.9909781110730972,1.0,7/74,8.71%,TGFA;JAG1;NRG3;VEGFC;FGF2;IGF2;JAG2
prerank,WW domain binding (GO:0050699),0.32210350351699374,0.7935380378025789,0.7268965517241379,0.9450310666392577,1.0,7/26,20.67%,ENAH;WBP1;TCEAL5;TCEAL8;KIF20B;TRAF4;PMEPA1
prerank,ribosomal small subunit binding (GO:0043024),0.34526933615529687,0.7924971633058912,0.722473604826546,0.9441881495286296,1.0,2/17,8.91%,CPEB2;EIF4B
prerank,pseudouridine synthase activity (GO:0009982),-0.30490730951640677,-0.7904451597003759,0.7526595744680851,0.9903815072258925,1.0,3/13,15.02%,PUS7;DKC1;RPUSD4
prerank,CoA-ligase activity (GO:0016405),-0.30859915839299634,-0.7888597963954367,0.7751937984496124,0.9870461674389656,1.0,4/14,16.94%,ACSS3;ACSL1;ACSS1;ACSBG1
prerank,signal sequence binding (GO:0005048),0.310012035068029,0.7882752545486729,0.7437252311756936,0.9482699387819636,1.0,10/35,17.57%,KPNA7;NFKBIA;TNPO2;KPNA4;TOMM20;TNPO1;BRAP;RANBP6;IPO4;KPNA1
prerank,chemokine activity (GO:0008009),0.3111110353118784,0.7880081450240631,0.7383798140770252,0.9462403557197416,1.0,1/31,1.51%,CCL5
prerank,glucose transmembrane transporter activity (GO:0005355),-0.28486468521447855,-0.7875223162096457,0.7744807121661721,0.9835044215459035,1.0,5/17,26.86%,SLC2A1;SLC5A3;SLC5A11;SLC2A3;SLC2A4
prerank,3'-5' exonuclease activity (GO:0008408),0.2966477513911552,0.7865870613537023,0.759493670886076,0.9459586567672141,1.0,6/45,10.31%,CNOT6;MRE11;XRN2;EXOSC3;ERI3;POLG
prerank,acid-thiol ligase activity (GO:0016878),-0.31285681807304705,-0.7840323952260978,0.7564102564102564,0.9833446732385955,1.0,3/13,10.90%,ACSS3;ACSL1;ACSS1
prerank,glutathione transferase activity (GO:0004364),0.3264070589449614,0.7837949387913374,0.7302725968436155,0.9477992992204618,1.0,5/23,15.85%,MGST3;GSTO1;HPGDS;GSTK1;GSTM2
prerank,L-amino acid transmembrane transporter activity (GO:0015179),0.28650626588809774,0.7823181994342587,0.7673830594184576,0.9476066918422871,1.0,13/53,15.34%,SLC36A3;SLC66A1;OCA2;CTNS;SLC36A4;SLC3A1;SFXN1;SLC25A38;SLC7A6;SLC1A4;SLC6A7;SLC25A12;SLC7A3
prerank,1-acylglycerol-3-phosphate O-acyltransferase activity (GO:0003841),0.3565726320524343,0.7822950560528982,0.7244582043343654,0.9452085369466922,1.0,2/13,11.96%,ABHD5;LPCAT2
prerank,hexosaminidase activity (GO:0015929),0.36770314699011764,0.7801066267768421,0.725752508361204,0.9460365955981613,1.0,4/12,16.26%,HEXA;HEXB;NAGA;HEXD
prerank,metal ion transmembrane transporter activity (GO:0046873),0.30727815709138806,0.7777482305981599,0.7588555858310627,0.9472368501399662,1.0,5/27,14.07%,ITPR2;TMEM165;AQP1;SLC41A1;ATP2B4
prerank,pyrophosphate hydrolysis-driven proton transmembrane transporter activity (GO:0009678),0.32182560679541544,0.7735357085543069,0.7426470588235294,0.9513136968030014,1.0,13/22,31.12%,ATP6V1E1;ATP6V1D;ATP6V0D1;ATP5F1B;ATP6V1B2;ATP6V0B;ATP6V0E1;ATP2C1;ATP6V0E2;ATP6V0D2;ATP6V0C;TCIRG1;ATP6V0A2
prerank,"catalytic activity, acting on a tRNA (GO:0140101)",0.2962956475169244,0.773030481312757,0.7768817204301075,0.9496995579103515,1.0,11/35,25.85%,NT5C3A;LCMT2;TRPT1;TRIT1;AARS1;DUS2;GATB;DUS3L;FTO;TARS2;FTSJ1
prerank,single-stranded DNA binding (GO:0003697),0.258787995622762,0.7728880432265877,0.8281786941580757,0.9474893594244307,1.0,28/93,22.47%,MLH1;SHOC1;POLR2H;NABP2;RNF138;CRY2;ERCC5;POLR3C;RPA3;REXO4;APTX;DHX9;MCM8;MCM6;POU4F1;SMC6;MCM7;PARK7;JCHAIN;PCBP2;NUCKS1;ERCC4;MAPT;NABP1;TWNK;MCM4;LONP1;IGHMBP2
prerank,"oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor (GO:0016646)",0.35361794436593164,0.7722629046068437,0.7265625,0.9460780436045342,1.0,4/14,14.81%,PYCR3;NOXRED1;ALDH1L2;ALDH1L1
prerank,GTP binding (GO:0005525),0.24927604909961804,0.7720938286810974,0.8713389121338913,0.9439254684924195,1.0,32/172,16.92%,MRAS;RAP1B;EEF1A1;RAP1A;ARL4A;ARL3;RHOQ;EIF2B2;NRAS;KRAS;RHEB;GLUD1;CDC42;RAB7A;ARHGEF5;GTPBP10;THG1L;BMS1;RAB35;ARFIP2;RHOA;RABL3;ARF4;RHOU;TUBB2B;RAB1B;HRAS;ATL2;RAP2C;ARL8A;ADSS2;DIRAS2
prerank,cytokine receptor binding (GO:0005126),0.26219663315526304,0.7719277140306385,0.8228438228438228,0.9417612889575627,1.0,10/83,11.61%,CRLF1;CCL5;CLCF1;EPO;CCRL2;PXDN;TGFB2;VEGFB;SOCS2;JAK1
prerank,peptidoglycan binding (GO:0042834),0.37067983863442533,0.77182800940715,0.715008431703204,0.9395632537458887,1.0,4/10,19.33%,PGLYRP3;HK1;RNASE7;JCHAIN
prerank,translation elongation factor activity (GO:0003746),0.35212410837980734,0.7702042895638639,0.7204968944099379,0.9396935697058973,1.0,1/14,2.89%,EEF1A1
prerank,"phosphatidylinositol-3,4-bisphosphate binding (GO:0043325)",0.31255764938542935,0.7672690379515138,0.7417974322396577,0.9418162719112441,1.0,3/25,3.94%,ANXA8;PHLDA3;FCHSD2
prerank,protein phosphorylated amino acid binding (GO:0045309),-0.22046750511421614,-0.7632966262139079,0.8679245283018868,1.0,1.0,10/42,13.37%,PIK3R1;NCK2;CRKL;SHE;ABL2;PTPN3;GRB2;BCAR3;SHF;PIK3R3
prerank,protein-arginine N-methyltransferase activity (GO:0016274),-0.31952536886720134,-0.76311506302375,0.7874659400544959,1.0,1.0,4/11,24.32%,PRMT3;PRMT9;PRMT6;CARM1
prerank,protein-cysteine S-palmitoyltransferase activity (GO:0019706),0.3099752702427339,0.7610897426200243,0.7743732590529248,0.9487446901316022,1.0,3/24,9.26%,GLUL;ZDHHC12;GOLGA7
prerank,peptide N-acetyltransferase activity (GO:0034212),0.3692704202944699,0.759955423665227,0.737649063032368,0.947973999799785,1.0,3/10,13.92%,NAA15;NAA20;NAA10
prerank,single-stranded DNA helicase activity (GO:0017116),-0.26845648762514307,-0.7564134341646747,0.8391167192429022,1.0,1.0,12/19,36.89%,WRNIP1;RFC3;HELQ;RAD51;RFC4;RFC2;DNA2;HELB;RFC5;DSCC1;CHTF18;PIF1
prerank,nucleosomal DNA binding (GO:0031492),0.31755926069454093,0.7550464174169994,0.7719821162444114,0.9527080334892899,1.0,7/21,18.29%,SMARCB1;ACTB;SMARCA4;SMARCD2;GATAD2B;SMARCC1;H3-3A
prerank,ubiquitin conjugating enzyme binding (GO:0031624),-0.2449129505247775,-0.7543981399922146,0.845360824742268,1.0,1.0,11/27,27.76%,RNF144A;TRAF6;RNF144B;DCUN1D3;PPARA;DCUN1D2;RNF180;SIAH2;FOXL2;RNF19B;DCUN1D4
prerank,DNA secondary structure binding (GO:0000217),0.29127695794714503,0.7527786326631076,0.7725437415881561,0.9536920309140454,1.0,10/31,23.69%,RECQL4;KMT2A;ERCC5;MEF2C;ABL1;LIN54;MAPT;YY1;MEN1;FANCM
prerank,GTPase inhibitor activity (GO:0005095),0.35171158244012646,0.7498517157492728,0.768025078369906,0.9554932516986361,1.0,2/13,8.46%,CPEB2;IQGAP1
prerank,single-stranded RNA binding (GO:0003727),0.2791050458412751,0.7485005304639394,0.8015267175572519,0.9549301460138204,1.0,8/43,15.32%,STRBP;L1TD1;EIF4B;LACTB2;FXR1;ENDOV;ZFR2;DHX9
prerank,ephrin receptor activity (GO:0005003),-0.2605249904994231,-0.74722947505348,0.8186968838526912,1.0,1.0,6/17,19.19%,EPHA7;EPHB2;EPHB4;EPHA5;EPHB3;EPHA8
prerank,transmembrane-ephrin receptor activity (GO:0005005),-0.2605249904994231,-0.74722947505348,0.8186968838526912,1.0,1.0,6/17,19.19%,EPHA7;EPHB2;EPHB4;EPHA5;EPHB3;EPHA8
prerank,acetylcholine-gated cation-selective channel activity (GO:0022848),-0.30782600176260866,-0.743828438397145,0.8050632911392405,1.0,1.0,7/11,52.93%,CHRNB1;CHRNA4;CHRNB2;CHRNA5;CHRNA3;CHRNB4;CHRNA1
prerank,ion gated channel activity (GO:0022839),0.3061498082778497,0.7420649899693403,0.7747489239598279,0.9616034908313703,1.0,8/24,18.85%,ANO8;ANO7;TRPM4;PKD2L1;ANO6;ANO3;TMEM63B;TTYH3
prerank,copper ion binding (GO:0005507),-0.20971277763224905,-0.7410636632224161,0.8792270531400966,1.0,1.0,5/42,10.36%,PAM;MOXD1;ATOX1;LOXL3;TP53
prerank,carboxylic acid binding (GO:0031406),0.281732049731798,0.7410300140822002,0.7898172323759791,0.9605996244455075,1.0,4/38,9.13%,RTN4R;SESN2;GLUD1;SHMT1
prerank,intracellular chloride channel activity (GO:0061778),0.32676587866009055,0.7387496958350034,0.7727272727272727,0.9589800207444589,1.0,5/16,18.85%,ANO8;ANO7;ANO6;ANO3;TTYH3
prerank,intracellular calcium activated chloride channel activity (GO:0005229),0.32676587866009055,0.7387496958350034,0.7727272727272727,0.9589800207444589,1.0,5/16,18.85%,ANO8;ANO7;ANO6;ANO3;TTYH3
prerank,hormone activity (GO:0005179),0.26672006477131227,0.7384948528803494,0.8335388409371147,0.9570017936375861,1.0,2/54,2.38%,GAL;PENK
prerank,gap junction channel activity (GO:0005243),0.30776546624736656,0.7382376490623529,0.7793296089385475,0.9549899574109482,1.0,2/22,5.32%,GJB6;GJC2
prerank,endopeptidase regulator activity (GO:0061135),0.2803849198235924,0.7358441997425095,0.8279430789133247,0.9560404169975064,1.0,4/40,11.07%,SLPI;SPINT2;PSMF1;ABCA2
prerank,"exoribonuclease activity, producing 5'-phosphomonoesters (GO:0016896)",0.29167749945728516,0.7352265870148398,0.7850467289719626,0.9546395929186541,1.0,4/33,9.41%,CNOT6;XRN2;EXOSC3;ERI3
prerank,wide pore channel activity (GO:0022829),0.3038833226958337,0.732563748498605,0.7925311203319502,0.9557977542926069,1.0,2/23,5.32%,GJB6;GJC2
prerank,galactosyltransferase activity (GO:0008378),0.34674600498646535,0.7325513690637814,0.7691029900332226,0.9535254076952534,1.0,1/11,3.91%,A4GALT
prerank,DNA polymerase binding (GO:0070182),0.31254091567354264,0.7299996711073281,0.8006230529595015,0.9545953986703575,1.0,6/18,21.80%,NABP2;SMARCA4;HSP90AA1;PCNA;PTGES3;LONP1
prerank,vascular endothelial growth factor receptor binding (GO:0005172),-0.2859478909495885,-0.7289385758736354,0.8293963254593176,1.0,1.0,2/12,5.29%,VEGFC;DAB2IP
prerank,phosphatidylinositol kinase activity (GO:0052742),-0.27319205643053646,-0.7264047896905035,0.8424068767908309,1.0,1.0,5/15,14.80%,PIK3CB;PIK3CD;PIK3R3;PI4K2B;PIK3C3
prerank,voltage-gated sodium channel activity (GO:0005248),0.3025228499504269,0.7229296923273114,0.7956521739130434,0.9615131620927089,1.0,1/22,1.20%,SCN3A
prerank,transition metal ion binding (GO:0046914),0.22603559730319792,0.7218673887008351,0.9798994974874372,0.960632426781451,1.0,87/397,22.22%,NAPEPLD;KLF4;FAM20C;MMP9;GPC1;MPPED2;FEN1;ADH7;TIMM10;EPRS1;ADAM33;GALNT1;HDAC4;LARGE1;TIMP1;RNF5;ALOX5;DUSP12;TIMP2;MGAT1;TES;KDM5C;KLF7;NQO2;TAB3;ANG;MSRB2;CHORDC1;CXXC4;FDX1;KMT2A;PITRM1;SHMT1;PHF5A;KDM3A;ZNF205;LACTB2;SOD2;HEPH;KDM4C;MYT1;PLSCR3;SCD5;MMP12;CHD3;ACO2;NPEPPS;CHMP1A;TARS1;LTA4H;SEC23A;SNCB;MDM2;TET1;ABL1;SIAH1;SLC11A2;TAB2;ZFYVE1;PDXK;PCK2;USP16;PARK7;RNF112;APIP;SEC24B;ENPP5;IDE;TIMM9;ISCA2;ZBTB32;LVRN;TYW5;QPCTL;ACR;ZCCHC4;QPCT;ZNF8;MELTF;ADPRM;DPF3;RASSF1;RCHY1;ARIH2;PHF2;XPNPEP1;AOX1
prerank,aspartic-type peptidase activity (GO:0070001),0.35063751763998796,0.7203827585574626,0.7895622895622896,0.9602310982224456,1.0,4/10,24.00%,NAPSA;BACE1;DDI2;PSEN1
prerank,G protein-coupled peptide receptor activity (GO:0008528),0.2512142363171519,0.7202076498583654,0.8781065088757396,0.9581816734040681,1.0,4/73,8.84%,SORCS2;CRHR2;LGR4;HCRTR1
prerank,3'-5'-exoribonuclease activity (GO:0000175),0.28409177931006513,0.7201464355471171,0.8125,0.9560178140880811,1.0,4/34,9.41%,CNOT6;XRN2;EXOSC3;ERI3
prerank,cysteine-type endopeptidase activity (GO:0004197),0.2505506531470783,0.7196500810472024,0.8819362455726092,0.9544131046985732,1.0,23/78,24.46%,USP46;USP29;USP10;CTSZ;CAPN2;GPAA1;CAPNS1;USP20;USP24;USP42;SFRP1;USP28;CTSH;USP25;USP16;CAPN15;CTSK;USP2;USP11;CASP3;USP13;USP34;CTSF
prerank,methyl-CpG binding (GO:0008327),-0.2474935590670554,-0.7192818077594954,0.8940397350993378,1.0,1.0,7/22,24.46%,MBD2;MECP2;TET3;ZBTB21;MBD3;ZBTB33;ZBTB38
prerank,phosphatidylinositol monophosphate phosphatase activity (GO:0052744),-0.26265448019233206,-0.7179720172291792,0.853448275862069,1.0,1.0,4/16,12.24%,MTMR14;MTM1;MTMR7;MTMR2
prerank,lysophosphatidic acid acyltransferase activity (GO:0042171),0.31742993080726806,0.7171739594212554,0.7936267071320182,0.9552746556081525,1.0,4/15,22.76%,ABHD5;LPCAT2;ABHD4;GPAT3
prerank,acetyltransferase activity (GO:0016407),0.28171374807465416,0.7163785139501377,0.8176795580110497,0.9540023901338652,1.0,5/31,13.92%,EP300;KAT6B;PAFAH2;NAA15;NAA10
prerank,methylation-dependent protein binding (GO:0140034),-0.19175890391636807,-0.7152204934434646,0.9613259668508287,1.0,1.0,12/57,16.53%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;THAP7;WDR5;ZMYND11
prerank,phosphoric ester hydrolase activity (GO:0042578),0.2583328163723303,0.7149934000542097,0.8394607843137255,0.9535085152721597,1.0,14/49,23.62%,MPPED2;ATP1A2;DUSP10;DUSP12;PPP1CB;PGP;PLCXD3;DUSP11;DUSP3;ACP2;DUSP16;ACP6;ARMT1;APEX1
prerank,fibroblast growth factor receptor binding (GO:0005104),-0.2505621326340154,-0.7135469562761325,0.8794117647058823,1.0,1.0,2/21,5.22%,KL;FGF2
prerank,cardiolipin binding (GO:1901612),0.3406319113190712,0.7118463705500896,0.7777777777777778,0.9550557961143903,1.0,3/10,19.88%,GSDME;OPA1;STOML2
prerank,protein serine/threonine phosphatase activity (GO:0004722),0.25212961849518034,0.711491774346989,0.8711583924349882,0.953252641032106,1.0,10/60,12.90%,PPM1L;PPP2CA;PPM1B;DUSP1;UBLCP1;PP2D1;PPM1A;MTMR3;PPP1CB;PPM1D
prerank,calcium ion transmembrane transporter activity (GO:0015085),0.2540178753367833,0.7097792606799338,0.8693528693528694,0.9531025593266855,1.0,9/55,14.07%,ITPR2;MCU;TMEM165;ANXA2;PKD1;PKD2L1;CACNB2;TRPM2;ATP2B4
prerank,"hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines (GO:0016813)",0.32706364848248376,0.7095778580372432,0.7791095890410958,0.9511514011270376,1.0,1/11,6.76%,DDAH2
prerank,single-stranded telomeric DNA binding (GO:0043047),0.3321787196156537,0.7048104961657446,0.8108974358974359,0.9544140704015224,1.0,6/11,29.49%,NABP2;RAD50;TERF2;RPA2;TERF1;TERF2IP
prerank,four-way junction DNA binding (GO:0000400),-0.24835105134024757,-0.7028038109850716,0.8633720930232558,1.0,1.0,6/17,27.01%,RAD51D;HMGB1;BLM;XRCC2;RAD51B;GEN1
prerank,telomeric DNA binding (GO:0042162),0.27965239927604807,0.7020190945955412,0.8342175066312998,0.9555708497978783,1.0,15/32,31.46%,UPF3A;SMG7;HMBOX1;KDM1A;RAD50;TERF2;TINF2;APEX1;ZBTB48;XRCC5;TERT;TERF1;TERF2IP;NCL;TELO2
prerank,voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization (GO:0086008),-0.2611215650635102,-0.7011735485640533,0.8770491803278688,1.0,1.0,4/14,25.53%,KCNJ2;KCNJ8;KCNIP2;KCNJ3
prerank,solute:sodium symporter activity (GO:0015370),-0.22424629677743946,-0.6972252337033298,0.9094076655052264,1.0,1.0,6/27,24.64%,SLC4A10;SLC5A3;SLC5A11;SLC5A7;SLC4A8;SLC5A6
prerank,ubiquitin-like protein-specific protease activity (GO:0019783),-0.24105155054856786,-0.6958162349386269,0.8963414634146342,1.0,1.0,8/20,23.80%,OTULINL;SENP2;SENP5;OTUB1;USP7;EIF3F;OTUD5;YOD1
prerank,ubiquitin-dependent protein binding (GO:0140036),0.33751205893835423,0.693110069880888,0.8070739549839229,0.9637290582385747,1.0,6/10,32.84%,FAN1;IDE;ANKRD13D;ANKRD13B;USP15;LAPTM5
prerank,N-acetyltransferase activity (GO:0008080),0.2967308853071158,0.6927241318396486,0.8416149068322981,0.9619900288450469,1.0,3/19,13.92%,EP300;AANAT;NAA10
prerank,protein serine/threonine kinase inhibitor activity (GO:0030291),-0.21864317484174808,-0.6925307898828289,0.9402985074626866,0.9983796902818368,1.0,8/29,19.24%,PRKAG2;PKIG;CIT;PRKAR2B;SPRED1;INCA1;PRKAR1B;CIB1
prerank,3'-5' DNA helicase activity (GO:0043138),0.3063339482681733,0.6923756356836162,0.8054298642533937,0.9602362395685039,1.0,7/16,26.94%,RECQL4;DHX9;MCM6;MCM7;FANCM;FBH1;MCM2
prerank,transcription corepressor binding (GO:0001222),0.2783388911114877,0.6914117529722731,0.8484438430311232,0.9591818006854043,1.0,13/27,27.48%,ZBTB16;PHF1;LCOR;HDAC3;HDAC6;HDGF;ZBTB7A;USP11;PER1;PER2;WIZ;EHMT1;CTBP2
prerank,triglyceride lipase activity (GO:0004806),0.2855402558328328,0.6898319733184839,0.8237822349570201,0.9587156410084936,1.0,1/20,3.17%,ABHD5
prerank,phosphatidylinositol-3-phosphatase activity (GO:0004438),-0.26448100340318575,-0.6886779873796816,0.8694444444444445,0.9968226615658805,1.0,4/14,12.24%,MTMR14;MTM1;MTMR7;MTMR2
prerank,channel activity (GO:0015267),-0.1923805160860218,-0.6857708296128776,0.963265306122449,0.9942369431435237,1.0,12/41,28.35%,BCL2;PANX1;AQP11;AQP4;BAX;KCNK3;MPV17;CHRNB1;SLC14A1;TRPA1;TMEM120B;PANX2
prerank,pyridoxal phosphate binding (GO:0030170),0.2863401039099468,0.68419618859032,0.8541033434650456,0.9628004878237855,1.0,9/20,31.08%,ABAT;SHMT1;PDXK;PYGB;PYGM;PLPBP;PNPO;OAT;PSAT1
prerank,myosin V binding (GO:0031489),-0.2500945899884074,-0.6792168296523252,0.8821917808219178,0.9951278946246757,1.0,4/15,19.53%,RAB11B;RAB39B;RAB3D;RAB3C
prerank,DNA replication origin binding (GO:0003688),0.27914175145965503,0.6788795855539669,0.86608442503639,0.9664570770038636,1.0,7/23,21.61%,GRWD1;DHX9;MCM8;MCM6;MCM7;ORC2;MCM4
prerank,ubiquitin binding (GO:0043130),0.23798445796540613,0.678256745200536,0.9096176129779838,0.9648904689643693,1.0,23/73,25.30%,CXCR4;HSPB1;NSFL1C;MARK4;UBXN7;NPLOC4;NEDD4;MDM2;IKBKG;RNF31;UBE2N;USP25;TSG101;USP16;RAE1;ILRUN;FBXW7;RNF168;DDI2;USP13;UBXN2A;NUP62;UBAP1
prerank,SUMO binding (GO:0032183),-0.261241984297225,-0.6770583516017209,0.8753462603878116,0.9919322807355769,1.0,4/13,17.50%,SERBP1;RNF4;SIMC1;USPL1
prerank,histone acetyltransferase binding (GO:0035035),0.2853672855673868,0.6760421631811175,0.8457059679767104,0.9650274556885343,1.0,5/21,19.56%,GLI3;FOXP3;BCAS3;PCNA;ZBTB7A
prerank,voltage-gated chloride channel activity (GO:0005247),0.3328256542042191,0.6747709770659712,0.8297161936560935,0.9641464158762246,1.0,2/10,12.24%,CLCN4;ANO6
prerank,calcium activated cation channel activity (GO:0005227),0.2918963917606749,0.6741763467393534,0.837245696400626,0.962566558217139,1.0,7/17,22.94%,TRPM4;PKD2L1;ANO6;TMEM63B;KCNMB2;KCNMB3;ANO10
prerank,calcium-activated potassium channel activity (GO:0015269),-0.2728268173131933,-0.6723699464544969,0.8762135922330098,0.9909224270123191,1.0,3/11,15.22%,KCNN2;KCNMB4;KCNMA1
prerank,kinase activity (GO:0016301),0.225008680902382,0.6711892502969109,0.9441401971522454,0.9635515023158986,1.0,23/109,17.86%,EPHA4;PIK3C2B;IP6K1;AGK;PMVK;STK39;MAPK15;NADK2;DCAKD;NADK;PPIP5K2;PI4KA;CKMT1A;DGKA;PKMYT1;PSTK;IRAK1;DOLK;GSK3B;IP6K2;ABL1;TRRAP;PDXK
prerank,protein serine/threonine/tyrosine kinase activity (GO:0004712),0.27154667697095536,0.6681592382358513,0.8640226628895185,0.9645164921024368,1.0,3/28,9.40%,PRKAA2;AURKC;MAP2K2
prerank,palmitoyltransferase activity (GO:0016409),0.26587260857269696,0.6678490279691109,0.8680272108843538,0.9626715913935924,1.0,3/28,9.26%,GLUL;ZDHHC12;GOLGA7
prerank,voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization (GO:1902282),-0.2750555391871559,-0.6674792374242539,0.8886075949367088,0.989863237249401,1.0,8/11,53.72%,KCNJ8;KCNJ3;KCND3;KCNE5;KCNQ1;KCNJ5;KCNE2;KCNE3
prerank,symporter activity (GO:0015293),-0.2753181804802094,-0.6657912165119034,0.870026525198939,0.986077556543675,1.0,3/10,24.64%,MFSD2A;SLC5A5;SLC5A6
prerank,cyclin-dependent protein serine/threonine kinase regulator activity (GO:0016538),0.24819556672648552,0.6652005816396022,0.8894601542416453,0.9632406552534415,1.0,7/42,18.87%,CDKN1A;CCND2;CCND1;CCNL2;HEXIM1;CCNG1;CDKN2D
prerank,phosphatidylglycerol binding (GO:1901611),0.30414432868403524,0.6646080527729382,0.8649921507064364,0.9616693331167688,1.0,3/13,12.70%,PITPNC1;GSDME;OPA1
prerank,MHC class I protein binding (GO:0042288),-0.25250143781520434,-0.6644162022490774,0.9002493765586035,0.9821047598422749,1.0,2/13,11.59%,TAP2;ATP5F1A
prerank,anion:anion antiporter activity (GO:0015301),0.2912066473210232,0.6598210214305182,0.8595166163141994,0.9643624068440377,1.0,6/17,25.03%,SLC4A2;SLC26A4;SLC25A4;SLC19A1;SLC25A11;SLC4A3
prerank,sulfate transmembrane transporter activity (GO:0015116),-0.2430335755616148,-0.6522943562058867,0.923943661971831,0.9867690742526981,1.0,1/14,1.56%,SLC26A7
prerank,protein phosphatase regulator activity (GO:0019888),0.24118642675326848,0.6505626945725914,0.9265060240963855,0.9711597836175921,1.0,14/53,19.18%,PPP6R3;RCAN1;PPP1R15A;PPP2R2D;LGALS3;LMTK2;PPP1R16A;PTN;SET;PPP1R1B;IGBP1;PPP2R2C;PPP2R5E;RCAN2
prerank,transaminase activity (GO:0008483),0.3035419784676051,0.6502132112661562,0.8689075630252101,0.9693687970210911,1.0,2/11,16.11%,ABAT;BCAT2
prerank,anion transmembrane transporter activity (GO:0008509),0.2986163141307543,0.6432482938239875,0.86709886547812,0.9735491372690229,1.0,1/12,2.52%,SLC4A2
prerank,protein phosphatase activator activity (GO:0072542),0.30168738041646753,0.6424992161608603,0.8730650154798761,0.9721404408723204,1.0,6/13,31.00%,PPP1R15A;PPP2R5E;CALM2;PHACTR4;CALM1;PPP2R5C
prerank,flavin adenine dinucleotide binding (GO:0050660),0.22997769184049782,0.6402679984250735,0.930778739184178,0.9719789389266809,1.0,11/53,17.84%,MICAL2;CYB5R3;NQO2;ACADL;MICAL1;CRY2;ILVBL;SQLE;PPOX;KDM1A;PRODH
prerank,mannosyltransferase activity (GO:0000030),0.2675243870620094,0.6391368118120547,0.8815028901734104,0.9708905047110326,1.0,4/21,13.67%,TMTC1;PIGZ;ALG1;ALG12
prerank,water transmembrane transporter activity (GO:0005372),0.29964852889854227,0.6378430843121548,0.8837209302325582,0.9699217122968136,1.0,2/11,12.80%,AQP1;PDPN
prerank,"hydrolase activity, hydrolyzing O-glycosyl compounds (GO:0004553)",-0.19639710819844247,-0.6378028091878146,0.9588014981273408,0.9924021279642723,1.0,12/29,27.43%,ACER2;GAA;GALC;GBA2;HPSE2;NEU1;CTBS;NEU3;HYAL2;ENGASE;OVGP1;HPSE
prerank,hormone receptor binding (GO:0051427),-0.2438350604173375,-0.6376471405813422,0.9238329238329238,0.9873182141230934,1.0,3/14,13.82%,JAK2;TYK2;PTHLH
prerank,phosphatase inhibitor activity (GO:0019212),0.2677689093276885,0.6295805084797095,0.889367816091954,0.9749832335040105,1.0,5/20,15.10%,LGALS3;LMTK2;PTN;SET;PPP1R1B
prerank,ubiquitin-like protein conjugating enzyme activity (GO:0061650),0.2375116518917911,0.6257796518229928,0.9192708333333334,0.9761011376696839,1.0,10/34,21.79%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2D3;UBE2F;UBE2J1;UBE2Z;UBE2E1
prerank,tumor necrosis factor receptor superfamily binding (GO:0032813),0.2493896948621868,0.6242601256760044,0.9183135704874835,0.9753362467362287,1.0,6/28,21.27%,EDA;FEM1B;PIDD1;TRIM37;TRAF4;TMBIM1
prerank,RNA polymerase binding (GO:0070063),0.2647923430290644,0.622821812595381,0.9012158054711246,0.9744306876783427,1.0,4/18,15.48%,STOM;NEDD4;DHX9;PABPN1
prerank,pentosyltransferase activity (GO:0016763),0.24027387125645716,0.6214618638521161,0.927321668909825,0.9733210428316179,1.0,8/36,18.27%,LARGE1;PARP3;UPP2;UMPS;PARP6;TNKS2;UPP1;PARP2
prerank,metalloaminopeptidase activity (GO:0070006),-0.22627778482477284,-0.6175085638936836,0.9517045454545454,0.9951056468137996,1.0,5/16,23.20%,MMP16;ENPEP;ANPEP;XPNPEP3;TRHDE
prerank,cysteine-type endopeptidase activator activity involved in apoptotic process (GO:0008656),-0.24047803856685956,-0.6171686414475469,0.9271356783919598,0.9901711572893666,1.0,2/12,12.35%,NOD1;RACK1
prerank,NADPH binding (GO:0070402),0.27908681609007013,0.6168014181791396,0.9067524115755627,0.9749079017562726,1.0,2/13,14.29%,HMGCR;DUS2
prerank,S-adenosylmethionine-dependent methyltransferase activity (GO:0008757),0.2340053682738346,0.6162833817259034,0.9538866930171278,0.9731614789432527,1.0,5/40,11.43%,CARNMT1;GAMT;NNMT;DNMT3A;THUMPD3
prerank,methylated histone binding (GO:0035064),-0.16328146959970075,-0.6161941945215427,0.9940476190476191,0.9857334984535563,1.0,12/62,16.53%,KDM7A;CHD8;SUZ12;PYGO1;RBBP5;ING2;MSL3;NCAPG2;MTF2;THAP7;WDR5;ZMYND11
prerank,RNA methyltransferase activity (GO:0008173),-0.21192090704687475,-0.612979069306078,0.9515151515151515,0.9825523195270248,1.0,6/19,24.67%,METTL8;TRMT5;TRMT9B;TYW3;MRM2;BCDIN3D
prerank,cAMP response element binding (GO:0035497),0.29522476207951404,0.6128688114484228,0.8899835796387521,0.9736680979789272,1.0,4/10,18.47%,CREB1;JUN;CREB3L2;ATF2
prerank,1-phosphatidylinositol binding (GO:0005545),0.2719986566844007,0.6126072259174655,0.904833836858006,0.9717766158884997,1.0,6/15,26.42%,WDFY3;ZFYVE1;SESTD1;WDFY1;SNX10;EEA1
prerank,protein kinase A regulatory subunit binding (GO:0034237),0.2602209890327526,0.6125470825938408,0.9051094890510949,0.9697341124448566,1.0,8/21,26.93%,EZR;AKAP5;WASF1;ARFGEF1;AKAP8;PRKACA;AKAP1;WASF3
prerank,cysteine-type endopeptidase inhibitor activity involved in apoptotic process (GO:0043027),0.26653601236125873,0.6104349062029257,0.9151785714285714,0.9692096484668525,1.0,1/18,2.60%,TNFAIP8
prerank,inorganic anion transmembrane transporter activity (GO:0015103),0.24541809386980545,0.6082859548460219,0.9367977528089888,0.9687761356891631,1.0,4/27,13.62%,ANKH;SLC22A8;SLC25A14;SLC26A4
prerank,zinc ion binding (GO:0008270),0.18941455356441592,0.6026467532299642,0.9979757085020243,0.9707095081546613,1.0,60/293,22.05%,NAPEPLD;KLF4;MMP9;ADH7;TIMM10;EPRS1;ADAM33;HDAC4;TIMP1;RNF5;DUSP12;TIMP2;TES;KDM5C;KLF7;NQO2;TAB3;MSRB2;CHORDC1;CXXC4;KMT2A;PITRM1;SHMT1;PHF5A;ZNF205;LACTB2;KDM4C;MYT1;MMP12;CHD3;NPEPPS;CHMP1A;TARS1;LTA4H;SEC23A;MDM2;TET1;SIAH1;TAB2;ZFYVE1;PDXK;USP16;RNF112;APIP;SEC24B;ENPP5;IDE;TIMM9;ZBTB32;LVRN;QPCTL;ACR;ZCCHC4;QPCT;ZNF8;DPF3;RASSF1;RCHY1;ARIH2;PHF2
prerank,DNA-(apurinic or apyrimidinic site) endonuclease activity (GO:0003906),-0.2522798798526561,-0.6000710179965036,0.9005376344086021,0.9846485797785808,1.0,5/11,27.37%,HMGA2;APLF;NEIL3;ALKBH1;NTHL1
prerank,voltage-gated cation channel activity (GO:0022843),0.2000473180884027,0.5913493944769582,0.9873708381171068,0.9758760537731427,1.0,11/97,13.57%,CACNA2D3;CACNA1A;CACNB3;PTK2B;CACNA2D4;TMC2;KCNA4;KCNB1;KCNA5;CACNB2;KCNQ5
prerank,ubiquitin-like protein conjugating enzyme binding (GO:0044390),0.22991402359456306,0.5903061249198781,0.9420689655172414,0.9744803632994983,1.0,15/33,31.13%,RNF5;DCUN1D5;SIAH3;DCUN1D1;SIAH1;PARK7;ARIH2;RNF14;UBE3D;RPS3;RNF19A;UBA2;TOLLIP;PRKN;ARIH1
prerank,MHC protein binding (GO:0042287),0.24515300364428946,0.5870740247481365,0.9308270676691729,0.9745043774636565,1.0,3/20,16.20%,CD81;ABCB9;ATP5F1B
prerank,ubiquitin conjugating enzyme activity (GO:0061631),0.2239664634355497,0.5787543581106941,0.9575596816976127,0.9774941880221323,1.0,9/31,21.79%,UBE2G2;UBE2B;UBE2Q1;UBE2H;UBE2N;UBE2D3;UBE2J1;UBE2Z;UBE2E1
prerank,regulatory RNA binding (GO:0061980),0.2259736513548634,0.5759745602257701,0.9590488771466315,0.9769507053643727,1.0,5/38,15.32%,ZC3H12A;TARBP2;TUT7;RBM10;DHX9
prerank,thioesterase binding (GO:0031996),-0.23828989334715608,-0.5699293278008716,0.9522546419098143,0.9931664169434596,1.0,4/11,21.98%,TRAF6;ARF6;TRAF1;HAUS7
prerank,"oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor (GO:0050664)",-0.21525599667667844,-0.5655042050099669,0.9572649572649573,0.9900473036319051,1.0,4/14,23.65%,NOX4;NCF2;CYBB;AIFM1
prerank,delayed rectifier potassium channel activity (GO:0005251),0.2180141424274572,0.5616806892604231,0.9785407725321889,0.9823830290066152,1.0,4/32,13.57%,KCNA4;KCNB1;KCNA5;KCNQ5
prerank,peptide hormone receptor binding (GO:0051428),-0.22263369319608337,-0.5452069958869868,0.9645569620253165,0.9921049872966566,1.0,11/11,77.76%,PTHLH;CCK;UCN2;GPHB5;GHRH;GPHA2;UCN3;PSMC5;GNRH1;VIP;ADCYAP1
prerank,O-methyltransferase activity (GO:0008171),0.2649245876846892,0.5449716024472437,0.9370748299319728,0.9881561007384996,1.0,4/10,25.59%,MEPCE;COQ3;CMTR2;LRTOMT
prerank,non-membrane spanning protein tyrosine kinase activity (GO:0004715),0.21099747882549016,0.5359635206363633,0.9748677248677249,0.9898446915664384,1.0,7/35,18.34%,PTK2B;CSK;STYK1;TXK;ABL1;PEAK1;YES1
prerank,alpha-tubulin binding (GO:0043014),0.21017372134840823,0.5340937017840697,0.9732620320855615,0.9885209196207415,1.0,15/31,31.19%,EFHC2;WASHC1;ARL8A;HDAC6;TBCE;CDK5R1;TRPV4;ARL8B;FYN;RACGAP1;SNCA;TBCEL;EFHC1;TAOK1;ARL4C
prerank,ubiquitin-specific protease binding (GO:1990381),0.2295992277349495,0.5314005114516175,0.9344262295081968,0.9875741826893003,1.0,3/19,18.47%,LCOR;RHBDD2;PARK7
prerank,P-type ion transporter activity (GO:0015662),-0.2092097299896748,-0.5313939388958009,0.9792207792207792,0.9913226846719743,1.0,1/12,3.59%,ATP2A2
prerank,tumor necrosis factor receptor binding (GO:0005164),-0.21477107765284753,-0.5311205626621297,0.9711815561959655,0.9864818806301056,1.0,3/12,20.74%,TRAF6;BABAM2;TRAF1
prerank,kinesin binding (GO:0019894),0.20951834781637013,0.5266957780559294,0.9782903663500678,0.9872451878289641,1.0,12/27,30.51%,KIF1B;ACTB;TOR1A;CROCC;AP1AR;KLC2;TTBK2;MAPK8IP1;SNCA;MAPK8IP2;AP1G1;SPAG9
prerank,aminopeptidase activity (GO:0004177),0.21075140480447632,0.5255201097871215,0.9801699716713881,0.9856493037611852,1.0,9/26,22.37%,NPEPPS;LTA4H;CTSH;LVRN;MMP14;RNPEPL1;METAP1D;XPNPEP1;BLMH
prerank,histone methyltransferase activity (H3-K4 specific) (GO:0042800),-0.19531309320785112,-0.5214916992593805,0.9780821917808219,0.9841025899425577,1.0,4/15,21.94%,RBBP5;WDR5;PRDM9;WDR82
prerank,miRNA binding (GO:0035198),0.19015837543321448,0.4736867037712669,0.9905405405405405,0.9979942645091207,1.0,3/30,13.20%,ZC3H12A;TUT7;RBM10
prerank,cysteine-type endopeptidase inhibitor activity (GO:0004869),0.18116857419722496,0.4545709291529805,0.9945945945945946,0.9994656355295232,1.0,4/30,19.49%,TNFAIP8;CARD16;XIAP;UBE2Z
prerank,N-methyltransferase activity (GO:0008170),0.17268796149736648,0.40141732153652554,0.9941434846266471,1.0,1.0,7/20,26.23%,NNMT;PRMT1;ZCCHC4;FDXACB1;N6AMT1;TRMT11;METTL5
prerank,carbohydrate:cation symporter activity (GO:0005402),0.16564147627416503,0.3517338507595976,1.0,1.0,1.0,11/11,83.45%,SLC2A9;SLC2A10;SLC5A9;SLC5A2;SLC5A1;SLC5A10;SLC17A5;SLC23A2;SLC23A1;SLC5A11;SLC5A3
prerank,phospholipase binding (GO:0043274),0.16141940890889359,0.34728613206060627,1.0,1.0,1.0,5/13,30.86%,PAFAH1B1;FYN;PDPK1;PRKN;SYK
prerank,"hydrolase activity, hydrolyzing N-glycosyl compounds (GO:0016799)",0.15382222125881279,0.3468588607193155,1.0,0.9995066390546961,1.0,1/16,6.49%,MACROD1
